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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
Walter C. MacKenzie Research Day: Introduction
Dr. Walter C. MacKenzie was pro­
fessor and chairman of the depart­
ment of surgery at the University of 
Alberta from 1950 to 1960, and from 
1959 to 1974 was the dean of med­
icine. As an outstanding clinical 
surgeon and a fine academic admin­
istrator he realized fully the value of 
research in guiding the minds of 
surgeons. He played an active role in 
many research projects and was al­
ways ready to extend a helping hand 
to young researchers.
Dr. MacKenzie was very much 
aware that most researchers in Can­
adian surgical departments, while 
maintaining close ties with colleagues
in the United States, had little contact 
with each other across Canada. He 
therefore suggested that the Univer­
sity of Alberta should host a surgical 
research day to which one member 
from a surgical department of each 
medical school in Canada would be 
invited to give a paper based on 
recent research work. Sadly, the first 
such meeting was held in the summer 
of 1978 only a few months after Dr. 
MacKenzie’s death. The meeting was 
so successful that the faculty of med­
icine and the department of surgery 
at the University of Alberta decided 
to make it an annual event — the 
Walter C. MacKenzie research day.
A year ago, the editors of the
Canadian Journal of Surgery offered 
to publish a short article by each 
surgeon participating in the program 
giving a broad outline of present day 
knowledge and opinions in his or her 
particular field, based on the paper 
presented at the research day. Those 
who gave papers at the 1981 meeting 
have contributed to this issue of the 
journal and their brief articles appear 
one pages 403 to 419.
H.T.G. W il l ia m s , m b , ch  b , f r c s ,
FACS, FRCS[C]
Professor and chairman,
Department of surgery,
University of Alberta,
Edmonton, Alta.
Vascular Surgery: the Unanswered Questions
Arteriosclerosis most commonly in­
volves the femoropopliteal segment of 
the arterial system. Consequently, 
femoropopliteal or more distal bypass 
grafting to the peroneal or tibial ar­
teries is the commonest operative pro­
cedure performed on a vascular sur­
gical service (approximately 40% on 
our service). The first femoropopli­
teal bypass operation was performed 
by Kunlin1 in 1949 and although 
thousands of such operations have 
been done since then, many questions 
pertaining to this procedure remain 
unanswered. What is the ideal site 
for the distal anastomosis in a femo­
ropopliteal bypass? Does it make a 
difference if the anastomosis is above 
the knee or below the knee? Must 
the proximal anastomosis always be 
done to the common femoral artery 
even when the superficial artery ap­
pears relatively normal? What is the 
role of the blind popliteal segment 
and when can a bypass to that seg­
ment be used as an alternative to a 
more distal bypass? What is the best
alternative to the autogenous saphen­
ous vein when it cannot be used? 
What is the role of the in-situ saph­
enous vein graft? When can profundo- 
plasty be used as an alternative to 
femoropopliteal bypass grafting? Does 
diabetes influence patency rates?
The answers to these and other 
vexing questions are not readily ob­
tained from a study of the literature 
since the reported data are often con­
flicting and confusing. In 1980 we 
reviewed 10 reports of femoropopli­
teal bypass procedures in the surgical 
literature between 1976 and 1979 to 
assess the reported results of femoro­
popliteal bypass grafting and to com­
pare them with our own. The reported 
patency rates ranged from 25% to 
68.5%, apparently due to many fac­
tors including variations in the selec­
tion of patients for operation, in the 
methods of reporting results and fol­
low-up, in the duration of follow-up, 
in the incidence of early postopera­
tive graft failure and in the relative 
frequency of use of prosthetic grafts.
A comparison of these 10 different 
series with our own was meaningless 
because data made comparative anal­
ysis extremely difficult.
Wooster and Provan in this issue 
(page 393) report a retrospective re­
view of 181 femoropopliteal or more 
distal bypass grafts placed during a 
3-year period. The article does not 
specifically address the issue of graft 
patency but attempts to answer the 
question of what happens to a limb 
when vascular reconstruction fails. 
There are three basic questions: What 
happens to the limb when graft throm­
bosis occurs after revascularization is 
performed (a) for intermittent claudi­
cation and (b) for limb salvage? (c) 
How often, if at all, does failure of 
revascularization alter the level of am­
putation from below to above the 
knee?
Revascularization for Claudication
In answer to the first question, it 
is important to emphasize that inter-
VOLUME 25, NO. 4, JULY 1982 /  THE CANADIAN JOURNAL OF SURGERY 359
mittent claudication is a symptom of 
a benign disorder with an amputation 
rate that approximates 1% per year 
of follow-up.24 In some patients the 
condition will improve, in many 
others it will remain stable and in 
only a small proportion will the clau­
dication become progressively worse. 
Consequently, when intermittent clau­
dication is the indication for revas­
cularization, the procedure must be 
carried out with minimal morbidity 
and mortality. Graft patency rates 
should be relatively high and exceed 
those in limb salvage situations since 
patients with intermittent claudication 
have the most favourable anatomic 
conditions for bypass grafting. Ideally, 
when graft occlusion does occur, the 
patient should not be made worse by 
the operation. In the series reported 
by Wooster and Provan, the indica­
tion for revascularization was inter­
mittent claudication in 94 of the 181 
patients. In this group, 26 grafts 
failed (27.6%) but only four of the 
graft occlusions resulted in amputa­
tion, all at a below-knee level. The 
status of the remaining 22 patients 
with occluded grafts is not mentioned. 
Wooster and Provan also present a 
compilation of 19 recently reported 
series totalling 2878 bypass grafting 
procedures. When the indication for 
revascularization was intermittent 
claudication, the occlusion rate ranged 
from 17% to 30% with a resultant 
amputation rate of 3% to 44% in 
patients with occluded grafts. Wooster 
and Provan’s amputation rate of 4% 
in this group of patients is in keeping 
with the natural history of the con­
dition. However, one can hardly jus­
tify operation in patients with claudi­
cation if the amputation rate is any 
greater. Therefore, the indications for 
femoropopliteal reconstruction in pa­
tients with intermittent claudication 
should be precise and should include 
the following:
•  The claudication should be se­
vere and progressive with a claudica­
tion distance on level ground of less 
than 100 m.
•  The claudication should mark­
edly interfere with the patient’s ability 
to work.
•  Revascularization should be per­
formed only after medical manage­
ment (cessation of smoking, weight 
loss, exercise program) has failed.
•  There should be no associated 
conditions to increase the operative 
risk.
•  The anatomic situation should 
be favourable and the saphenous vein 
available. It is questionable whether 
bypass to the tibial or peroneal ar­
teries should be performed when the 
indication is limited to claudication.
Revascularization for Limb Salvage
The second issue raised by the au­
thors is the fate of the limb when 
revascularization is performed for 
limb salvage. The term “limb salvage” 
commonly refers to patients who have 
rest pain, ischemic ulceration, pre­
gangrene or frank gangrene. The im­
plication of the term is that amputa­
tion will be mandatory if revascular­
ization is not successful. In this group 
of patients a discrepancy between 
graft patency and salvage rates is to 
be anticipated. Temporary patency of 
the graft may allow healing of an 
ischemic ulcer or minor foot amputa­
tion and when graft occlusion does 
occur the limb may remain viable and 
functional. In Wooster and Provan’s 
series, 42 (48.3%) of the 87 grafts 
placed for limb salvage occluded and 
graft failure resulted in amputation 
in 31 (73.8%) of the 42 patients. Of 
the 31 amputations, 18 were above 
and 13 below the knee. When the 
bypass grafting was performed distal 
to the popliteal artery, 11 of the 18 
grafts thrombosed and this resulted 
in 10 amputations, 6 below and 4 
above the knee. In the 19 compiled 
series, the rate of thrombosis in limb 
salvage situations ranged from 11% 
to 65% with amputation resulting in 
13% to 83% of these cases. The wide 
discrepancy reflects the many vari­
ables involved in treating these pa­
tients. Moreover, it appears that in 
the limb salvage group, graft failure 
does not always mean that amputation 
will follow.
Level of Amputation
The third question the authors at­
tempt to answer is the frequency with 
which a failed revascularization re­
sults in a change in the level of am­
putation from below-knee to above­
knee. Unfortunately, the lack of pre­
cise objective criteria for predeter­
mining the level of amputation makes 
it difficult to determine with certain­
ty if graft failure has resulted in a 
higher level of amputation. It has 
been estimated by Kazmers and asso­
ciates5 that approximately 80% of the 
dysvascular amputations can be per­
formed below the knee if prior re­
vascularization is not performed. 
Burgess and Marsden6 reported suc­
cessful below-knee amputation in 
83% of patients who had no previous 
vascular procedures and in 75% of 
limbs with failed reconstruction — an
insignificant difference. However, in­
cluded in the failed reconstructions 
were those patients in whom only 
lumbar sympathectomy was per­
formed, and by eliminating these pa­
tients, only 67% had successful 
below-knee healing when bypass 
failed. Furthermore, those who had 
previous revascularization had much 
longer and more difficult periods of 
rehabilitation. LoGerfo and asso­
ciates7 have also reported a 67% 
healing rate at the below-knee level 
after a failed femoropopliteal recon­
struction. Dardik and associates8 re­
ported 79 major limb amputations in 
a group of 552 lower extremity re- 
vascularizations utilizing glutaralde- 
hyde-stabilized umbilical vein grafts. 
Final healing occurred at the below- 
knee level in 39 (49%) of the 79 
procedures. Others5,911 have reported 
below-knee healing rates of 19% to 
59% following failed revasculariza­
tion. In their series Szilagyi and asso­
ciates12 postulated that 60% to 70% 
of patients who could have had a 
primary below-knee amputation had 
an above-knee amputation after a 
failed revascularization. In the series 
of Wooster and Provan the below- 
knee amputation rate was 49%.
Conclusions
In spite of the wide variations re­
ported, some general conclusions can 
be drawn. First, graft patency rates 
are highest in patients with intermit­
tent claudication but when the graft 
fails amputation is a real possibility. 
Undoubtedly, in some patients with 
graft failure the claudication will be 
worse. Second, when revasculariza­
tion is performed for “limb salvage”, 
graft occlusion occurs more often and 
graft failure is much more likely to 
lead to amputation. Third, it seems 
reasonable to assume that failed re­
vascularization will raise the level of 
amputation in at least some patients, 
particularly if amputation is per­
formed shortly after graft failure.5 If 
amputation can be delayed until all 
the incisions are healed, then below- 
knee amputation is more likely to be 
successful.
The importance of preserving the 
knee cannot be overemphasized. Ap­
proximately 80% of elderly patients 
will regain independent bipedal gait 
following unilateral below-knee am­
putation. Only half this number will 
be able to walk unaided when the 
knee is sacrificed, and the rehabilita­
tion period is much longer. Although 
successful revascularization does in­
deed salvage many limbs, failure oc-
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curs frequently, particularly in those 
patients with the most advanced de­
grees of ischemia in whom the dis­
ease is extensive and multisegmental. 
Some of these patients will require 
an above-knee amputation if revas­
cularization fails, whereas a below- 
knee amputation may have been suc­
cessful if revascularization had not 
been attempted.
Can one define a group of patients 
in whom graft failure is likely to oc­
cur and in whom a primary below- 
knee amputation would be prefer­
able? Wooster and Provan state that 
they did not find “a subgroup in 
which vascular reconstruction was fu­
tile”. However, O’Mara and asso­
ciates13 have demonstrated by intra­
operative arteriography that revascu­
larization to the tibial or peroneal ar­
teries is likely to be successful when 
there is a patent primary or secondary 
pedal arch and is likely to fail when 
po patent arch is visible. Unfortunate­
ly, preoperative angiography does not 
usually demonstrate the pedal arches 
though improved angiographic tech­
niques may do so in the future. How­
ever, one can initially expose the tibial 
or peroneal artery that is the proposed 
site of distal anastomosis and obtain 
an intraoperative arteriogram before 
performing an extensive bypass. If the 
pedal arches are not visible, then the 
revascularization procedure can be 
abandoned and a primary below-knee 
amputation performed.
Space does not permit discussion of 
another question raised by Wooster 
and Provan — the role of revision 
when graft failure occurs — or of the 
two current alternatives to the saph­
enous vein, polytetrafluoroethylene 
(PTFE) and glutaraldehyde-stabilized 
human umbilical vein. Although ex­
cellent results have been reported by 
Gupta and Veith14 with the former 
and by Dardik and associates15 with 
the latter, these results have not been 
uniform. Another technique currently 
available is the in-situ saphenous vein 
graft repopularized by Leather and 
associates.16
Summary
In summary, definitive answers to 
the many questions regarding femoro- 
popliteal and femorodistal bypass 
grafting are hot available. The results 
vary widely for many reasons. Al­
though many aspects of vascular sur­
gery do not lend themselves to scien­
tific investigation by randomized, con­
trolled, prospective studies, some of 
these questions can be answered by 
such studies. Since large numbers of 
patients may be required for pro­
longed follow-up, multicentre coop­
erative studies can provide meaningful 
data. There is also a need for stand­
ardization of follow-up techniques. 
The classification of vascular disease 
by symptoms and presentation such 
as claudication, rest pain, ischemic ul­
cers, pregangrene and gangrene is in­
adequate and highly subjective. A 
more objective classification is essen­
tial, perhaps using the current tech­
niques of the vascular laboratory or 
newer techniques that are sure to be 
developed. The national and regional 
vascular societies must be the leaders 
in these efforts. A start has already 
been made and it is hoped that pro­
gress will be rapid.
N a t h a n  M. S h e i n e r , m d , c m , f r c s [c ]
Department of surgery,
Sir Mortimer B. Davis-Jewish
General Hospital,
Montreal, PQ
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Blood Substitutes — a Misnomer, 
Nevertheless a Promise
Blut ist ein ganz besonderer Saft.
[Blood is a very special substance.] 
J.W. G o e t h e , 1808
The use of blood and blood products 
has become an increasingly important 
adjunct to the surgical and medical 
management of patients. Over the 
past 10 to 15 years, the introduction 
of plastic containers and advances in 
the technology of separation and 
storage has enabled whole blood to
be separated into its many constitu­
ents. One unit of blood can be sep­
arated into erythrocytes, platelets, cry- 
oprecipitate and plasma. The plasma, 
in turn, can be fractionated into al­
bumin, specific clotting factor con­
centrates and various immunoglobulin 
preparations. Approximately 20 dif­
ferent blood products are now avail­
able so that the physician can fill an 
individual patient’s specific need.1
Blood component therapy is now a 
standard modality of treatment that 
has saved the lives of many patients 
and helped others to a normal life­
style. Like many other effective ther­
apies, it has been associated with some 
morbidity. Therefore, investigators 
have for years been attempting to 
develop synthetic substances that 
could perform certain functions of 
blood, be more readily available and
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associated with less morbidity than 
blood products. To date, blood sub­
stitutes are capable of performing 
only two of the many functions pres­
ently served by whole blood: the on­
cotic or plasma-expanding property of 
albumin and the oxygen-carrying 
property of the hemoglobin in ery­
throcytes. The oncotic role of albumin 
can be replaced by a number of syn­
thetic substances including dextran, 
hydroxyethyl starch, polyvinylpyrro­
lidone and various gelatins. Unlike al­
bumin, these substitutes cannot carry 
hormones and metabolites. Further­
more, albumin is sterilized during its 
preparation and is noninfectious. 
Thus, it remains the most widely used 
plasma expander in clinical medicine.
The development of a replacement 
for erythrocytes has proven much 
more difficult, but progress is being 
made. In this issue (page 422) Bolin 
summarizes the recent developments 
in the field of oxygen-carrying agents 
which can be used in place of human 
erythrocytes. Although these sub­
stances have oxygen-carrying ability, 
preliminary human and animal studies 
show that both hemoglobin solutions 
and perfluorochemicals will not re­
place the need for erythrocytes be­
cause their capacity to transport oxy­
gen is limited and they remain in the 
intravascular compartment for only a 
short time. Even if these two obstacles 
are overcome, plasma-expanding and 
oxygen-carrying substances can re­
place only two of the many complex
functions of blood. The oxygen car­
riers outlined by Bolin have no clot­
ting ability, none of the functions of 
platelets, no antibody activity and no 
phagocytic function. Thus, the appel­
lation “blood substitute” is a misnom­
er that may be misleading.
Of great promise is the potential 
use of oxygen-carrying blood substi­
tutes for treating patients with is­
chemic vascular disease. In experi­
mental animals, two recent reports 
indicate that perfluorochemicals can 
reduce the extent of experimentally 
induced myocardial and cerebral in­
farction.2*3 These substances presum­
ably work because their particle size 
is much smaller than that of erythro­
cytes and they are therefore capable 
of delivering oxygen to an ischemic 
area where red cells cannot normally 
penetrate. Clinical trials in man are 
clearly indicated.
The fundamentalist sect known as 
Jehovah’s Witnesses interprets very 
strictly the biblical passages admon­
ishing against the eating of blood. 
They consider the therapeutic use of 
blood and blood products as morally 
equivalent to eating blood and there­
fore refuse blood and blood products 
in even the most life-threatening situa­
tions. The press, over the past 2 years, 
has extensively reported the use of 
synthetic oxygen carriers for desper­
ately ill Jehovah’s Witnesses. Ade­
quate clinical evaluation of these 
agents has, however, not yet been 
done and the long-term side-effects
are not fully appreciated. Still, it is 
likely that such oxygen carriers can 
save lives in emergency situations.
Oxygen carriers thus hold great 
promise in both acute thrombotic epi­
sodes and emergency situations re­
quiring the rapid replacement of lost 
oxygen-carrying ability. The next gen­
eration of oxygen carriers will likely 
be more effective than current prod­
ucts. But, it is unlikely that these 
substitutes will eliminate the need for 
blood donors. Human blood donations 
will be as necessary as ever to provide 
for the many functions of that very 
special substance — blood.
I thank Dr. J. Kelton for his helpful 
comments in the preparation of this 
manuscript.
M o r r is  A. B l a j c h m a n , m d , f r c p [c] 
Professor,
Departments, of pathology and medicine, 
McMaster University;
Medical director,
Hamilton Centre,
Canadian Red Cross Blood 
Transfusion Service,
Hamilton, Ont.
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Knee Ligaments Revisited
In this issue (page 454) Frank and 
associates are to be commended for 
their careful and realistic review of 
midsubstance tears of the anterior 
cruciate ligament. Repair of this in­
jury is statistically worse than exci­
sion, at least in some aspects. This is 
not to say that excision is a good 
thing; theoretically, the result should 
not be good after primary repair or 
for that matter after replacement or 
augmentation. Frank and colleagues 
report that 80 years ago Battle,1 Rob­
son2 and Pringle3 were satisfied with 
their results of primary repair. One 
wonders what their criteria were and 
how long the follow-up was.
A ligamentous or tendinous struc­
ture of more or less uniform construc­
tion inserted through drill holes at
each end cannot successfully replace 
any knee ligament. This is not because 
the material lacks strength (the repair 
can be “beefed up”) or because the 
bony insertion tears out (this can be 
prevented) but because of the under­
lying mechanics. Unfortunately (in the 
case of the damaged knee) or for­
tunately (in the case of the normal 
knee) the ligaments do not have a 
single point of origin, they are not 
uniform throughout their substance 
in length, width or direction and the 
joint surfaces consist of two unequal, 
curved, nonspherical forms both in the 
femoral and tibial portions. Engineers 
will tell us that this describes a cam. 
The knee is a complicated cam. It 
cannot be made stable by a ligament 
or ligament substitute that is essen­
tially a uniform structure. Either the 
new ligament must be constructed and 
attached in exactly the same way as 
normal ligaments are or there must be 
some adjustability allowing different 
parts of the ligament to be tight (i.e., 
to give stability) at different positions 
of the knee while weight bearing. In 
the absence of such a mechanism, 
stability is present only if the range 
of motion of the knee is limited to 
the point at which the ligament has 
reached its maximum tightness. If 
knee motion is pushed beyond this, 
either no further motion is obtained 
or if more is obtained it must be at 
the expense of stretching (really tear­
ing) of the ligament or crushing of 
the articular surfaces; the first results 
in a ligament repair that is loose in
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at least part of its range and the sec­
ond in degenerative changes. But de­
generative changes are inevitable be­
cause of (a) the repeated crushing of 
the joint surfaces with a tight liga­
ment, (b) the crushed surfaces of the 
joint that has been forced to move 
and (c) wear and tear in an unstable 
joint in the case of the loose unre­
paired or repaired ligament. Ligament 
substitutions that use a tendon with 
an active, strong muscle still attached 
offer a possibility of a stable knee. 
Altering the direction of muscle pull 
in order to make it more effective in 
controlling stability also should help. 
On the other hand, we must remem­
ber that when a tendon goes through 
a tunnel in bone it will adhere to the 
bone and the muscle activity will be 
lost. Some of these methods of repair 
are now being questioned.4
Where, then, do we go? The old 
notion of intensive exercise and build­
up, especially of the quadriceps and 
tensor fascia muscles, is a good one. 
This does give increased stability, but 
it may not be enough. Instability often 
is most felt during walking on un­
even ground, going down steps or in 
twisting motion of the knee. Of 
course, these should be avoided. But 
you can’t only go up stairs or always 
walk in a straight line. Some of the 
complicated and cumbersome braces 
help. Perhaps a synthetic ligament 
can be constructed in the exact form 
of the original, of very strong mate­
rial, attached to bone at the correct 
locations. Or failing that, a material 
might be developed that has all the 
desirable properties and in addition, 
elasticity, which allows the ligament 
to be tight in all positions of the joint. 
The ligamentous materials that are 
now available, be they human or syn­
thetic, do not have these properties.
Experienced surgeons who have 
done various repairs of torn ligaments 
report functionally successful results. 
Yet when some of these ligaments are 
examined they are quite unstable. 
Why are they working? As Frank and 
associates have noted, all should de­
generate in time.
J.L. SHUGAR, MD, FRCSfC]
Senior associate editor
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SESAP III Question
337. The most common cause of late occlusion (beyond three years) 
of autogenous vein grafts in the lower limb is
(A) intimal thickening
(B) persistent obstructive valve
(C) aneurysmal dilatation
(D) atherosclerosis in the graft
(E) narrowing secondary to technical fault
For the incomplete statement above select the one answer that is best 
of the five given. For the critique of Item 337 see page 419 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education 
and Self-assessment Program No. 3. For enrolment in the Surgical 
Education and Self-Assessment Program No. 3, please apply to the 
American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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CORRESPONDENCE
Management of Malignant 
Pseudomyxoma: Can Anyone 
Help?
To the editors.— Can readers of the 
Journal help me in the management 
of a case of malignant pseudomyxoma 
peritonei? I have not been able to 
find a case similar to that of a man 
under my care and I am hoping that 
I might benefit from the experience 
of others.
My patient, a 48-year-old Caucasian 
man, knew for several years that he had 
a right inguinal hernia. The hernia began 
to bother him when lifting and straining 
so he sought medical help. There was an 
unusual feeling of thickness of the hernia. 
It remained reducible, so it was repaired 
on an outpatient basis. At operation, the 
hernial sac was thickened and contained 
gelatinous material. Quick sections indi­
cated that this was pseudomyxoma peri­
tonei and was most likely benign. A 
nodular mass could be felt within the 
pelvis. The patient was admitted to hos­
pital, his colon prepared and a laparo­
tomy performed 3 days later. At opera­
tion, the pseudomyxoma was found to 
arise in the distal appendix, which was 
adherent to the lower sigmoid loop. There 
was a fistulous tract through the appendix 
from cecum to sigmoid colon. There were 
extensive implants going through the 
peritoneum in the floor of the pelvis. 
There was one 2-cm implant along the 
right colic gutter, just at the hepatic 
flexure and another at the hilum of the 
liver. En bloc dissection was performed, 
removing the right colon, the sigmoid 
colon to well below the peritoneal re­
flection, along with retroperitoneal dissec­
tion, removing all the peritoneal implants 
in the pelvis and staying well away from 
the margins of the implant. There were 
implants within the omentum so a radical 
omentectomy was also performed. The 
secondary line just proximal to the bi­
furcation of the bile ducts was locally 
excised, again taking as much normal 
tissue around it as possible.
The patient did well after operation 
and returned to work. But, having re­
moved all of the visible tumour that 
I was able to, what can I do in terms
Contributions to the Correspondence sec­
tion are welcomed. They should be type­
written and double spaced.
of further management? Most reports 
of malignant pseudomyxoma have 
been in elderly men presenting with 
the “jelly belly” who have died of the 
disease or of other causes shortly after 
diagnosis. There seems to be no con­
sensus as to benefits of adjuvant 
therapy, or indeed as to how one 
should best follow-up these patients 
with a view to early reoperation for 
signs of recurrent disease.
If anyone has had a case of malig­
nant pseudomyxoma in a young man 
and has found himself in similar 
circumstances, I would greatly appre­
ciate the benefit of his experience.
Adrian A. M inor , b sc, m d , frcs[c]
The Peterborough Clinic,
327 Charlotte St.,
Peterborough, Ont.
Wound Volume: Measurement 
and Radiology of Casts
To the editors.—While the rate of 
healing in surface wounds is measured 
and plotted in two dimensions, wound 
volume can be measured accurately
FIG. I—Decrease in wound volume.
FIG. 2—Posteroanterior and lateral 
views of radiopaque wound cast.
by making a cast of the wound. By in­
corporating a radiopaque material 
into the cast, the ramifications of the 
wound can also be shown radiologi- 
cally. We used radiopaque casts to 
assess the ramifications, the volume 
and the rate of healing of extensive 
abdominal wounds, as described be­
low.
A 32-year-old man, involved in a 
traffic accident, sustained multiple ske­
letal injuries and a lacerated left kidney 
with a retroperitoneal hematoma. Left 
nephrectomy was carried out because of 
continued hematuria. The retroperitoneal 
hematoma became infected and we were 
asked to deal with the ensuing abscess. 
The loculated abscess cavity was incised 
and drained and the wound packed open. 
We made biweekly casts of the wound 
to review the extensions and the volume 
of the cavity. The volume was plotted 
and the early rapid healing is noteworthy 
(Fig. 1).
To make the cast, we first removed the 
wound packing, then mixed type II, heavy 
body, alginate (Jeltrate; Dentsply Inter­
national Inc., Milford, Del.) with an 
equal volume of water. This mixture was 
poured into the wound until it was flush 
with the wound edge. The material set in 
1 to 2 minutes. The rubbery cast was 
then easily removed and suspended in a 
measuring beaker for volume displace­
ment. Sinograms failed to delineate the 
cavity because of the size of the wound. 
We therefore mixed equal parts of bari­
um and Jeltrate to make the cast radio­
paque (Fig. 2).
Alginate is a nontoxic seaweed ma­
terial used in making dental impres­
sions. This technique for making a 
cast of a wound may be valuable in 
prospective studies to determine the 
influence of various factors on the 
rate of wound healing. By making the 
cast radiopaque, extensions of the 
wound can be shown, allowing for 
daily packing. We have been unable 
to find any reference to this technique 
in the literature.
F rancis Sutherland 
Peter  Cruse, m d , fr c s(ed in ),
frcs[c]
Department of surgery,
University of Calgary,
Foothills Hospital,
Calgary, Alta.
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Arterial Embolectomy in the Modern Era
Nathan M. Shein er , md , frcs[c], J ack Z eltzer , md and E lizabeth  M acintosh , rn
The introduction of the Fogarty 
catheter heralded a new era in the 
management of patients with arterial 
embolism. In the 15 years from 1966 
to 1980, the authors managed, 
operatively, 148 separate episodes of 
arterial embolization in 134 patients. 
Excluded from the series were 
patients who had visceral emboli and 
those who were managed nonoper- 
atively. The emboli occurred in the 
upper extremities in 22 patients who 
had 24 embolic episodes and in the 
lower extremities in 112 patients 
who had 124 separate embolic 
episodes. The source of the embolus 
was the heart in 106 patients and 
in the remaining 28 patients a 
proximal aneurysm or atherosclerotic 
artery, a prosthetic graft or an 
unknown source. Most operative 
procedures were performed under 
local anesthesia using a transverse 
arteriotomy. The limb was saved in 
all 24 episodes of upper extremity 
embolism and in 115 (87%) of 132 
lower limbs at risk (seven patients 
had emboli in both lower extremities 
simultaneously and one had emboli 
in an upper extremity and lower 
extremity simultaneously). The mortality 
for the 148 embolectomies was 20% 
and included all deaths occurring 
within 30 days after operation or
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during the same hospital admission. 
An analysis of our results indicates 
that embolectomy may not be 
successful when the delay between the 
occurrence of the embolus and its 
removal is excessively prolonged 
(more than 48 hours), when the 
patient is elderly and when the 
source of the embolus is unknown.
L'apparition du catheter de Fogarty 
annonpait une ere nouvelle dans le 
traitement des patients souffrant 
d’emboiie arterielle. En 15 ans, de 
1966 a 1980, les auteurs ont traite  
chirurgicalement 148 embolies 
arterielles survenant chez 134 patients. 
Ont ete exclus de cette serie, les 
patients qui avaient une embolie 
viscerale ou ceux qui ont ete traites 
de fagon non chirurgicale. Des 
embolies des extremites superieures 
sont survenues chez 22 patients qui 
ont presente 24 incidents emboliques 
et 112 patients ont subi 124 embolies 
des extremites inferieures. Chez 
106 patients I'embolie etait d’origine 
cardiaque alors que chez les 28 
autres, elle etait reliee a un anevrysme 
ou a une artere atheromateuse 
proximale, a une greffe prosthetique 
ou a une cause inconnue. La plupart 
des interventions chirurgicales ont ete 
pratiquees sous anesthesie locale en 
procedant par arteriotomie transverse. 
Le membre put etre conserve dans 
chacun des 24 incidents emboliques 
des extremites superieures et il en 
fut de meme pour 115 (87%) des 132 
membres inferieurs menaces (sept 
patients presentaient simultanement 
des embolies des deux membres 
inferieurs et un avait des embolies 
d'un membre superieur et d’un 
membre inferieur simultanement).
Pour I'ensemble des 148 embolec­
tomies, la mortalite incluant tous les
d6ces survenus dans les 30 jours 
qui ont suivi I’operation ou durant 
la meme hospitalisation, a ete de 
20%. L’analyse des resultats indique 
que I’embolectomie peut etre 
infructueuse quand le delai ecoule 
entre l’apparition de I'embolie e t son 
ablation est excessivement prolonge 
(plus de 48 heures), quand le patient 
est age et quand I’origine de I'embolie 
est inconnue.
With the development of the Fogarty 
embolectomy catheter in the early 
1960s1 the prognosis of peripheral 
arterial emboli improved. Before then, 
the prognosis for limb salvage in this 
group of patients was closely related 
to the time interval between lodge­
ment of the embolus and its surgical 
removal.2-4 Use of the Fogarty cathe­
ter made removal of the embolus 
and its propagated thrombus a 
relatively simple procedure. In spite 
of this ingenious device not all 
extremities are salvaged and death 
from arterial embolism is still 
common.5-7 We have termed the era 
following the introduction of the 
Fogarty catheter “the modern era” 
and have retrospectively analysed 
our surgical experience during the 15 
years from 1966 to 1980. In this 
period we operated on 134 patients 
who have had 148 separate embolic 
episodes; 8 patients had multiple 
simultaneous emboli. Excluded from 
our study are those who had visceral 
or carotid artery emboli and those in 
whom no attempt was made to re­
move the embolus. The latter group 
included patients who were moribund 
on admission, whose limbs were ob­
viously not salvageable and those whose limbs were not severely 
ischemic.
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Patients
There were 74 men and 60 women. 
The mean age for the entire group 
was 69.0 years, for men 71.3 years 
(range from 34 to 93 years) and for 
women 67.3 years (range from 33 to 
92 years). Most patients were in the 
seventh, eighth or ninth decades.
Location of the Embolus
Embolism occurred in the upper 
extremity in 22 patients. Two patients 
in this group had recurrence in the 
upper extremity giving a total of 24 
separate embolic episodes. The re­
maining 112 patients had 124 separate 
embolic episodes in the lower ex­
tremity, with 12 patients having two 
embolic episodes. Seven patients had 
emboli in both lower extremities 
simultaneously and a single patient 
with an upper extremity embolus had 
a simultaneous embolus in the lower 
extremity (Table I).
Of the 24 episodes of upper ex­
tremity emboli, the embolus lodged 
in the subclavian or axillary arteries 
in 7 and in the brachial artery above 
its bifurcation in 15; in two instances 
the embolus involved the bifurcation 
of the brachial artery with extension 
into the radial and ulnar arteries. In 
the lower extremities there were mul­
tiple emboli at various sites in some 
patients, for example, superficial and 
deep femoral arteries or popliteal and 
tibial arteries. Consequently the total 
number of lodgement sites exceeds 
the number of embolic episodes. How­
ever, if only the most proximal lodge­
ment site is considered for each 
patient, then in only five instances did 
the embolus lodge in the aorta. The 
common femoral artery was the com­
monest location followed in order by 
the popliteal, superficial femoral and 
iliac arteries (Table II).
Source of the Embolus
The heart was considered to be 
the source of the embolus in 106 
(79.1%) of the 134 patients. Of the
other 28 patients, the embolus origi­
nated from a prosthetic graft in 6 
(4.5%) — in 5 patients an axillo- 
femoral graft and in 1 an aortofemoral 
graft. Embolization in the upper ex­
tremity following occlusion of an 
axillofemoral graft accounted for the 
relatively high incidence of upper 
extremity embolization in our series. 
In three patients (2.2%) emboliza­
tion was presumed to arise from a 
proximal aneurysm and in two of 
these patients the aneurysm was quite 
small. In four other patients (3.0%) 
the embolus originated from a proxi­
mal atheromatous artery and in two 
of them embolization occurred fol­
lowing arteriography. In 15 instances 
(11.2%) the source of the embolus 
could not be determined and in 
several the distinction between em­
bolization and acute in-situ thrombosis 
could not be precisely established.
Arteriosclerotic heart disease with 
either atrial fibrillation (77 patients) 
or recent myocardial infarction (14 
patients) was the commonest type of 
heart disease associated with em­
bolism. Rheumatic heart disease has 
been a diminishing problem as a 
source of emboli in our experience 
and our series contains only nine pa­
tients with rheumatic heart disease all 
of whom were in atrial fibrillation. 
Cardiomyopathy occurred in three 
patients and three patients had atrial 
fibrillation from causes other than 
arteriosclerotic or rheumatic heart 
disease.
Preoperative Preparation and 
Operative Approach
Patients with arterial emboli are 
prepared for surgery as rapidly as 
possible. Arteriograms are obtained 
only in patients with a palpable 
femoral pulse and only when arte­
riography can be performed without 
delay. If delay is anticipated, heparin 
(5000 to 6000 units) is administered.
Almost all patients were operated 
on under local anesthesia, although 
a few patients had either epidural
or general anesthesia. An epidural 
or general anesthetic is selected when 
multiple incisions are anticipated or 
a bypass procedure is contemplated, 
and then only when the patient is con­
sidered a good operative risk. Up­
per extremity emboli are extracted 
through a brachial arteriotomy made 
in the mid- or lower segment of the 
arm. A second, more distal, arterio­
tomy is used only when the proximal 
approach appears to be unsuccessful. 
The primary operative approach for 
all aortic, iliac and femoral emboli 
is by way of the groin using a bilateral 
approach for aortic emboli. For 
popliteal emboli the initial approach 
is through the groin and more distal 
incisions are used only if the proxi­
mal approach appears unsuccessful. 
The arteriotomy is generally trans­
verse. Angiography is performed in- 
traoperatively only when there is 
doubt about the success of the pro­
cedure. Postoperatively, the patients 
are monitored in the recovery room 
and if there is any question about 
the success of the procedure or if a 
successful embolectomy is followed 
by reocclusion of the artery, re-ex­
ploration is carried out. Angiography 
is generally performed during the re­
exploration. Heparin is always admin­
istered during the operative proce­
dure but is not continued postopera­
tively. Oral anticoagulant therapy is 
started immediately after embolec­
tomy and continued on a long-term 
basis.
In four patients in this series an­
other operative procedure was per­
formed in addition to the embolec­
tomy — femorofemoral bypass in 
one, a femoropopliteal bypass in one 
and femorotibial bypass grafting in 
two. Three of these procedures were 
successful. Lower extremity fascio- 
tomy was performed in five patients.
T a b le  I I — L o c a tio n  o f E m bo lus  
in  A r te r ia l  S ys te m *
L o c a tio n N o . T o ta l
U p p e r  e x tr e m ity  
S u b c la v ia n  o r  a x il la r y
24
a r te r y 7
B ra c h ia l a r te ry 15
B ra c h ia l b ifu rc a tio n 2
L o w e r e x tre m ity 132
A o rta 5
l l ia c a r t e r y 25
C om m on fe m o ra l a r te ry 49
S u p e rf ic ia l fe m o ra l a r te ry 18
P o p lite a l a r te ry 35
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Results
In assessing results, patients were 
divided into two groups, those whose 
limbs were salvaged (128 limbs) and 
those whose limbs were not (20 limbs). 
If a limb was functional without rest 
pain and did not require a further 
reconstructive procedure it was con­
sidered to be salvaged.
Limb salvage was achieved in all 
24 instances of upper extremity em­
bolization. In 22 instances, one or 
both pulses at the wrist were restored. 
In the lower extremity, 20 of the 124 
embolic episodes were originally not 
managed successfully by embolec- 
tomy. However, in three patients of 
this group, an additional bypass pro­
cedure gave a functional limb. Since 
there were seven patients in the group 
with lower extremity emboli who had 
simultaneous emboli in both lower 
extremities and one patient in the 
upper extremity group who had a 
simultaneous lower extremity em­
bolus there were 132 lower limbs at 
risk. The ultimate salvage rate was 
87% (115 of the 132 limbs).
The 20 instances of embolectomy 
failure occurred in 14 men and 6 
women, a group with an average age 
of 77.3 years. Comparison of the pre­
operative delay in the successful and 
unsuccessful groups demonstrated that 
over 50% of the successful embolec- 
tomies were carried out within 12 
hours of embolization, whereas only 
15% in the unsuccessful group were 
performed in this interval and more 
patients in the failed group had de­
lays of longer than 48 hours. The 
source of the embolus in the failed 
group compared with the successful 
group differed only in that a crypto­
genic source was much more com­
mon on a percentage basis in those 
who had unsuccessful procedures. 
Of the 20 patients who had unsuc­
cessful embolectomy, 12 (60%) died. 
Of the eight survivors, three had 
an additional bypass procedure that
Table III— Comparison of Success and 
Failure of Embolectomy with Respect to 
Timing of Operation
Preoperative Failure, Success,
delay, h no. (%) no. (%)
0-  6 1 (5) 34 (26.6)
6-12 2 (10) 36 (28.1)
12-24 4 (20) 27 (21.1)
24-48 6 (30) 12 (9.4)
>48 7 (35) 19 (14.8)
20 (100) 128 (100)
resulted in limb salvage and five had 
amputation (Table III).
Mortality
Thirty patients (16 men, 14 women) 
died, for a patient-related mortality 
of 22.4%. However, if the 148 sepa­
rate embolic episodes are considered 
then the episode-related mortality was 
20%. The mean age of those who 
died was 77.7 years. In 18 of them 
the limb was salvaged. The 30 deaths 
included all those occurring within 30 
days of operation or during the same 
hospitalization. Since many patients 
were elderly with a multitude of 
problems, discharge was difficult; 9 
of the 30 patients died more than 
30 days after operation.
Discussion
The results obtained in our retro­
spective study of 148 embolic epi­
sodes compare favourably with re­
spect to limb salvage and mortality 
with the results of other recently re­
ported studies.8,9 Between 85% and 
95% of lower limbs can be saved 
with a mortality ranging from 20% 
to 30%. This relatively high rate re­
flects pre-existing disease in this group 
of patients. Rheumatic heart disease 
as a source of embolism is decreasing. 
The most common source of em­
bolism is the heart of elderly patients 
with arteriosclerotic coronary artery 
disease who are in fixed or paroxys­
mal atrial fibrillation or who have 
sustained a myocardial infarction 
with the formation of a mural throm­
bus. Because they often have diffuse 
cardiovascular disease, the operative 
mortality is high even after success­
ful embolectomy under local anes­
thesia. However, in our experience, a 
failed embolectomy markedly in­
creased the mortality, from 20% to 
60%.
Another feature that was apparent 
from our study was that cryptogenic 
sources of emboli are not uncommon, 
a finding also noted recently by Elliot 
and associates.9 Although it is gen­
erally assumed that the cryptogenic 
focus is within the heart, this assump­
tion is not necessarily correct and a 
diligent search should be made to ex­
clude other foci, in particular proxi­
mal aneurysms or arteriosclerotic ves­
sels. Furthermore, in at least some 
patients in the cryptogenic group the 
cause of the arterial occlusion may be 
a thrombus rather than an embolus. 
The relatively high incidence of up­
per extremity embolism in our ex­
perience reflects the large number of
axillofemoral grafts that we have 
placed. Since this study was com­
pleted we have encountered three 
more patients who had an upper ex­
tremity embolus at the time of the 
acute occlusion of an axillofemoral 
graft, making a total of eight such 
episodes.
An analysis of our failures reveals 
certain common features. The pa­
tients were older, had a higher inci­
dence of cryptogenic foci and the 
delay before operation was longer. 
Moreover, it is possible that several 
patients who had no discernible source 
of the embolus had a thrombus and 
required more than simple clot ex­
traction to save the limb.
Summary
Embolectomy using the Fogarty 
catheter was successful in all our cases 
of upper extremity emboli but in the 
lower extremities the limb salvage 
rate was 87%. The operative mor­
tality was 20% for the entire group 
but was 60% in those patients in 
whom embolectomy was not success­
ful. Rheumatic heart disease has de­
creased in importance as a source of 
embolism and cryptogenic foci occur 
with appreciable frequency. Patients 
in whom successful embolectomy 
could not be achieved were older, had 
a higher incidence of cryptogenic foci 
and a longer delay before operation.
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Elase Ointment&Solutiori
Simple, low-cost therapy 
for decubitus ulcers:
“Decubitus ulcers present a great problem in prolonged bed 
occupancy and expensive and protracted nursing care"'*'
•  Helps speed healing through enzymatic debridement1131
•  Has a highly selective lytic function1231
•  Total elimination of odour and necrotic tissue11
•  As high as 95.9% show improvement or healing11
References: 1. Lee, M. et al: The decubitus ulcer patient: Statement of the problem. Contemporary Surgery/Vol. 14, 3/79. 2. Landi. G.: Local enzymatic 
treatment in dermatology: First results with fibrinolysin and desoxyribonuclease. Clin. Ter. 25: 47-57. 1963. 3. Coon. W.W.. et al: Enzymatic debridement with 
bovine fibrinolysin. Am. J. Surg. 98: 4-8, 1959. 4. Vasile, J., Chaitin, H.: Prognostic factors in decubitus ulcers of the aged. Geriatrics 27: 126-129. 1972.
THERAPEUTIC CLASSIFICATION
Fibrinolysin— Desoxyribonuclease Enzymatic Debriding Agent. 
INDICATIONS
Elase is indicated for topical use as a debriding agent in a variety of 
inflammatory and infected lesions. These include: f l ) general surgical 
wounds: (2) ulcerative les ions-troph ic  decubitus, stasis, arteriosclero­
tic; (3) second-and third-degree burns; (4) circumcision and episiotomy 
Elase is used intravaginally in: (1) cervicitis-benign, postpartum, and 
postconization and (2) vaginitis. Elase is used as an irrigating agent in 
the following conditions: (1) infected wounds-abscesses, fistulae, and 
sinus tracts; (2) otorhinolaryngologic wounds; (3) superficial hematomas 
(except when the hematoma is adjacent to or within adipose tissue).
If in the judgement of the physician both a debriding agent and a topical 
antibiotic are indicated, Elase-Chloromycetin* Ointment provides both 
types of therapeutic action. Establishment in the laboratory of bacterial 
sensitivities will guide the physician in selecting the proper antibiotic 
Elase-Chloromycetin may be useful in the topical treatment of infected 
burns, ulcers, wounds, cervicitis and vaginitis when the organisms are 
susceptible to chloramphenicol and utilize a process of fibrin deposition 
as a protection device.
PRECAUTIONS
The usual precautions against allergic reactions should be observed, 
particularly in persons sensitive to materials of bovine origin, anti­
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Celiac Compression Syndrome
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The authors present their experience 
at the Hopital St-Luc in Montreal 
with seven patients who had celiac 
compression syndrome. All underwent 
section of the median arcuate 
ligament to free the celiac axis and 
resection of the connecting nerve 
fibres of the solar plexus (peri­
arterial neurectomy). At a mean 
follow-up of 36 months all patients 
were asymptomatic. In some cases, 
extrinsic compression of the celiac 
axis by the arcuate ligament can 
explain upper abdominal pain. An 
epigastric bruit in the presence of a 
normal digestive tract is an indication 
for lateral aortography to detect 
extrinsic compression. The pain in 
this syndrome cannot be explained 
solely on hemodynamic grounds; 
surgical treatment should include 
release of the celiac axis and complete 
periarterial neurectomy.
La compression extrinseque du tronc 
coeliaque par le ligament arque 
median du diaphragme est une cause 
rare de douleur abdominale chronique. 
Sept patients atteints de cette 
condition ont ete traites a I'Hopital 
Saint-Luc de Montreal. La section 
du ligament arque ainsi qu'une 
neurectomie periarterielle genereuse
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ont ete effectuees chez tous les 
patients, avec des resultats tres 
satisfaisants.
Les auteurs sont convaincus que 
des cas bien selectionnes de douleur 
abdominale chronique, ou (’investiga­
tion bilio-digestive est negative, 
une aortographie avec incidences de 
profil doit etre effectuee pour 
eliminer une compression du tronc 
coeliaque. Dans ces cas, la douleur 
ne peut etre expliquee uniquement 
par des phenomenes hemodynamiques 
et le traitement chirurgical de cette 
condition doit, en plus de la liberation 
du tronc coeliaque, comporter une 
neurectomie periarterielle complete.
The origin of chronic abdominal pain 
is often undetermined. The role of 
the vascular system in the genesis of 
such pain may be ignored or ne­
glected.1 Arteriosclerotic stenosis of 
the mesenteric arteries and of the 
celiac axis are the most frequently en­
countered lesions;2-5 however, a most 
unusual and controversial vascular 
entity is the celiac compression syn­
drome (Fig. 1).
Since the first description by Dun­
bar and colleagues6 in 1965 and by 
Marable and colleagues7 in 1966, the 
celiac compression syndrome has 
been the subject of much discussion. 
Its existence has been questioned 
many times and the results of the 
recommended treatment have been 
conflicting.8-12 Because the signs and 
symptoms in this syndrome simulate 
other common abdominal conditions, 
the diagnosis is one of exclusion. A 
systolic epigastric murmur is present 
in 10% to 16%13 of asymptomatic 
patients and 12% to 50%14,15 have
FIG. 1—Compression of celiac axis 
by median arcuate ligament.
radiologically identifiable stenosis of 
the celiac axis, characteristic of this 
syndrome. We do not confirm or deny 
the different theories of pathogenesis, 
but we report here our experience 
with the surgical treatment of this 
condition.
Patients
Clinical Findings
At the Hopital St-Luc in Montreal 
during the 10 years between January 
1972 and December 1981, seven pa­
tients (five women, two men) were 
admitted with a diagnosis of celiac 
compression syndrome. The mean 
age was 44.7 years (range from 24 
to 57 years). Pain was the chief 
complaint in all. It was related to 
meals in five patients and was located 
in the epigastrium radiating to the 
back and to the left hypochondrium. 
In two patients the pain was related 
to position; it was aggravated when 
the patient was sitting and ameliorated 
when lying down. Postprandial vomit­
ing was associated with the pain in 
four patients but was mild and oc­
curred irregularly.
Postprandial flatulence was noted 
in three and diarrhea in one patient. 
The pain was so disabling that the 
patients were forced to reduce their 
food intake, resulting in a mean 
weight loss of 7 kg (range from 5 to 
12 kg). The duration of symptoms 
ranged from 2 months to 30 years 
(mean 13 years).
A loud epigastric murmur was 
heard in six patients. It was systolic 
with a protodiastolic component, 
varying with the patient’s position 
(increased when standing) and respira­
tion (increased on expiration and de­
creased on inspiration).16'17
Epigastric tenderness was noted in 
four patients and an epigastric thrill 
in one. Three patients had never been 
operated on before; the other four 
had undergone various procedures. 
One patient had had only a tubal 
ligation but the other three had had 
multiple surgical procedures: cholecys­
tectomy (three), transduodenal sphinc­
teroplasty (two), caudal pancreatec­
tomy (one), subtotal gastrectomy 
(one).
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Investigations
All patients underwent thorough 
gastrointestinal and biliary tract in­
vestigations, and no abnormality was 
found. Angiography, including lateral 
projections and performed because 
the syndrome was suspected, dem­
onstrated severe stenosis (70% to 
90%) of the celiac axis in four pa­
tients, poststenotic dilatation in two 
and complete obstruction of the celiac 
axis in one patient.
There was associated mesenteric 
compression (Fig. 2) in two patients.
FIG. 2—Complete obstruction of 
celiac axis associated with severe stenosis 
of superior mesenteric artery near its 
origin.
FIG. 3— Characteristic lateral angio­
gram.
Both had severe symptoms and weight 
loss.18,19 The celiac axis had a charac­
teristic direction (Fig. 3) beginning 
with a steep descending slope which 
then changed at an acute angle to an 
ascending course. On the aorta and 
the superior mesenteric artery, little 
or no sign of arteriosclerosis was 
found.
Procedures
All the patients were operated 
upon after years of unsuccessful med­
ical therapy or surgical procedures, 
or both.
Five patients had a median supra- 
umbilical laparotomy; two, because 
of the multiple operations done in 
this area, had a left posterolateral 
thoracotomy. All patients underwent 
section of the median arcuate liga­
ment with a generous periceliac 
neurectomy.
The celiac artery was dissected and 
liberated from the dense neural tissue 
that surrounds it. Because the arterial 
wall and the inferior diaphragmatic 
arteries, often arising from the celiac 
trunk, are particularly fragile, special 
care must be taken during this dissec­
tion.
An aortosplenic anastomosis was 
done in one case to revascularize a 
thrombosed celiac trunk.20
Results
In the postoperative period, there 
were no deaths or complications. 
Relief of pain was dramatic and oc­
curred almost immediately after the 
operation. In six patients the relief 
persisted.
The mean duration of the follow­
up is 36 months (range from 7 to 
74 months). In one patient the symp­
toms returned 2 years after the initial 
surgery. This was the patient who 
had aortosplenic anastomosis; the 
recurrence of her symptoms was due 
to “splenic arterial steal”. She under­
went a splenectomy and has since 
been free of symptoms.
Comment and Conclusions
Surgical treatment of the celiac
Table I— Pathogenesis of Pain in the 
Celiac Axis Compression Syndrome23
Ischemic
Intermittent claudication of the stomach 
Celiac steal 
Neurogenic
Irritation due to arterial vasodilatation 
Arterial spasm
compression syndrome has given 
good results at our institution as at 
many others.9'12,21,22 However, other 
authors emphasize a particular tech­
nical aspect according to their own 
convictions as to the pathogenesis of 
the syndrome (Table I23). We think 
that complete liberation of the celiac 
trunk by an extensive periarterial 
neurectomy is essential and must al­
ways be done along with section 
of the median arcuate ligament.
In all cases we noted dense, trabe­
cular periarterial nerve fibres sur­
rounding the celiac artery and as the 
dissection proceeded we observed the 
artery regaining its normal calibre 
and the thrill disappearing.
Finally, we emphasize the impor­
tance of selecting candidates for oper­
ation. Any gastrointestinal or bilio- 
pancreatic condition must be ruled 
out before considering a diagnosis of 
celiac compression syndrome.
The selection of cases and type of 
operation performed explain in part 
the differences between the results of 
surgical treatment in different series. 
We believe in the existence of this 
unusual entity and that our results 
show the importance of a combined 
vascular and neurologic approach to 
its treatment.
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Polytetrafluoroethylene and Bovine Grafts for Vascular 
Access in Patients on Long-Term Hemodialysis
D .L . D o y l e , m d  and  P .D . F ry , m d , f r c s ( i ) ,  f r c s [c ]
A 4-year retrospective chart review 
of patients whose vascular access 
for hemodialysis was via a polytetra­
fluoroethylene (PTFE) or a bovine 
graft revealed that cumulative patency 
differed little between the two 
groups. The average graft life was 
27 months. Those with vascular access 
through the forearm, particularly 
with a loop type of graft, fared 
the best.
Recurrent thrombosis was a serious 
problem. For this the authors 
recommend elective graft replacement 
followed by a “rest period” of 
2 to 3 weeks. Failing grafts should 
be repaired as directed by 
fistulographic findings.
Polytetrafluoroethylene seems to 
be safer, if not more reliable, than 
the bovine graft. Rupture and life- 
threatening hemorrhage did not occur 
with PTFE.
line etude retrospective, portant 
sur une periode de 4 ans, des dossiers 
de patients ayant un greffon de 
polytetrafluoroethylene [PTFE) ou 
une greffe de tissu bovin comme 
acces vasculaire a I'hemodialyse, 
a revele que la periode cumulative 
de fonctionnement differait peu 
entre les deux groupes. La duree 
moyenne des greffes etait de 27 mois. 
Les patients dont I'acces vasculaire 
etait sur I’avant-bras, particulierement 
ceux ayant une greffe en forme de 
boucle, ont eu les meilleurs resultats.
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Les thromboses recidivantes 
posaient un probleme serieux. Dans 
ces cas, les auteurs recommandent 
le remplacement du greffon suivi d’une 
“periode de repos” de 2 a 3 semaines. 
Les defauts de greffe devraient 
etre repares d’apres les constatations 
de la fistulographie.
Le polytetrafluoroethylene semble 
etre plus sur, sinon plus fiable 
que la greffe de tissu bovin. On 
n’a constate aucune rupture avec 
hemorragie pouvant etre fatale avec 
le PTFE.
Late in 1974 the first bovine hetero­
grafts were used at Vancouver Gen­
eral Hospital to provide vascular ac­
cess in patients with chronic renal 
failure on long-term hemodialvsis. 
With the advent of polytetrafluoro- 
ethvlene (PTFE) (GORE-TEX; W.L. 
Gore & Associates, Flagstaff, Ariz.) 
the use of bovine grafts rather sud­
denly and without scientific reason, 
declined. For the past few years 
PTFE grafts have been used almost 
exclusively to establish vascular access.
A rising number of complications 
with PTFE grafts, particularly throm­
bosis and skin erosion, prompted us 
to review our use of PTFE and bo­
vine grafts in patients with renal fail­
ure.
Patients with chronic renal failure 
are difficult to study because there 
are many variables. These include 
age, sex, hematocrit and creatinine 
levels, coexistent atherosclerotic and 
cardiac disease, coagulopathy, home 
or hospital dialysis and differences in 
venous and arterial line pressures. 
Since no real controls exist, many pa­
tients must be studied to provide stat­
istically significant data. Furthermore, 
assessment of cumulative patency by 
life-table analysis is essential.
Patients and Data
We conducted a retrospective chart 
review of patients whose vascular ac­
cess for hemodialysis was via a PTFE 
or bovine heterograft. During the 4- 
year period, 113 grafts were placed 
in 75 patients, bovine in 47 instances 
and PTFE in 66. Twelve patients 
(16%) died during the study.
Often four or more surgeons oper­
ated on the same graft. The reporting 
of surgical techniques and vessel and 
graft size was often incomplete. 
Where recorded, the majority of 
PTFE grafts had an internal diameter 
of 6 mm and the bovine grafts were 
tapered from 7 to 8 mm. Use of pro­
phylactic antibiotics was inconsistent. 
As a rule, a Fogarty catheter was used 
for thrombectomy, which was per­
formed for the first graft thrombosis 
or when the etiology of thrombosis 
was obscure. Obvious stenoses were 
usually repaired with a vein-patch 
angioplasty. Occasionally the stenotic 
section of a graft was removed and, 
if necessary, the anastomosis placed 
more proximally. Polytetrafluoroethyl­
ene was usually used for graft ex­
tension.
Findings
Despite graft infection, pseudo­
aneurysms and other problems, no loss 
of life or limb was attributable to the 
graft.
Recurrent thrombosis was a real 
problem. In the 113 grafts there were 
115 thromboses. Seventy-one (63 %) 
grafts were abandoned because of this. 
In another five, recurrent thrombosis 
contributed to infections that neces- 
sited graft removal.
Cumulative patency for PTFE 
grafts differed little from that for
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bovine grafts (Fig. 1). There was a 
rapid initial attrition rate; half of 
both the PTFE and bovine grafts be­
came thrombosed within 15 months. 
By 27 months, 68% of all grafts had 
become thrombosed at least once. 
Some of these grafts were salvaged 
by thrombectomy.
The cumulative patency to the time 
of final graft failure showed that 50% 
of all grafts were abandoned by 27 
months with no real difference be­
tween PTFE and bovine grafts. There 
was a further attrition rate of 10% 
of the PTFE grafts, so that by 3 years 
there was a cumulative patency of 
only 40% (Fig. 2).
Graft position seemed to play a 
role in reducing thrombosis in PTFE 
forearm grafts. The 23 PTFE fore­
arm straight grafts had a thrombosis 
rate of 148% while only eight throm­
bectomies (26%) were required in the 
31 PTFE forearm loop grafts. The 
22 forearm straight bovine grafts
FIG. 1— Cumulative patency rate for 
polytetrafluoroethylene (PTFE) and bo­
vine grafts from time of placement to 
first thrombosis. Closed circles =  bo­
vine grafts, open circles =  PTFE grafts.
required 21 thrombectomies (95% 
thrombosis rate). Ten thrombectomies 
were required in the seven bovine 
forearm loop grafts (143% throm­
bosis rate). These numbers for bovine 
grafts are small and are not statisti­
cally significant (Table I).
Other complications (Table II) were 
encountered. Correction of an arte­
rial steal resulted in removal of an 
infected graft. Hemorrhage from 
needle lacerations occurred in four 
patients; in three, all PTFE, the graft 
had been used within 24 hours of 
placement.
Pseudoaneurysms occurred in four 
bovine heterografts. Two ruptured 
spontaneously; both were infected 
with Staphylococcus aureus. Another 
graft was removed and a fourth re­
paired.
Infection occurred in 12% of 
PTFE and 11 % of bovine grafts. All 
but one bovine and one PTFE re­
quired removal.
FIG. 2—Cumulative patency rate for 
PTFE and bovine grafts from time of 
placement to final failure of graft. 
Closed circles — bovine grafts, open 
circles =  PTFE grafts.
Skin erosions at the radial end of 
the PTFE forearm straight graft were 
common early in the series. Three of 
these were, or became, infected and 
were removed. This seemed to be a 
technical problem that could be 
avoided if adequate skin flaps were 
created at the time of graft implant.
Discussion
Grafts that are needled approxi­
mately 300 times per year are prone 
to infection, hemorrhage and throm­
bosis. In view of this, we must strive 
to provide the safest and most re­
liable access possible.
Polytetrafluoroethylene and bovine 
grafts differ little in terms of graft 
complications and patency. Our pa­
tency data are at variance with those 
of others.1"3 In our hands PTFE 
grafts, however, seem to be safer. 
When infected they can sometimes be 
salvaged. They are not prone to aneu­
rysm formation, rupture and hemor­
rhage. In spite of their association 
with rapid tissue ingrowth and fix­
ation, PTFE grafts are technically 
much easier to revise and remove 
than the bovine type.
Unlike the practices at most cen­
tres (Currier C: Unpublished data),4’5 
our grafts are used within 24 to 
48 hours of placement or repair. 
The majority of thrombectomies, re­
visions and even some new graft im­
plants are performed on an emergency 
basis and the patients are sometimes 
dialysed almost immediately.
We believe it is essential to identify 
impending graft failure so that pa­
tients may be adequately dialysed be­
fore operation and the new or re­
paired graft be allowed to “rest” be­
fore being used.
There are often warning signs of 
impending graft failure. Venous 
“duds” may be discovered, when there 
is little or no bleeding at the time of 
needling. Increased venous line pres­
sures may be noted. Both suggest the 
need for a fistulogram followed by
Table 1-Graft Position and Thrombosis*
No. of thrombosesino. of grafts (%)
Graft position PTFE Bovine
Forearm
Straight 34/23 (148) 21/22 (95)
Loop 8/31 (26) 10/7 (143)
Arm
Straight 11/10 (110) 23/17 (135)
Leg
Loop 0/2 (0) 3/1 (300)
*5 thromboses were secondary to prolonged use of a tourniquet.
Table II-Complications Other Than 
Thrombosis
Graft, no (%)
Complication PTFE Bovine
Infection 8 (12.0) 5 (11.0)
Skin erosion 5 (8.0) 0
Pseudoaneurysm 0 4 (8.5)
Arterial steal 1 (1.5) 0
Hemorrhage 
(from needle 
laceration)
3 (5.0) 1 (2.0)
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announcing 
the all-new 
sesapIV
the touchstone 
of surgery
T he touchstone. ..  a hard black 
stone used through the ages to meas­
ure the purity of gold or silver; a 
criterion, a standard. For surgeons, 
the Surgical Education and Self- 
Assessment Program (SESAP IV) 
represents a modern-day touchstone. 
A way to confirm your knowledge of 
current clinical advances in surgery.
To identify and correct areas of 
personal educational need, lb  compare 
your achievement with that of your 
peers. To chart an efficient continuing 
education plan for the future.
If you were to select only one con­
tinuing medical education program in 
which to participate this year, it seems 
unlikely that any other choice could 
offer as much. SESAP IV not only 
can let you discover where you stand, 
but can help you do something about 
possible knowledge deficiencies.
The product of more than 
a decade of refinement
Every three to five years since 1972, 
the American College of Surgeons has 
made available a new Surgical Educa­
tion and Self-Assessment Program. 
Each SESAP is carefully designed to 
present much material that should be 
understood by all practicing surgeons 
regardless of their special competence.
Successive SESAP programs have 
been refined in response to partici­
pants’ suggestions to meet your 
expressed needs and interests. SESAP 
IV is an entirely new program which 
reflects the efforts of seven College 
committees composed of 49 nationally 
recognized surgical authorities.
Pinpoint and satisfy your 
own needs-to-know
SESAP IV is more than simply an 
exercise in self-assessment. It starts 
with a carefully selected series of 400 
multiple-choice items covering 16 
important areas of surgical interest, 
and with seven challenging Patient 
Management Problems (PMP). The 
multiple-choice items require approxi­
mately ten hours to complete; the 
PMPs approximately four hours. The
program continues with confidential 
computerized individual scoring and 
feedback (optional), and with two 
comprehensive syllabi with response 
critiques and references for further 
study. Lastly, Norm Tables will allow 
you to compare efforts with those of 
your peers.
There’s much more to SESAP IV. 
But, a significant point is that the 
experience will not only help you 
identify knowledge deficiencies, but 
help you plan more precisely how to 
meet your personal CME needs.
The challenge and satisfaction of 
knowing where you stand
SESAP IV is designed to help you 
attain that level of knowledge which is 
expected of a surgeon conscientiously 
continuing his or her education in the 
interest of good, competent patient 
care. It offers up to 75 hours of 
Category 1 CME credit. More impor­
tantly, it offers you a unique oppor­
tunity to assess your knowledge of the
principles as well as the clinically 
accepted advances in surgery of the 
last decade.
SESAP IV may be especially valu­
able if you are a candidate for certifi­
cation or recertification; the American 
Board of Surgery bases the greater 
part of its examination for recertifica­
tion on material contained in SESAP.
Participants in past SESAP pro­
grams have found them most helpful. 
A survey of more than 4,200 
participants in SESAP III indicated 
that 90% felt the experience was 
valuable or extremely valuable. In 
addition, nearly 80% felt that 
participation helped them take better 
care of their patients.
Whether you are among the more 
than 50,000 surgeons in all specialties 
who have participated in previous 
SESAP programs or are new to the 
concept, SESAP IV merits becoming 
an integral part of your personal plan 
for continuing education. Send for 
more information today.
Enrollment now open for the most comprehensive, authoritative, flexible, 
and individualized home-study continuing education program in surgery.r
SESAP
American College 
of Surgeons
55 East Erie Street 
Chicago, Illinois 60611
Yes, I wish to learn more about SESAP IV. Please send me, 
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urgent repair before the graft fails. 
This alone should improve our pa­
tency data.
Frequent needling of the graft in 
the same place must be discouraged. 
All four pseudoaneurysms in bovine 
grafts and two of the five PTFE graft 
erosions occurred in these circum­
stances. The problem of puncture- 
induced pseudoaneurysm formation in 
bovine grafts is not unique. Merickel 
and colleagues5 described this in 3 of 
their 100 bovine grafts. Needle site 
rotation is necessary, especially in pa­
tients on a home dialysis program.
Polytetrafluoroethylene forearm loop 
grafts fared much better than 
PTFE forearm straight grafts. This is 
not surprising. Loop grafts are anas­
tomosed to the much larger brachial
artery, while in the straight graft the 
small radial artery is anastomosed to 
the inappropriately large graft. Also, 
the loop graft provides double the 
length for needling, therefore there 
is less chance of pseudoaneurysm for­
mation from overuse.
The need for vascular access in 
patients on long-term hemodialysis is 
predictable. We need time to place 
the graft electively. Requests for 
emergency establishment of vascular 
access for long-term dialysis are rare­
ly justified. The ultimate aim is to 
provide a safe, reliable access for 
maintenance dialysis. Although no 
more reliable, PTFE appears safer 
and our rather sudden and unscientific 
switch to PTFE was justified on these 
grounds alone.
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Aortoiliac Reconstruction for Occlusive Disease: 
Comparison of End-to-End 
and End-to-Side Proximal Anastomoses
D.A. Dunn, mb, bs, frcs[c],* A.R. Downs, md, facs, FRCs[c]f 
and C.R. Lye, md, frcs[c]$
Between 1968 and 1979, 192 
aortofemoral bifurcation grafts were 
placed for aortoiliac occlusive disease. 
The proximal anastomosis was 
end-to-end in 101 and end-to-side in 
91 patients. Anastomoses were 
end-to-end in 38 (37%) of 104 patients 
from 1968 to 1976 and 63 (72%) of 
88 patients from 1977 to 1979. 
Embolization occurred intraoperatively 
in four end-to-end and five end-to-side 
anastomoses. The grafts became 
occluded in the early postoperative
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period in two patients with end-to-end 
proximal anastomoses. There were 
two aortoduodenal fistulas, both 
associated with end-to-side proximal 
anastomosis. The cumulative patency 
rate at 5 years was 87% for end-to-end 
and 85% for end-to-side anastomoses. 
An end-to-end proximal anastomosis 
is indicated for associated aneurysmal 
disease or in the presence of aortic 
occlusion, while an end-to-side 
anastomosis is indicated when there 
are low-lying accessory renal arteries 
or in the presence of occlusive 
disease in the external iliac arteries. 
The authors’ experience suggests that 
there is no difference in the incidence 
of intraoperative embolization or late 
occlusion between end-to-side and 
end-to-end proximal anastomosis.
The incidence of aortoduodenal fistula 
appears to be lower with end-to-end 
proximal anastomosis possibly because 
of better tissue apposition at the 
anastomosis.
Cent quatre-vingt-douze derivations 
aorto-femorales ont ete pratiquees 
entre 1968 et 1979 pour traiter des 
arteriopathies obliterates des 
vaisseaux aorto-iliaques. Chez 101 
patients, il s’agissait d'une anastomose 
proximale termino-terminale et chez
91 patients, d’une anastomose 
termino-laterale. De 1968 a 1976, 38 
(37%) des 104 patients ont eu des 
anastomoses termino-terminales, alors 
que de 1977 a 1979, la proportion 
etait de 63 (72%) sur 88 patients.
Une embolisation est survenue durant 
I'operation dans quatre cas 
d'anastomose termino-terminale et 
dans cinq cas d’anastomose termino- 
laterale. Les greffes sont devenues 
obliterees tot apres I'operation chez 
deux patients ayant une anastomose 
proximale termino-terminale. II y a eu 
deux cas de fistule aorto-duodenale, 
les deux etant reliees a des 
anastomoses proximales termino- 
laterales. Le taux cumulatif de patence 
a 5 ans a ete de 87% pour les 
anastomoses termino-terminales et 
de 85% pour les anastomoses 
termino-laterales. Une anastomose 
proximale termino-terminale est 
indiquee dans les cas d’anevrysme 
associe ou en presence d’une occlusion 
de I’aorte; une anastomose termino- 
laterale s'impose quand il y a des 
arteres renales accessoires basses 
ou en presence d’une arteriopathie 
o b litera te  des arteres iliaques 
externes. L’experience des auteurs 
indique qu’il n'existe pas de difference 
entre I'incidence des embolisations
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peroperatoires ou occlusion tardive 
lors d'une anastomose proximate 
termino-terminale et celle des 
anastomoses termino-laterales. La 
frequence des fistules aorto-duodenales 
semble plus faible avec les 
anastomoses proximales termino- 
terminales, possiblement a cause 
d’une meilleure apposition des tissus 
a I’anastomose.
The reported patency rate of aorto- 
bifemoral bypass grafts varies between 
62% and 90% at 5 years and be­
tween 41% and 75% at 10 years.1"6
Table 1 - O perative Procedures
No. of
Procedure patients
Aortoiliac endarterectom y 50
Aortobifem oral bypass 186
Aortoiliac bypass 6
Crossfem oral bypass 44
Iliofem oral bypass 29
Axillofem oral bypass 20
335
Table ll-0 p e ra tiv e  Deaths 
(N =  192)
Cause of death
No. of 
patients
M yocardial infarction 2
Stroke 1
Hemorrhage 1
Gut ischem ia 1
Burns 1
6
Table Ill-E a r ly  Com plications
No. of
Com plication patients (%)
Pulm onary 45 (23)
A telectasis 33
Pneumonia 12
Cardiac 15 (8)
Arrhythm ia 10
M yocardial infarction 1
Ischem ia 1
Congestive heart failure 3
D istal em bolization 9 (5)
End-to-end 4
End-to-side 5
Wound infection 6 (3)
Abdomen 1
Groin 5
Deep vein throm bosis or 
pulmonary em bolism 5 (2.6)
Graft occlusion (end-to-end) 2 (1)
When an end-to-side proximal anas­
tomosis is used, intraoperative distal 
embolization has been considered 
more likely,7 late graft occlusion more 
frequent4'8"10 and aortoduodenal fis­
tula more common.4
The purpose of this report is to 
review our experience with aorto- 
bifurcation grafts and to compare the 
results of end-to-end with end-to-side 
proximal anastomosis.
Patients
During the 12-year period Jan. 1, 
1968 to Dec. 31, 1979, 335 patients 
underwent operation for aortoiliac 
occlusive disease at the Health Sciences 
Centre in Winnipeg. The operative 
procedures are listed in Table I. We 
selected the 186 aortobifemoral and 
the 6 aortoiliac bypass procedures for 
review.
Clinical information was obtained 
by retrospective analysis of patients’ 
records. Associated disease, presenting 
symptoms, operative mortality and 
early and late complications were de­
termined. Late patency rates were 
studied by life-table methods.11'13
Follow-up, obtained in 96% of the 
patients, ranged from 3 months to 10 
years (mean 3 years). Patency rates 
were determined per patient rather 
than per limb; this produces lower 
patency rates but is more relevant to 
patient outcome.7
Of the 192 patients, 139 (72%) 
were men. The average age of all pa­
tients was 60 years and was the same 
for women as for men. Femoropop- 
liteal disease was present in 129 
(67%). Hypertension greater than 
140/90 mm Hg was present in 79 
(41%), carotid bruits or previous 
symptomatic cerebrovascular disease 
in 60 (31%), cardiac disease in 56 
(29%), pulmonary disease in 54 
(28%), diabetes in 18 (9%) and renal 
disease in 9 (5%). Associated, inci­
dental, aneurysmal disease was pres­
ent in 29 (15%). There was no ap­
preciable difference in the incidence 
of associated conditions in patients 
who had end-to-side or end-to-end 
proximal anastomoses, except that all 
patients with associated aneurysmal 
disease had an end-to-end anastomo­
sis. Indications for operation were 
claudication in 123 (64%), rest pain 
in 50 (26%) and tissue necrosis in 19 
(10%).
Particular attention was directed at 
ensuring adequate outflow at the fem­
oral level. Any disease at the orifice 
of the deep femoral artery was treated 
by carrying the graft across its origin 
thus creating a profundaplasty. This
was not done if the superficial fe­
moral artery alone was occluded. 
If the common femoral and superfi­
cial femoral arteries were both oc­
cluded the deep femoral artery was 
usually divided and an end-to-end 
anastomosis to that artery performed. 
If there was extensive disease of the 
deep femoral artery, a profundaplasty 
was done distally and the anastomosis 
was brought over the deep femoral 
orifice.
An end-to-end proximal aortic anas­
tomosis was done whenever there was 
associated aneurysmal disease and 
when there was aortic occlusion 
either at the juxtarenal level or in 
midaorta.
The proximal aortic anastomosis 
was made end-to-side to maintain 
aortic flow into the internal iliac sys­
tem when the external iliac arteries 
were stenosed or occluded. An end- 
to-side proximal anastomosis was 
done when there were accessory renal 
arteries arising well down on the 
aorta. The body of the graft was kept 
short, not more than 5 cm long and 
bevelled at 45° to prevent kinking 
of the limbs. The anastomosis was 
done well up on the aorta between 
the inferior mesenteric and renal ar­
teries and particular care was taken 
to cover the proximal anastomosis 
with para-aortic tissue.
Results
An end-to-end anastomosis was 
done in 101 patients and an end-to- 
side in 91. From 1968 to 1976, 37% 
(38 of 104) of the anastomoses were 
end-to-end, but between 1977 and 
1979, 72% (63 of 88) were end-to- 
end; this change followed reports that 
end-to-end anastomoses were supe­
rior.4'7"10
There were six operative deaths 
(3%) (Table II), three in the group 
with an end-to-end proximal anasto­
mosis and three in the end-to-side 
group. The early complications are 
summarized in Table III. In five of 
the patients with distal embolization 
this occurred down the open side 
when the other side was occluded. 
Both patients with graft occlusion un­
derwent thrombectomy and their 
grafts were patent at the time of dis­
charge.
Seven patients (3.6%) had false 
aneurysms at an average of 4.5 years 
after operation. Three (1.6%) graft in­
fections occurred, necessitating remov­
al of the graft; in one of these a uni­
lateral amputation was necessary. 
Aortoduodenal fistula occurred in two 
patients (1%) both with end-to-side
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proximal anastomoses. These two pa­
tients had upper gastrointestinal tract 
hemorrhage 3 years after operation. 
Both died following laparotomy at 
other hospitals. Late occlusion oc­
curred in 17 patients. Eleven of these 
patients had reconstructions and in 
three, subsequent amputation was re­
quired.
The late patency rate for the whole 
group was 86% at 5 years and 82% 
at 8 years (Table IV). Patency rates 
at 5 years for end-to-end anastomoses 
were 87% and for end-to-side anas­
tomoses 85% (Tables V and VI). 
This difference was not significant.
Discussion
Our late patency rates for aorto- 
bifurcation grafts of 86% at 5 years 
and 82% at 8 years compare favour­
ably with those of other reports.1-6
Brewster and Darling4 have stressed 
the importance of adequate femoral
outflow but reported a 44% incidence 
of limb failure at 5 years with end- 
to-side proximal anastomoses com­
pared with 15% for end-to-end anas­
tomoses. Mulcare and associates8 re­
ported that 10 of 11 late graft fail­
ures occurred with an end-to-side 
proximal anastomosis. Gaylis9 re­
ported occlusion of three end-to-side 
grafts and prefers an end-to-end prox­
imal anastomosis. Our patency rates 
at 5 years do not confirm these re­
ports of increased frequency of oc­
clusion with end-to-side anastomoses.
Wylie and associates7 considered 
that distal embolization was more 
likely with an end-to-side proximal 
anastomosis. In our series, distal em­
bolization occurred with 4 (3.96%) of 
101 end-to-end and 5 (5.49%) of 91 
end-to-side anastomoses; this differ­
ence was not statistically significant. 
We believe that this complication oc­
curs as a result of the initial mobil­
ization of the aorta rather than the
type of anastomosis used. Proximal 
coverage of the graft is more difficult 
with end-to-side anastomoses and two 
aortoduodenal fistulas occurred in 
this series, both from end-to-side 
anastomoses.
Queral and associates14 have pre­
sented evidence of decreased penile 
blood pressures after end-to-end prox­
imal anastomoses in the presence of 
external iliac disease and we agree 
that this requires further study.
Conclusion
With the possible exception of aor­
toduodenal fistula our review of early 
and late results does not favour one 
type of proximal anastomosis over 
the other. In the absence of specific 
indications we consider it acceptable 
to use either. We stress, however, that 
the anastomosis should be done high 
and care should be taken in covering 
the prosthesis.
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T a b le  I V - C u m u la tive  P a te n c y Rate fo r P atients w ith  
A o rto b ifu rc a tio n  Grafts
In te rva l, N o . o f N o . of P ate n c y Standard
y r patients a t risk occlu sio ns rate, % erro r, ±  %
0.5 181 2 99 0
1 159 5 96 0.8
1.5 122 1 95 2
2 105 4 91 2
3 71 2 89 2
4 58 2 86 3
5 38 0 86 4
6 25 1 82 4
7 17 0 82 5
8 12 0 82 5
Ta b le  V - C u m u l a t i v e  P a te n c y Rate fo r P atie n ts w it h  
End-to-End P ro xim a l A n a sto m o se s
In te rva l,
V
N o . of
p atients at risk
N o . of 
occlusio ns
C u m u la tive 
p a te n c y, %
Standard 
erro r, ±  %
0.5 93 1 99 0
1 78 2 96 1
1.5 55 0 96 2
2 44 2 92 2
3 23 0 92 4
4 19 1 87 4
5 10 0 87 6
T a b le  V I - C u m u la t iv e  P a te n c y Rate fo r  P atients 
w it h  End-to-S ide A n a sto m o se s
In te rva l,
y r
N o. o f
patients at risk
N o . o f 
occlu sio ns
C u m u la tive 
p a te n c y, %
S tandard 
e rro r, ±  %
0.5 88 1 99 0
1 81 3 95 1
1.5 68 1 94 2
2 62 2 91 3
3 49 2 87 3
4 39 1 85 4
5 28 0 85 5
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Fate of the Limb after Failed Femoropopliteal
Reconstruction
D.L. Wooster, md, b sc,
Sixty-eight occluded femoropopliteal 
bypass grafts were studied to deter­
mine the fate of the limb after graft 
occlusion. There were 25 reversed 
saphenous vein grafts and 43 
polytetrafluoroethylene grafts. Thirty- 
five limbs required amputation and 
the timing of amputation after graft 
thrombosis ranged from 1 day to 
24 months. Twenty of the amputations 
occurred following an unsuccessful 
revision of the thrombosed graft and 
an additional 15 limbs were amputated 
without further attempts at revascu­
larization. In 17 of the patients there 
were no disabling signs or symptoms 
after graft occlusion. Twenty-two grafts 
were successfully revised to avoid 
amputation.
The need for amputation and the 
level of amputation were analysed 
with respect to the age of the patient, 
the indication for the original proce­
dure, inflow and outflow status, the 
type of graft and the level of distal 
anastomosis. In 26 patients with 
intermittent claudication only four 
amputations resulted from graft 
occlusion and these were all below 
the knee. There was a weakly 
significant (P <  0.1) correlation 
between poor outflow and the need 
for amputation after occlusion of the 
graft. In particular, patients with 
femorodistal bypass faired poorly, 
four of five occluded saphenous vein 
grafts and all six PTFE grafts requiring 
amputation. There was no significant 
age difference with respect to the 
level of amputation or the need for 
amputation and there was a wide 
range from the time of thrombosis to 
amputation.
The authors conclude that am­
putations are infrequent after bypass
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grafting for claudication. The level of 
distal anastomosis, poor inflow and 
run-off and gangrene before the 
bypass procedure all correlate with 
the need for amputation in thrombosed 
grafts initially placed for limb salvage. 
Vigorous attempts at revision of 
failed grafts may prevent or construc­
tively delay amputation.
Soixante-huit cas d’occlusion d'un 
pontage femoro-poplite par greffe ont 
ete etudies afin de determiner le 
sort du membre apres ('obliteration 
du greffon. On comptait 25 greffes de 
veines saphenes inversees et 43 
greffons de polytetrafluoroethylene 
(PTFE). Trente-cinq membres ont 
necessite I'amputation, d’un jour a 
24 mois apres la thrombose du 
greffon. Vingt de ces amputations 
ont suivi une revision infructueuse 
d’un greffon thrombose et 15 autres 
membres ont ete amputes sans autres 
tentatives de revascularisation. 
Dix-sept de ces patients n'ont presente 
ni signe d’incapacite ni symptome 
d'occlusion du greffon. Vingt-deux 
greffons ont ete revises avec succes, 
evitant ainsi I'amputation.
La necessite d'amputer et le niveau 
d'amputation ont ete analyses par 
rapport a I'age du patient, a I'indication 
ayant commande ('intervention initiale, 
au pouvoir de remplissage et 
d’ejection, au type de greffon et au 
niveau de I’anastomose distale. Chez 
26 patients souffrant de claudication 
intermittente, il n'y eut que quatre 
amputations resultant de I'occlusion 
du greffon, toutes sous le genou.
II y avait une correlation faible 
significative (P <  0.1) entre un 
mauvais debit et la necessite 
d'amputer apres I'occlusion du greffon. 
Les patients ayant une derivation 
femoro-distale s’en sont particu- 
lierement mal tires, quatre des cinq 
occlusions de veines saphenes 
greffees et les six greffes de PTFE 
necessitant une amputation. On 
n'observait pas de difference 
significative d’age par rapport au 
niveau d’amputation ou a la necessite 
d’amputer et il existait un ecart 
considerable en ce qui a trait au 
temps ecoule entre la thrombose et 
I'amputation.
Les auteurs concluent que les
amputations sont peu frequentes 
apres un pontage par greffe pour 
claudication. Le niveau de I’anastomose 
distale, un mauvais ecoulement et 
une gangrene avant ('intervention 
sont tous relies a la necessite 
d'amputer apres thrombose du greffon 
qui avait ete pose initialement pour 
sauver le membre. Une tentative 
serieuse de reviser les greffons 
obliteres peut prevenir ou retarder 
I’amputation de fa?on appreciable.
Femoropopliteal and femorodistal 
grafting is frequently performed to 
relieve symptoms of claudication and 
rest pain and to salvage limbs threat­
ened with tissue loss. Many studies 
have assessed patency rates associated 
with various types of graft, but rela­
tively few have examined the fate of 
the limb in patients whose grafts have 
failed. Just as it is important to iden­
tify factors that may be lead to failure 
of arterial reconstruction, so those 
factors that may determine the fate 
of the limb after failure must also be 
recognized.
We followed up patients in whom 
reversed saphenous vein and poly­
tetrafluoroethylene (PTFE) (GORE- 
TEX; W.L. Gore & Associates, Flag­
staff, Ariz.) femoropopliteal and femo­
rodistal grafts had failed over a 3-year 
period, with particular regard to re­sultant major amputations. This was 
done in an attempt to answer the fol­
lowing questions about graft failures: 
What are the incidence and level of 
amputation and what factors deter­
mine these when the initial reconstruc­
tion is performed for relief of claudi­
cation? Are there factors that predict 
the need for amputation after throm­
bosis of grafts in limb salvage opera­
tions? Are graft revisions of any 
value? Does a failed revascularization alter, either detrimentally or advan­
tageously, the level of eventual am­
putation in dysvascular limbs?
Method
We undertook a retrospective re­
view of 181 femoropopliteal or more 
distal bypass grafts inserted between 
Jan. 1, 1977 and Dec. 31, 1979. The 
68 occluded grafts and the 35 ampu­
tations that resulted were analysed,
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noting the age of the patient at the 
time of initial operation, the rate of 
thrombosis, the indication for opera­
tion, the type of graft placed, the 
level of distal anastomosis and the 
adequacy of inflow and run-off deter­
mined by arteriography; subsequent 
symptoms, attempts at revision, tim­
ing and level of amputation were cor­
related with these factors.
Procedures were performed by one 
of two surgeons on a peripheral vas­
cular unit. The operative approach 
was standard, with anastomoses to 
the common femoral artery proximal- 
ly and to the popliteal artery at the 
level of the knee. Anticoagulation was 
used and reversed intraoperatively: 
anticoagulants were not given post- 
operatively. Antiplatelet agents were 
not given.
Graft thrombosis was diagnosed 
by clinical and Doppler assessment 
and occasionally by angiography, re­
gardless of return or progression of 
signs and symptoms. Inflow was classi­
fied by angiography as good (normal 
or minimal stenosis, patent aorto- 
femoral graft) or poor (appreciable 
stenosis). Run-off was classified on 
the basis of the angiograms as good 
(three or two vessels beyond the popli­
teal artery) or poor (one or no vessels). 
No assessment of the completeness of 
the plantar arch was possible in most 
instances.
The indications for amputation 
were progressive frank gangrene un­
suitable for local amputation, uncon­
trollable infection or disabling rest 
pain. Recurrent or continued claudica­
tion was never an indication for am­
putation. When amputation was nec­
essary, primary below-knee amputa­
tion was performed whenever clinical. 
Doppler and arteriographic findings 
indicated the possibility of a suc­
cessful outcome.
Statistical analysis of the findings 
was carried out by the paired Student’s 
t-test.
Findings
Overall
Of the 181 grafts studied, 68 
(37.6%) thrombosed; they resulted 
in 35 amputations —  51.5% of 
thrombosed grafts or 19.3% of all 
grafts. Of the 68 patients with oc­
cluded grafts, 17 were initially asymp­
tomatic; 11 remained so. Twenty- 
two patients, including 6 who were 
initially asymptomatic, underwent suc­
cessful revision. Twenty patients re­
quired amputation after unsuccess­
ful revision and 15 had amputation 
without revision. Above-knee ampu­
tation was carried out in lSUcases — 
51.4% of all amputations and 26.5% 
of all thrombosed grafts — in 2 be­
cause below-knee amputation had 
failed. Primary healing resulted in the 
remaining 17 below-knee amputations 
(25% of all thrombosed grafts).
The average age of patients who 
underwent bypass grafting and who 
underwent amputation was 64 years. 
For below-knee and above-knee am­
putation, the average ages were 62.3 
and 66.3 years respectively. However, 
the age of the subgroup of patients 
who needed above-knee amputation 
for failed saphenous vein grafts was 
71 years.
The interval from primary grafting 
to thrombosis and from thrombosis to 
amputation both ranged from 1 day 
to 24 months. In patients who re­
quired amputation, the interval from 
grafting to thrombosis was often less 
than 1 month. Amputation was most 
frequently performed within 1 month 
of graft occlusion, although the aver­
age delay for above-knee amputation 
was 3.4 months (range from 0 to 24 
months); and for below-knee amputa­
tion 2.1 months (range from 0 to 9 
months). In 20 patients whose revi­
sion procedure was unsuccessful, only 
6 (30%) required amputation within 
1 month. The limb was saved from 
amputation for longer than 4 months
in 10, for longer than 11 months in 
4 and longer than 24 months in 2 
patients.
Correlation of Amputation with 
Indications for Initial Grafting
Table I correlates the incidence and 
level of amputation with the indica­
tion for the initial bypass grafting.
Claudication.—When claudication 
was the indication, 27.7% of the 
grafts failed and of these failures 
only 15.4% led to amputation, all 
below the knee (P <  0.05). In one 
patient whose run-off was “good”, 
inflow was “poor”, and this was 
not remedied by aortofemoral bypass 
and subsequent revision of the bypass. 
Revision was attempted in three of 
the four patients who subsequently 
had amputation of the limb.
Ulceration and gangrene, rest pain. 
—Of the grafts placed for frank ul­
ceration and gangrene or rest pain in 
order to save the limb, 48.3% failed, 
and of these, 73.8% led to amputa­
tion, 58.1% above the knee. When 
frank ulceration and gangrene were 
the indications, above-knee amputa­
tion was significantly (P <  0.01) more 
common than below-knee amputation.
Type of Graft Used
Table II shows the incidence and 
level of amputation in relation to the 
type of graft material used.
Saphenous vein.—Of the 84 saphe­
nous vein grafts inserted, 25 (29.8%) 
became occluded and 11 (13.1%) re­
sulted in amputation. In 10 of the 
amputations, the original reconstruc­
tion was performed to save the limb.
PTFE.—This material was used in 
97 cases; in 43 (44.3%) of them the 
graft failed and in 24 (25%) amputa­
tion was necessary. Twenty-one of 
the amputations were in patients 
originally operated on for limb sal­
vage. The three amputations in pa­
tients who received grafts for relief 
of claudication were at the below-
Table I- Correlation of Indications for Initial Grafting Procedure 
and Incidence and Level of Amputation
Grafting, no. (%) Amputation, no. (%)
Indication Total* Success Failure Total! Above-knee Below-knee
Claudication 94 (52) 68 (72.3) 26 (27.7) 4 (15.4) 0 § 4 (100)
Limb salvage 87 (48) 45 (51.7) 42 (48.3) 31 (73.8) 18(58.1) If 13 (41.9)
Rest pain - - - 19 9 (47.4) 10 (52.6)
Ulceration and gangrene - - - 12 9(75) 3(25)
181 (100) 113 (62.4) 68 (37.6) 35 (51.5) 18 (51.4) 17 (48.6)
*%  of total group of 181 grafts placed. 
t%  of failures leading to amputation. 
§P  <  0.05.
If P <  0.01.
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knee level and one was performed 37 
months after the initial procedure.
Although the incidence of amputa­
tion was higher in failed PTFE grafts, 
the percentage of amputations per­
formed at the two levels did not dif­
fer.
Level of Anastomosis
Of the 163 femoropopliteal anas­
tomoses performed with the distal 
anastomosis at or below the knee, 57 
(35%) grafts thrombosed and re­
sulted in 25 amputations. This rep­
resents 15.3% of all grafts in this 
group or 43.8% of thrombosed grafts. 
On the other hand, 11 (61%) of 18 
more distal bypasses thrombosed, re­
sulting in 10 amputations (91% of 
thrombosed or 55.5% of all grafts in 
this group). Of the 11 thrombosed 
grafts, 4 of 5 saphenous vein grafts 
and all 6 PTFE grafts led to amputa­
tion. This difference in the incidence 
of amputation in failed grafts by level 
of anastomosis is significant (P < 
0.005). Of the 10 more distal grafts 
that failed and led to amputation, 
run-off was poor in 9 and inflow 
was poor in 2. In five, aggressive at­
tempts at thrombectomy were made. 
In none of these patients was a more 
distal bypass done or grafting of a 
different distal vessel attempted. Elev­
en below-knee and 14 above-knee am­
putations were performed in those 
patients who underwent femoropopli­
teal bypass. Six below-knee and four 
above-knee amputations were per­
formed in the more distal grafts.
Adequacy of Inflow and Run-off
As noted earlier, angiography was 
used to assess the status of graft in­
flow and run-off.
Inflow.—In patients who had had 
previous or concurrent aortofemoral 
bypass grafting, flow was reclassified 
as good. Even after this consideration, 
the inflow status of patients who re­
quired amputation was significantly 
worse, when reviewed retrospectively, 
than the overall group of patients who 
had femoropopliteal bypasses. Fur­
thermore, 50% of patients who re­
quired amputation after an operation 
for claudication had poor inflow.
In the above-knee amputations good 
inflow was recorded in 6 and poor in 
10. For below-knee amputations the 
figures were 10 and 2 respectively. 
Inflow to saphenous vein and PTFE 
grafts was comparable.
Run-off.—Run-off was substantially 
worse in patients who required am­
putation than in the group as a whole 
or in the group who had thrombosed 
grafts; 75% of patients who required 
amputation after an operation for 
claudication and 90% of those with 
failed femorodistal reconstructions 
had poor run-off.
No above-knee amputations were 
performed in patients with good run­
off or those with failed saphenous 
vein grafts, but in patients who had 
PTFE prostheses, run-off was not 
predictive of the level of amputation. 
Good run-off was recorded in 4 
above-knee amputations and poor 
run-off in 13. For below-knee am­
putations the figures were 5 and 11 
respectively. Run-off was better in 
those with PTFE grafts than with 
saphenous vein grafts.
R e v is io n s
Revision, performed in 42 (62%) 
patients with thrombosed grafts, was 
successful in preventing amputation 
in 22 (52%). Thrombectomy alone 
was done in 24 (57%) patients, where­
as more distal revision was used in 
13 (31%). Of the distal revisions. 
11 were graft extensions and 2 were 
exploration of the popliteal anasto­
moses. Three inflow procedures and 
two lumbar sympathectomies were 
performed. There was no difference 
in the incidence of amputation be­
tween PTFE and saphenous vein 
grafts that required revision nor in 
the level of amputation with or with­
out revision. Although it was impos­
sible to predict the level of amputa­
tion according to whether or not 
the graft was revised, we believe that 
all those who require revision are at 
risk of amputation if further recon­
struction is not performed.
The interval from graft thrombosis 
to amputation was markedly different 
in patients who had revision com­
pared with those who did not. In the 
30% of patients who had amputation 
less than 1 month after revision, 83% 
underwent simple thrombectomy with­
out clear demonstration of adequate 
run-off or anastomotic integrity. No 
deaths resulted from aggressive revi­
sion.
Correlation with Level of Amputation
As it was impossible to determine 
what level of amputation would have 
resulted without initial grafting or 
subsequent revision, it is not possible 
to determine if the variables such as 
age and type of graft reflect a bene­
ficial or detrimental effect on these 
therapies. Only 48.6% of amputa­
tions were successful at the below- 
knee level. Claudication, as an initial 
indication for operation, and good 
inflow to the graft correlate signifi­
cantly (P <  0.05) with below-knee 
amputation, although patients in this 
group were slightly younger (62.3 
versus 66.3 years) and had slightly 
better run-off (good run-off in 31% 
versus 23.5%) than the above-knee 
amputees. No patient with good run­
off and a saphenous vein graft re­
quired above-knee amputation but 
graft type did not otherwise predict 
the level of amputation. Revision did 
not alter amputation levels.
Poor inflow and frank gangrene at 
the time of the initial repair and to 
a lesser degree poor run-off correlated 
with above-knee amputation.
D is c u s s io n
Femoropopliteal bypass grafting is 
the reconstructive procedure of 
choice for disabling claudication or 
threatened tissue loss due to ischemia 
that is related to superficial femoral 
artery occlusion. Saphenous vein is the 
preferred conduit and patency rates 
of 60% to 85%1-4 are noted im­
mediately and at 5 years. Polytetra- 
fluoroethylene and umbilical vein 
prostheses have been used. The pat­
ency rates for these conduits are poor 
in some series,48 ranging from 33% 
to 48% at 36 to 48 months. Other 
reports using these materials are more 
optimistic.9’10
Table II-Correlation of Graft Material Used with 
______________________________________________________ Incidence and Level of Amputation
__________________ Bypasses, no. (%) Amputation, no. (%)
Graft material_________________________Total* Success Failure Totalt Above knee Below knee
Saphenous vein 84 (46) 59 (70.2) 25 (29.8) 11 (44) 6~(54 5j 5 (4551
Polytetrafluoroethylene 97 (54) 54 (55.7) 43 (44.3) 24 (55.8) 12 (50) 12 (50)
*%  of total 181 grafts placed. 
t%  of failures leading to amputation.
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In the limb-salvage situation, tem­
porary patency of a graft may allow 
healing of ulcerated tissue, and the 
limb may be saved despite later graft 
failure. Although no studies have 
addressed the characteristics of this 
particular group, limb salvage ex­
ceeds graft patency by approximately 
10% ,u'14 regardless of individual 
graft patency rates. On the other 
hand, patients with very poor distal 
run-off, spreading infection or severe 
neuritic pain, occasionally require 
amputation despite a patent graft.6’15'17 
Such procedures are often performed 
many months after the initial opera­
tion, but as this study related to am­
putations following graft thrombosis, 
no relevant data were available.
In 19 recently reported studies using 
a total of 2878 grafts,5’6’8'11’13’15'26 911 
occluded grafts (32%) resulted in 399 
amputations. This represents a 44% 
amputation rate in a large, widely 
disparate series of patients with oc­
cluded grafts and is similar to the 
51% amputation rate in thrombosed 
grafts reported in our study. In this 
collected series the graft occlusion 
rate ranged from 17% to 30% for 
patients with claudication and re­
sulted in amputation in 3% to 44%. 
The incidence of occlusion in limb 
salvage situations ranged from 11% 
to 65% and amputation resulted in 
13% to 83% of cases.
Patients with claudication that 
was not severely disabling had a de­
creased life expectancy but did well 
with conservative management; pro­
gressive symptoms or severe ischemia 
requiring surgery developed in only 
10% to 25%.23 Nevertheless, claudi­
cation is distressing to many patients, 
and patency rates up to 88% at 5 
years for saphenous vein bypass 
grafting may be expected in such 
patients.21 King and associates23 found 
90% of patients were improved by 
operation and only 15% of occluded 
grafts resulted in worsening of the 
patient’s claudication, whereas Bad- 
deley and associates18 reported am­
putation in 7 (44%) patients with 
claudication who had occluded grafts. 
Amputation in the face of a symp­
tom that threatens neither life nor 
limb is disastrous.
In our series amputation was only 
performed for severe rest pain, frank 
gangrene or spreading infection and 
not for recurrent claudication. Al­
though 15% of failed grafts inserted 
for claudication led to amputation of 
the limb, this represented only 4% 
of all grafts placed for claudication. 
Furthermore, in one case amputation
was performed 17 months after graft 
occlusion and 37 months after the 
initial operation. Poor inflow and 
outflow and the use of PTFE grafts 
correlated with amputation after 
thrombosis of the graft; hence, early 
operation in this situation should be 
resisted if claudication is the only 
indication for vascular reconstruction. 
Although amputations are generally 
performed within 1 month of graft 
occlusion, in this series the range 
was from 1 day to 24 months. Veith 
and associates10 noted delay up to 14 
months after failed revisions and 
Burgess and Marsden27 showed that 
22% were delayed for at least 1 year. 
Kazmers and associates28 found that 
if amputation was delayed, 64% 
could be successful at a below-knee 
level compared with only 39% if am­
putation was necessary within 2 weeks 
of occlusion.
Role of Revision
Reoperation to revise technically 
faulty anastomoses and improve in­
flow and run-off, as well as simple 
thrombectomy, has been helpful in 
maintaining patency, particularly in 
PTFE grafts. Veith and associates1" 
reported patency at 27 months with 
no amputations in 9 grafts from which 
thromboses had been removed within 
1 month of the primary procedure 
and three amputations following revi­
sion of 22 grafts that failed after 1 
month. Raithel and Franke29 found 
patency rates of 87% at 30 days and 
48% at 48 months after revision. 
Only in three amputations had there 
been vigorous attempts at revision.
Although 15 patients with rest 
pain or gangrene after failed grafts 
had conditions unsuitable for further 
revision and therefore required am­
putation of the limb, and a further 9 
patients were asymptomatic with 
failed grafts, 62% of occluded grafts 
were revised. It was considered that 
all patients who underwent revision 
would have suffered disabling rest 
pain and would have required ampu­
tation if revision was not carried out; 
therefore, substantial benefit was 
achieved in 52% of patients who 
did not require amputation after revi­
sion. We could not determine on an 
individual basis if the level of am­
putation was altered in those who had 
amputation, but overall, equal num­
bers needed above-knee and below- 
knee amputations subsequently. On 
the basis of type of conduit there was 
no difference in the results achieved 
and the number of deaths was not 
increased. Patients in whom simple
thrombectomy was performed without 
clear delineation of the distal run­
off status or demonstration of ade­
quate anastomosis did poorly com­
pared with those in whom the distal 
status was adequate or more exten­
sive revision was undertaken. Finally, 
the question of whether revision was 
detrimental because it delayed the 
inevitable amputation was addressed. 
Clearly, amputation is delayed by 
revision but, whereas all patients not 
subjected to revision required amputa­
tion within 2 months, amputation was 
delayed more than 4 months in 50% 
and more than 11 months in 20% 
when reoperation was necessary. 
This delay suggests a beneficial re­
sult even from some failed revisions.
Factors Determining Level 
of Amputation
Although it is important to select the 
lowest possible amputation level that 
will provide primary healing, accurate 
parameters by which to select appro­
priate level from history, physical 
examination, angiographic or labora­
tory data are not reliable, so it was 
impossible to predict which patients 
would have undergone amputation at 
different levels with and without ini­
tial grafting and subsequent revision. 
Only 49% of patients in this series 
had successfully healed below-knee 
amputations, which correlates well 
with the series of Finch and asso­
ciates30 in which only 42% of am­
putations were performed on a large 
vascular service at the below-knee 
level. Kazmers and associates28 have 
calculated that, ideally, 80% of am­
putations in dysvascular limbs should 
be successful at a below-knee level; 
if this calculation is accurate, grafting 
was either detrimental to the success 
of amputation or more-distal amputa­
tions should have been attempted. 
Burgess and Marsden,27 Dardik and 
associates" and Evans and associates6 
did not show any change in the level 
of amputation with failed reconstruc­
tion. Hunter and Holliday31 suggested 
that failed vascular reconstructions 
interfered with wound healing of 
above-knee amputations but had no 
effect on healing of below-knee ampu­
tations nor in determining the level of 
amputation. Previous vascular sur­
gery doubled (41% versus 20%) the 
need for local revision of amputation 
stumps.
Other reports suggest that recon­
struction has a detrimental effect, 
producing more primary above-knee 
amputations than expected. An early 
report by Couch and associates19
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chose objective parameters to predict 
the level of amputation and reapplied 
these after a graft had failed. By 
these criteria 33% of patients were 
converted from a below-knee to an 
above-knee level by a failed proce­
dure. Reinhold and associates25 and 
Kazmers and associates28 have shown 
significantly increased incidences of 
above-knee amputations with failed 
vascular reconstructions especially 
when femorodistal bypasses were 
used. Although wound complications 
and edema may cause this detrimental 
effect, propagated thrombus and im­
paired collateral flow may play a role.
The factors that might influence 
which limbs would need amputating 
after grafting had failed include age, 
indication for the initial procedure, 
inflow, run-off, type of conduit and 
level of the distal anastomosis.
Although the patients who had 
above-knee amputation were slightly 
older than those who underwent 
below-knee procedures, neither this 
nor the difference in the delay from 
the time of graft occlusion to amputa­
tion was significant. Above-knee am­
putations correlated with poor inflow 
and run-off, and with frank gangrene 
present before the initial procedure. 
We did not find a subgroup in which 
vascular reconstruction was futile. 
However, failed femorodistal bypass 
grafts were almost always followed 
by amputation. It is particularly im­
portant to improve inflow.
Claudication as the indication for 
the initial bypass was the only con­
sistent predictor of successful below- 
knee amputation. However, saphenous 
vein bypass in the presence of good 
run-off resulted in successful below- 
knee amputation, if it was necessary, 
irrespective of whether the indication 
for the vascular reconstruction was 
claudication or limb salvage.
Conclusions
Important findings regarding the 
need for amputation following failed 
femoropopliteal bypasses suggest that 
amputations are infrequent after by­
pass procedures for claudication and 
that such amputations are generally 
at the below-knee level. Poor inflow 
and poor run-off were both found 
in patients with claudication. The level 
of distal anastomosis of the graft, 
poor inflow and run-off, as well as 
frank gangrene before the initial pro­
cedure, all correlate with the need 
for amputation in thrombosed grafls 
placed initially to save the limb. 
Vigorous revision of failed grafts to 
ensure integrity of the distal anas­
tomosis may prevent amputation or 
delay it in a constructive way. These 
findings should allow a critical ap­
proach to the patient when first seen 
for consideration of vascular recon­
struction and in the management of 
patients with failed reconstruction.
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WALTER C. MACKENZIE RESEARCH DAY
Treatment of Primary Melanoma
A.J. Bodurtha, m b , bs, facs, frcs[c] and S.T. N orvell JR., MD, FRCSfC]
Surgery is the only effective treat­
ment for malignant melanoma. But 
controversy continues over the man­
agement of both primary lesion and 
the regional lymph nodes. The work 
of Clark and associates1 has led to 
an expansion of the clinical-histo­
logic classification of melanoma to 
include both the morphologic type 
(lentigo maligna melanoma, superfi­
cial spreading melanoma, nodular me­
lanoma) and the histologic microstag­
ing related to the depth of penetration 
of the lesion in the skin layers. Bres- 
low2 showed a better correlation of 
prognosis to the measured depth of 
invasion of the lesion from the outer­
most part of the granular layer of the 
epidermis. Thin melanomas (less than 
0.76 mm thick) carry an excellent 
prognosis while the thicker lesions 
(greater than 1.5 mm) carry an in­
creasingly poor prognosis. These two 
methods of classification provide a 
scientific basis for adequate staging 
of melanoma patients so that the 
various forms of therapy can be 
evaluated.
Excisional biopsy is recommended 
for all suspected lesions that can be 
excised completely, including an un­
derlying area of subcutaneous fat, 
and closed primarily. This will allow 
the pathologist adequate tissue for 
serial sampling to make a histologic 
diagnosis, to document the Clark’s 
classification and to measure Breslow’s 
depth of invasion. For larger tumours 
that cannot be totally excised with­
out a skin graft or those so situated 
that total removal would involve a 
disfiguring procedure, an incisional
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or punch biopsy is a reasonable al­
ternative to complete excision. How­
ever, it is essential that tissue is ob­
tained from the nodular area of the 
lesion for adequate sampling at its 
maximum depth of growth in order 
to provide satisfactory microstaging. 
No adverse effect has been docu­
mented for patients who undergo in­
cisional biopsy followed by immedi­
ate definitive surgery.3 The technique 
of electrocoagulation or desiccation of 
nevi is to be discouraged until the 
possibility of melanoma is excluded 
by biopsy.
Once a histologic diagnosis, includ­
ing microstaging, has been confirmed, 
the patient should be clinically staged 
by routine physical examination, 
chest roentgenogram, lung tomo­
graphy and nuclear scans of bone, 
brain and liver. Patients are then 
classified into stage I (localized 
melanoma without nodal or distant 
metastases), stage II (metastases con­
fined to regional lymph nodes) or 
stage III (disseminated metastatic 
melanoma). Curative surgery is re­
stricted to patients with clinical stages 
I and II disease.
Primary melanomas or the scars 
left after excisional biopsy have been 
treated by wide, three dimensional 
excision of the lesion with subsequent 
closure by skin graft or rotational 
flap. Excision of a 5-cm area of nor­
mal tissue at the periphery of the 
lesion is recommended and should in­
clude the deep fascia. The rationale 
for this approach dates back to 1907 
when Handley4 described centrifugal 
spread and lymphatic permeation in a 
patient with recurrent melanoma. 
His assumption was that metastases 
in the subdermal lymphatics occurred 
within 2.5 cm of the primary, hence 
the recommendation for a minimum 
of 5 cm excision of normal tissue. 
Further support for this 5-cm resec­
tional “margin” stems from the 
analysis by Petersen and associates5 
of local recurrence following exci­
sion.
Recently, the need for such wide
excision of all primary melanomas 
has been questioned. Breslow and 
Macht6 studied patients with mela­
nomas less than 0.76 mm thick 
who were managed by conservative 
excision and primary closure without 
grafting. Local control with no recur­
rence at 5 years was accomplished in 
this group using resection margins as 
small as 0.5 cm. Stehlin7 has ques­
tioned the necessity for the standard 
5-cm excisional margin in patients 
with clinical stage I, Clark’s level I, II 
and III melanomas. He proposed that 
primary melanomas less than 1.5 cm 
thick should be managed by regional 
perfusion in conjunction with immu­
notherapy and more limited local 
excision of the primary lesion. Until 
more results of limited surgical re­
sections are available, the three 
dimensional 5-cm margin, including 
the deep fascia, is recommended un­
less the extent of surgical excision 
will lead to compromise of vital organ 
function. Certain melanomas, because 
of their more benign behaviour or 
location, are exceptions to this. 
Lentigo maligna melanoma occurring 
on the face can be treated by excision 
and primary closure if the resection 
margins are histologically negative. 
Subungual melanomas require ray 
amputation through the appropriate 
metatarso- or metacarpophalangeal 
joint.
For patients with stage II mela­
noma, therapeutic regional node dis­
section should be performed. Where 
anatomically possible, in-continuity 
nodal dissection should be done 
since the procedure removes the pri­
mary, the regional lymph nodes and 
the lymphatics connecting these two 
areas. However, there appears to be 
no therapeutic advantage for syn­
chronous versus asynchronous, or for 
in-continuity versus discontinuity 
nodal dissections.8
The value of prophylactic node dis­
section for patients with clinical stage 
I melanoma is debatable. Many work­
ers9"11 have documented improved 
survival for patients treated with
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prophylactic node dissection. Other 
studies, including the recent prospec­
tive randomized study of Veronesi 
and coworkers,12 have demonstrated 
no survival benefit for patients treated 
with wide local excision and prophy­
lactic node dissection compared with 
a control group treated by wide ex­
cision and then therapeutic node dis­
section only if nodal metastases de­
velop. Yet, there are a number of 
circumstances in which most authors 
will agree that a prophylactic node 
dissection is contraindicated. These 
are patients with lentigo maligna 
melanoma, those with superficial 
spreading melanoma, Clark’s level I 
and II and Clark’s level III with a 
Breslow depth of invasion less than 
0.76 mm, and patients with primary 
melanoma so anatomically situated 
that the lymphatics drain to more 
than one group of regional nodes.
Until further randomized studies 
with adequately staged patients are 
carried out, the decision to undertake 
a prophylactic node dissection for 
clinical stage I melanoma must re­
main the individual surgeon’s choice. 
However, the decision must be guided
Tumours, trauma, scarring and sur­
gery constitute the main causes of 
destruction or section of the facial 
nerve. Otoneurosurgeons and neuro­
surgeons, working as a team, can re­
construct the facial nerve from a 
proximal stump located in the 
posterior fossa to its exit at the 
stylomastoid foramen. At this site 
the facial nerve is readily accessible 
for various procedures. Re-establish-
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by two factors: first, the incidence of 
histologically positive nodes follow­
ing node dissection in patients with 
clinically uninvolved regional nodes 
is reported to vary from 15% to 
40%; second, the morbidity of re­
gional node dissection, especially that 
involving the inguinal node region 
where wound infection, flap necrosis 
and lymphedema of late onset can 
be important.
The difficult and unpredictable 
problem of hematologic dissemina­
tion in melanoma accounts for its 
high mortality. At present, no effec­
tive adjuvant therapeutic regimen has 
been reported, but clinical trials con­
tinue in an effort to determine an 
effective immuno- or chemotherapeu­
tic regimen.
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portion with some fascicular divisions 
in the mastoid portion and at the 
stylomastoid foramen. The fascicles 
from the anterior portion of the facial 
nerve are thought to innervate mostly 
the inferior part of the face while 
those from the posterior portion in­
nervate mainly the upper part of the 
face.1 However, grafts made follow­
ing this theory are still associated with 
some mass movement, supporting the 
hypothesis that each fascicle within 
the main trunk contains fibres going 
to every facial nerve branch.
The great auricular nerve from the 
ipsilateral side of the neck represents 
the material of choice for grafting 
since1,2 its main trunk matches the 
proximal facial nerve in diameter. As 
a second choice the sural nerve may 
be used. If, for some reason, the 
proximal stump is not available, the 
seventh nerve of the normal con­
tralateral side can be used, but part 
of its innervation must be sacrificed. 
Results obtained by this technique do 
not match those of ipsilateral recon-
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struction. Indeed, many1,3 would pre­
fer to use an ipsilateral anastomosis 
with the hypoglossal nerve or spinal 
accessory nerve despite the muscular 
deficit that results. The graft should 
have the same diameter as the nerve 
being grafted and its length must 
exceed the gap by 15% to 20% to 
allow for retraction associated with 
the healing process. A few millimetres 
of epineurium are removed near both 
suture lines to give better visualiza­
tion of the fascicles and to ensure 
maximum coaptation between their 
cut ends. The anastomosis is made 
with 10-0 monofilament suture on an
atraumatic needle using 5 x  to 10 X 
magnification. One suture5 is placed 
to obtain good approximation of the 
cut ends and, where there is no ten­
sion, this, with the help of fibrin 
normally present in the wound, is suf­
ficient to maintain contact between 
the ends.
The importance of esthetic and 
functional movements of the face is 
such that attempts at reconstruction 
of the facial nerve should be made 
as soon as possible. However, some 
success may be achieved when re­
construction is performed as long as 
24 months after the onset of paralysis.
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Acute Gastroduodenal Mucosal Ulceration 
(Stress Ulceration)
D avid P. G irvan , m d , m  c l  sc , f r c s [c ]
Acute gastroduodenal mucosal lesions, 
frequently referred to as acute stress 
ulceration, have a spectrum of pa­
thologic features. These include: sim­
ple mucosal erythema, mucosal hem­
orrhage, superficial erosions and frank 
ulceration with the potential for major 
gastrointestinal hemorrhage or, more 
rarely, perforation. The occurrence 
of minor lesions as proved by flexible 
endoscopy is much higher than is gen­
erally realized, but many of these 
heal without complication. Although 
major hemorrhage or perforation is 
infrequent, the morbidity of this com­
plication is appreciable and the mor­
tality approaches 50% to 60%.
As our life support systems improve 
and use of critical care and trauma 
units increases, together with the con­
tinued flow of multiple trauma pa­
tients from our highways and the in­
creased age of our population as a 
whole, we can expect stress ulcers to 
remain a problem. Many such patients 
are already seriously ill from major 
trauma or previous surgical proce­
dures and the further insult of hemor-
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rhage or perforation results in stress 
ulcers of potentially lethal nature. 
Acute gastroduodenal mucosal lesions 
are seen with intracranial trauma 
(Cushing’s ulcers) and burns (Curling’s 
ulcers). Acetylsalicylic acid and other 
anti-inflammatory agents, such as 
phenylbutazone, indomethacin and 
some newer agents, are the leading 
offenders in drug-induced mucosal 
ulceration. It is doubtful that steroids 
and alcohol alone are ulcerogenic. 
Steroids probably reactivate or poten­
tiate peptic ulcer disease whereas al­
cohol is frequently used in association 
with acetylsalicylic acid and may be 
synergistic. Sepsis, hypotension and 
hypoxemia are commonly associated 
factors in patients who have acute 
gastroduodenal mucosal lesions.
The pathophysiology of these le­
sions is thought to be a disruption in 
the fine balance between the aggres­
sive acid peptic factors and the mu­
cosal defence barrier, which consists 
principally of gastric mucus and the 
gastric mucosal cell. Except in Cush­
ing’s ulcers, acid hypersecretion has 
not been an important factor in acute 
stress ulceration. Recent work1"3 has 
centred on the role of mucosal per­
meability, gastric blood flow, the 
secretory state of the gastric mucosal 
cells, acid-base balance and pros­
taglandins. The ability of the gastric 
mucosal cell to neutralize acid enter­
ing the cell from the lumen is particu­
larly important; a major factor in 
this neutralization is the appearance
of an alkaline tide of bicarbonate on 
the serosal surface or in the gastric 
venous blood. Important in influenc­
ing this delicate mechanism are the 
active secretory response by the mu­
cosal cell to build up the bicarbonate 
level, an adequate mucosal blood 
flow and a normal acid-base balance. 
Deficient mucus production, de­
creased epithelial renewal and defi­
cient gastric mucosal energy meta­
bolism, especially in the body and 
fundus of the stomach, which are 
classically involved in acute gastro­
duodenal mucosal lesions, have also 
been implicated. Prostaglandins of 
the E series are synthesized by the 
gastric mucosa and secreted into the 
gastric juice. These prostaglandins 
and their synthetic analogues inhibit 
gastric secretion and are also thought 
to have cytoprotective properties al­
though the mechanism for this is not 
clear.4
If the pH of the stomach can be 
kept above 4, development of acute 
gastroduodenal mucosal lesions can 
be prevented. This can be achieved 
by giving antacids frequently through 
a nasogastric tube or by administer­
ing cimetidine intravenously.5 Occa­
sionally both drugs must be combined 
to keep the intragastric pH above 4. 
Experience has shown that failure to 
control the acidity is often an early 
indicator of developing or ongoing 
occult sepsis.6 These patients have an 
extremely high mortality unless the 
sepsis can be dealt with quickly and
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effectively. The role of prostaglandins 
in the prophylaxis of acute gastro­
duodenal mucosal lesions is still un­
certain but they may well be of 
value.
Surgical intervention is indicated 
when prophylaxis fails and in patients 
who have continued bleeding that 
does not respond to the usual non­
operative measures. Many of these 
are already seriously ill from other 
diseases or complications, and the tim­
ing of surgical intervention is critical 
because they will not withstand pro­
longed bleeding. The operation of 
choice, with the least chance of re­
bleeding, is a generous partial gas­
trectomy and vagotomy, but if signifi­
cant bleeding from the gastric rem­
nant continues, total gastrectomy 
should be carried out initially.
Acute gastroduodenal mucosal ul­
ceration (stress ulceration) is part of 
a sequential system of organ failure 
involving the lungs, kidney, liver, 
blood clotting mechanisms and not 
infrequently the gastrointestinal tract.
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Drug-Induced Urinary Incontinence
H .G . K ir u l u t a , m d , f r c s [c]*
Urinary incontinence as a direct side- 
effect of commonly used drugs is 
increasing. Recent research into the 
pharmacology and physiology of 
bladder and urethral functions has 
given us a clearer picture of their 
mechanism of action. The bladder and 
the urethra are innervated by both 
parasympathetic and sympathetic 
nerve fibres. Parasympathetic stimu­
lation causes emptying of the bladder. 
Acetylcholine released by postgan­
glionic parasympathetic neurons stim­
ulates cholinergic receptors, resulting 
in contraction of smooth muscle in 
the body of the bladder. Alpha- 
adrenergic receptors are located pre­
dominantly in the bladder base and 
proximal urethra and their stimula­
tion by the neurotransmitter nore­
pinephrine causes contraction of the 
smooth muscle of the bladder neck 
and proximal urethra. Beta-adrenergic
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receptors predominate in the body of 
the bladder and their stimulation re­
sults in smooth muscle contraction 
in that portion of the bladder.
Urinary incontinence is thus a dys­
function of both the bladder, through 
its accommodating property during 
filling, and the proximal urethra, 
where a-adrenergic receptors are 
located. The latter is the common 
site of action of most drugs that cause 
urinary incontinence.
The neuroleptic drugs, major tran­
quillizers, are widely used to treat 
various psychoses. There are basically 
two types — the phenothiazines and 
the butyrophenones. All neuroleptic 
agents act selectively at dopamine re­
ceptors throughout the brain and body 
to produce a dopamine receptor block­
ade. They exhibit a wide range of 
central and peripheral action includ­
ing alterations in motor activity and 
sleep patterns. Because of their wide­
spread action, the phenothiazines 
cause a variety of related side-effects 
including blood dyscrasias, dyskinesia, 
parkinsonian syndrome, neuroleptic 
hypotension and jaundice. Bladder 
dysfunction is one of the least com­
mon side-effects of these drugs. How­
ever, in the last decade, voiding dis­
orders, particularly urinary inconti­
nence, have been widely reported. 
The patients showed no evidence of 
urinary tract abnormalities before 
treatment and in most cases the void­
ing disorders disappeared immediately 
following the withdrawal of the neuro­
leptic drug. The mechanism of this 
urinary incontinence is not known.
It has been suggested that the a -  
adrenergic blocking action of these 
drugs causes the internal urinary 
sphincter to relax in anatomically 
predisposed patients.1 However, other 
systemic a-adrenergic blocking effects 
are not seen. More likely neuroleptic 
agents produce bladder disturbance 
through a centrally mediated action.2 
Phentolamine and phenoxybenzamine 
may be used to treat atonic neuro­
genic bladders. They produce com­
petitive a-adrenergic blockade. Phen­
tolamine is supplied for intravenous 
use only and is not commonly used. 
However, phenoxybenzamine has been 
used with great success for urinarv 
retention secondary to neurogenic 
bladder dysfunction. In several pa­
tients on long-term treatment, stress 
urinary incontinence has developed 
with the use of this drug.3
Antihypertensive drugs can also 
produce bladder dysfunction. Reser- 
pine is the purified alkaloid of rau- 
wolfia and exerts its sympatholytic 
action by depleting the body of 
norepinephrine, dopamine and sero­
tonin. Stress incontinence has occurred 
in susceptible patients, particularly 
women, treated with reserpine.4 Al- 
pha-methyldopa has also been re­
ported to produce urinary inconti­
nence.5 It reduces peripheral sympa­
thetic tone but its mechanism of ac­
tion is not clear. The presently ac­
cepted view is that it exerts its effect 
within the central nervous system. 
Alpha-methyldopa is metabolized to 
a-methylnorepinephrine, which stim­
ulates inhibitory a-adrenergic recep-
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tors in the central nervous system and 
thus results in reduced peripheral sym­
pathetic tone. The combination of a -  
methyldopa and phenoxybenzamine 
has been noted to act synergistically 
in producing bladder dysfunction.6
Prazosin hydrochloride, a quina- 
zoline derivative with important anti­
hypertensive properties, is effective in 
controlling clinical hypertension. It 
exerts its effect by blocking a-adrener- 
gic receptors and causing peripheral 
vasodilation. Urinary incontinence as 
a result of its blocking effect on the 
a-adrenergic receptors in the proximal 
urethra occurs in susceptible pa­
tients.7,8 We have had a similar case in 
which total urinary incontinence oc­
curred in a woman who was taking 
prazosin; the incontinence disappeared
when the drug was discontinued. Uro- 
dynamic studies performed while this 
patient was on the medication re­
vealed a depressed urethral pressure 
profile, which returned to normal 
when the drug was withdrawn.3
The incidence of drug-induced 
urinary incontinence is small in the 
general population. Middle-aged 
women with borderline urinary stress 
incontinence make up most of the 
case reports in which drug-induced 
incontinence has occurred. However, 
bladder dysfunction in response to 
neuroleptic drugs does not appear to 
be restricted to any particular patient 
population or age group.
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Noninvasive Studies in the Intensive Care Unit
R ichard D. Weisel , m d , frcs[c]
A better understanding of the hemo­
dynamic alterations that take place 
in critically ill patients has improved 
their treatment. Recent technologic 
advances permit bedside assessment 
of cardiac function in surgical patients 
by noninvasive methods. The new 
techniques may further improve the 
results of postoperative therapy.
A clinically applicable, thermistor- 
tipped, flow-directed pulmonary artery 
catheter became available in 1972.1 
This catheter permits assessment of 
left ventricular filling pressure and 
cardiac output2 in critically ill pa­
tients. Manipulation of preload to 
achieve optimal cardiac perform­
ance became accepted therapy in 
1979.3 These measurements of left 
ventricular filling pressure and car-
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diac output demonstrated myocardial 
depression in patients who have re­
ceived large volumes of old blood 
or who have overwhelming sepsis.4,5 
The treatment of acute respiratory 
failure was revolutionized when posi­
tive end-expiratory pressure (PEEP) 
was introduced in 1969.6 Hemodynam­
ic monitoring has become routine 
with this modality, since PEEP de­
presses intrinsic cardiac function in 
addition to reducing cardiac filling.7
Nuclear angiography and echocar­
diography are noninvasive techniques 
that have been applied recently to 
critically ill surgical patients. These 
techniques will likely have as great 
an impact on our understanding of 
cardiac function and our methods of 
treatment as did pulmonary artery 
catheterization.
Radionuclide angiography permits 
direct assessment of ventricular vol­
umes and function, independent of 
geometric assumptions. Red cells are 
labelled in vivo with technetium-99m. 
A gamma camera is positioned over 
the heart and the counts in the regions 
of the right and left ventricles are 
divided into systolic and diastolic 
phases with the electrocardiogram. 
Ventricular ejection fraction and end- 
diastolic volume can be accurately 
and reproducibly obtained from nu­
clear angiograms. Postoperative stud­
ies have shown that the ejection frac­
tion is a sensitive index of systolic
performance.8,9 The end-diastolic vol­
ume is a more accurate index of left 
ventricular preload than the pul­
monary capillary wedge pressure.10,11 
Following cardiac surgery, studies at 
the Toronto General Hospital (un­
published data) demonstrated that 
volume loading from a low wedge 
pressure produced a large increase in 
volume and a small increase in pres­
sure and improved cardiac metabo­
lism. Volume loading from a high 
wedge pressure produced a large in­
crease in pressure with a minimal 
increase in end-diastolic volume and 
ischemic cardiac metabolism. The 
monoexponential relation between 
wedge pressure and end-diastolic 
volume prevents a linear extrapola­
tion from pressure to volume.11,12 In 
patients with sepsis or myocardial 
ischemia, nuclear angiograms provide 
information not available from rou­
tine hemodynamic monitoring.13 The 
additional information will improve 
our understanding of postoperative 
cardiac physiology and permit a more 
rational approach to therapy.
Two-dimensional echocardiography 
is an excellent method of assessing 
ventricular wall motion and can be 
employed to search for treatable 
causes of postoperative ventricular 
dysfunction. Echocardiography can 
assess global and segmental ventri­
cular wall motion, valve function, 
pericardial effusions and intracardiac
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shunts.14 Moreover, this technique is 
the most sensitive method of assessing 
the cardiac response to PEEP. Trans­
mural left atrial pressure appears to 
rise when more than 15 cm of PEEP 
are applied, but the change in end- 
diastolic dimension and septal wall 
motion is variable. Volume loading 
patients with more than 15 cm of 
PEEP can restore diastolic volume, 
but recent studies have shown that 
the interventricular septum may shift 
to the left and depress intrinsic car­
diac performance.13 Reducing right 
ventricular afterload may improve left 
ventricular function. Echocardio- 
graphic measurements provide the 
best currently available technique bv 
which to assess treatable causes of 
depressed performance15 and to evalu­
ate septal wall motion in response 
to PEEP.13
Hemodynamic monitoring has im­
proved the care of surgical patients 
in the intensive care unit, and the 
addition of nuclear angiographic and 
echocardiographic monitoring will 
provide further refinements in ther­
apy.
The author is indebted to the cardiol­
ogists who performed these studies: Drs. 
P.R. McLaughlin, J.D. Hilton and R.J. 
Burns and Ms. Sue Seawright from nu­
clear cardiology; and Drs. H. Rakowski 
and RJ. Howard from echocardiology.
References
1. Forrester JS, G anz W, D iamond G, Mc­
Hugh T, Chonette DW, Swan HJC: 
Thermodilution cardiac output determina­
tion with a single flow-directed catheter. 
Am Heart J 1972; 83: 306-11
2. Weisel RD, Berger RL, Hechtman HB: 
Measurement of cardiac output by thermo­
dilution. N Engl J Med 1975; 292: 682-4
3. Manny J, Grindlinger GA, Dennis RC, 
Weisel RD, Hechtman HB: Myocardial 
performance curves as guide to volume 
therapy. Surg Gynecol Obstet 1979; 149: 
863-73
4. Weisel RD, Dennis RC, Manny J, Man- 
nick JA, Valeri CR, Hechtman HB: 
Adverse effects of transfusion therapy dur­
ing abdominal aortic aneurysectomy. Sur­
gery 1978; 83: 682^90
5. Weisel RD, V ito L, Dennis RC, Valeri 
CR, Hechtman HB: Myocardial depres­
sion during sepsis. Am J Surg 1977; 133: 
512-21
6. Ashbaugh DG, Petty TL, Bigelow DB, 
Harris TM : Continuous positive -  pressure 
breathing (CPPB) in adult respiratory dis­
tress syndrome. J Thorac Cardiovasc Surg 
1969; 57: 31-41
7. Manny J, Grindlinger G, Mathe AA,
Hechtman HB: Positive end-expiratory
pressure, lung stretch and decreased myo­
cardial contractility. Surgery 1978; 84:
127-33
8. H ilton JD , Weisel RD, Baird RJ, Gold­
man BS, J ablonsky G, Pym J, Scully HE, 
Ivanov J, M ickle DAG, F eiglin DH, 
Morch JE, McLaughlin PR: The hemo­
dynamic and metabolic response to pacing 
after aortocoronary bypass. Circulation 
1981: 64 (2 pt 2): 48-53
9. Gray R, Maddahi J, Berman D, Raymond 
M, Waxman A, Ganz W. Matloff J, 
Swan HJC: Scintigraphic and hemodyna­
mic demonstration of transient left ven­
tricular dysfunction immediately after un­
complicated coronary artery bypass grafting. 
J Thorac Cardiovasc Surg 1979; 77: 504—10
10. Ellis RJ, Mangano DT, VanDyke DC: 
Relationship of wedge pressure to end dias­
tolic volume in patients undergoing myo­
cardial revascularization. J Thorac Cardio­
vasc Surg 1979; 78: 605-13
11. Calvin JE, Driedger A A, Sibbald WJ: 
Does the pulmonary capillary wedge pres­
sure predict left ventricular preload in 
critically ill patients? Crit Care Med 1981; 
9: 437-43
12. Lewis BS, Gotsman MS: Current concepts 
of left ventricular relaxation and com­
pliance. Am Heart J 1980; 99: 101-12
13. Calvin JE, Driedger AA, Sibbald WJ: 
The hemodynamic effect of rapid fluid 
infusion in critically ill patients. Surgery 
1981; 90: 61-76
14. Popp RL, Fowles R, Coltart DJ, Martin 
RP: Cardiac anatomy viewed systematically 
with two-dimensional echocardiography. 
Chest 1979; 75: 579-85
15. Spotnitz HM: Two-dimensional ultrasonic 
and cardiac surgery (abstr 20). Abstracts. 
61st annual meeting of the American As­
sociation for Thoracic Surgery, Washington, 
DC, May 11 to 13, 1981
Reflux Nephropathy and Low-Molecular-Weight
Proteinuria
A.H. Irvine, md, facs, frcs[c]* and E.Z. Rabin, md, ph d, FRCP[c]t
The term reflux nephropathy refers 
to the clinical, pathologic and radio- 
logic findings in the kidney resulting 
from vesicoureteral reflux. For reas­
ons unknown, some patients with 
reflux nephropathy experience pro­
gressive chronic renal failure that may 
occur even though the reflux has 
ceased spontaneously or has been 
corrected surgically.1 These patients 
may account for 10% to 20% of 
adults and almost 30% of children
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who enter a dialysis or transplant pro­
gram.2 Reflux nephropathy has also 
been said to be the commonest cause 
of hypertension in children.3
The presence of hypertension, the 
association of urinary tract infection 
and the grade or severity of the reflux 
do not help in establishing the prog­
nosis. Significant proteinuria (albumin­
uria), defined as the excretion of 
more than 0.2 g of high-molecular- 
weight protein in 24 hours, is the 
strongest indicator of a poor prognosis 
but is a late finding; renal biopsy 
carried out at this time will usually 
show that a glomerulopathy already 
exists.
The pathological findings are char­
acterized by focal glomerular hvper- 
cellularity, sclerosis and hyalinosis, 
with varying degrees of tubular 
atrophy and interstitial inflammation. 
Since tubular damage likely precedes 
glomerular involvement in cases of 
reflux, the early detection of tubular 
injury might serve as a marker for 
those patients at risk.
The proximal renal tubules are ac­
tively engaged in the absorption and 
degradation of low-molecular-weight 
proteins such as insulin, prolactin, 
lysozyme, growth hormone, ribonu- 
clease and ,82-microglobulin. Clinical 
studies in a variety of renal diseases 
have used the excretion of ^-micro- 
globulin and lysozyme as indices of 
low-molecular-weight proteinuria and, 
by inference, of tubular damage.4
Previous work5 in our renal labora­
tory has shown that the excretion 
of ribonuclease parallels that of 82- 
microglobulin. The level of urinary 
excretion of ribonuclease as an index 
of low-molecular-weight proteinuria 
has an important advantage in that 
the assays can be carried out by 
spectrophotometric techniques and are 
therefore simple and rapid. Polyacry­
lamide gel electrophoresis with sodium 
dodecyl sulfate is a reliable method of 
demonstrating low-molecular-weight 
proteinuria qualitatively and has been 
used as a screening test in our clinical 
studies. This condition will be pres-
408 VOLUME 25, NO. 4, JULY 1982 /  THE CANADIAN JOURNAL OF SURGERY
ent when tubular damage has oc­
curred, before any other measure of 
renal function has become abnormal.
In a group of 10 adults who had 
gross vesicoureteral reflux corrected 
surgically, 6 had low-molecular-weight 
proteinuria and 5 of these had normal 
creatinine clearance. We are present­
ly conducting a prospective study to 
assess the value of qualitative (gel
electrophoresis) and quantitative (ri- 
bonuclease) estimations of low-mole- 
cular-weight proteinuria in the evalua­
tion and management of vesicoure­
teral reflux.
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Disordered Cerebrovascular Responses 
after Subarachnoid Hemorrhage
D.P.J. Boisvert, md, ph d
One of the major complications of 
subarachnoid hemorrhage from a rup­
tured cerebral arterial aneurysm is the 
development of cerebral ischemia. 
Spasm of the major cerebral arteries 
is frequent in these patients and there 
is now compelling experimental and 
clinical evidence to support the view 
that this vasospasm is the major cause 
of the ischemia. However, the fact 
that some patients can tolerate 
moderate or even severe cerebral 
vasospasm without resulting neurol­
ogic deficit suggests that the ischemic 
potential of vasospasm is not solely 
a function of the degree of arterial 
narrowing.
Normally, autoregulatory constric­
tion or dilatation of cerebral arteries 
maintains cerebral blood flow ap­
proximately constant over a wide 
range of arterial or intracranial pres­
sures. My investigations1,2 and those 
of others3 have shown that the nor­
mal relation between cerebral blood 
flow and perfusion pressure can be­
come disordered after subarachnoid 
hemorrhage. Induced alterations in
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systemic blood pressure result in pro­
portional changes in cerebral blood 
flow.
If cerebrovascular responses are 
normal, distal vasodilatation can com­
pensate for focal vasospasm; however, 
further dilatation to compensate for 
systemic hypotension, increased in­
tracranial pressure or further proximal 
arterial narrowing is impaired. So a 
precarious state of “compensated 
vasospasm” may exist in patients with 
subarachnoid hemorrhage. Conversely, 
if cerebrovascular responses are mark­
edly impaired as a direct result of 
the subarachnoid hemorrhage, the 
subsequent occurrence of vasospasm 
may produce ischemia because ade­
quate distal compensatory dilatation 
is lacking. In the absence of vaso­
spasm, the combination of severely 
impaired cerebrovascular responses, 
hypotension and increased intracra­
nial pressure can produce critically 
low levels of cerebral blood flow.
These relationships indicate the 
potential importance of disordered 
cerebrovascular responses in determin­
ing cerebral perfusion in patients with 
subarachnoid hemorrhage — with or 
without vasospasm. Recent clinical 
observations strongly support this 
concept. Patients with impaired auto­
regulation run a greatly increased risk 
of neurologic deficit.4,5 On the other 
hand, impaired responses suggest that 
an increase in blood pressure may 
enhance perfusion. This has been con­
firmed by the demonstration that, in 
postoperative patients with severe
vasospasm, neurologic deterioration 
can be reversed by the prompt in­
duction of hypervolemia and hyper­
tension.6
It is now clear that vasospasm and 
impairment of cerebrovascular re­
sponses are both involved in deter­
mining the onset of cerebral ischemia 
in patients with subarachnoid hemor­
rhage. Therefore, management re­
gimens for these patients require care­
ful consideration of all systemic and 
intracranial factors that affect cere­
bral perfusion.
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Current Status of Needle Aspiration Biopsy 
of the Head and Neck
J .E .M . Y o u n g , m d , fa c s , f r c s [c ]
In the 1930s Hayes Martin1 was the 
first clinician to urge cytologic ex­
amination of needle aspiration biopsy 
specimens of solid tumours in the 
head and neck. The technique was 
widely used at Memorial Hospital in 
New York but was never generally 
accepted because few pathologists 
possessed the expertise, experience or 
the interest to interpret the cytologic 
preparations and few surgeons con­
sidered the techniques safe or reliable. 
Simplification of the Hayes Martin 
technique using a fine 22-gauge needle 
seems to have solved the theoretical 
risk of tumour seeding and the will­
ingness of pathologists to learn this 
technique has resulted in its increas­
ing popularity over the past decade.
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A 5-year retrospective analysis of 
516 needle aspiration biopsies done 
on the head and neck service at St. 
Joseph’s Hospital, Hamilton, has 
shown that this technique is not only 
safe, simple, cheap and rapid, but 
also is 94.5%  accurate.2 There were 
no complications and no tumour im­
plantations in this series. In cystic 
thyroid lesions ultrasonography is no 
longer necessary since aspiration 
cytology is equally accurate in differ­
entiating cystic from solid lesions, pro­
vides cytologic specimens to evaluate 
malignant tumours and is therapeutic 
in 40% of cases (n = 30). The overall 
diagnostic accuracy in thyroid lesions 
was 94.8% (n = 156). For nonthyroid 
lesions it was 94.4% accurate (n = 
280) in differentiating metastatic 
disease from benign lesions.
Needle aspiration of metastatic 
malignant nodes in the neck avoids 
the need for open biopsy and the risk 
of spreading malignant cells into the 
surrounding tissues where they cannot 
be detected at the time of radical 
surgical excision and are, at the same 
time, rendered anoxic and therefore 
relatively resistant to radiotherapy.
To derive the maximum benefit 
from this method, there must be close
cooperation between an interested and 
trained cytopathologist and an experi­
enced clinician. Valuable experience 
with this technique can be obtained 
by aspirating fresh surgical specimens.
If a malignant lesion is suspected 
clinically, a negative cytology report 
must be disregarded and the test re­
peated or an open biopsy considered. 
Needle aspiration biopsy is valuable 
because it is highly accurate, but it 
must be considered only as an aid 
in assessing a patient with a mass in 
the neck. It should not replace care­
ful initial examination and continued 
reassessment.
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Experimental Model for Investigating 
Embryogenesis in Congenital Vertebral Malformations
C harles  H . R ivard , m d , f r c s [c ]
This is a preliminary report on studies 
into the embryogenesis of congenital 
vertebral malformations using the 
mouse as the experimental animal and
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hypobaric hypoxia1 of the embryos as 
the teratogenic agent.
Congenital vertebral malformations 
occur during the mesenchymal stage 
of development of the vertebral col­
umn because all types of segmenta­
tion and structural abnormalities al­
ready exist in the cartilaginous stage 
of development of the vertebral col­
umn2. The malformations induced in 
this experimental model are identical 
to those described in humans.
Eighty-five percent of vertebral 
malformations are located in the an­
terior portion of the vertebral column.
The notochord is responsible for nor­
mal formation and segmentation of 
the anterior part of the vertebral 
column and the neural tube for the 
posterior part. During early develop­
ment the notochord produces nonsul- 
fated glycosaminoglycans and col­
lagen type I which induce the proli­
feration of cells around the notochord. 
It also produces sulfated glycosa­
minoglycans and collagen type II 
which induce mesenchymal cells to 
differentiate into chondroblasts. The 
distribution of glycosaminoglycans in 
our experimental model is sometimes
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asymmetrical and our working hypo­
thesis is that this asymmetry may 
induce the formation of hemiver- 
tebrae.3
Treated embryos, immediately af­
ter exposure to hypobaric hypoxia, 
had a reduced growth rate, but 8 days 
after treatment they had reached the 
same size as untreated controls. There 
must therefore have been a com­
pensatory stage of increased growth. 
With tritiated thymidine autoradio­
graphy, the treated mice were found 
to be in the stage of hyperprolifera­
tion 48 hours after treatment,4 but 72 
hours after treatment there was no 
difference between the growth rates
of the treated and untreated mice. To 
obtain more precise quantitative data 
the embryo cells were tested in tissue 
culture. The ratio of uptake of triti­
ated thymidine in treated cells over 
control cells at 24 hours was 5:1, at 
48 hours 5:2.5; after 72 hours the 
rates were equal.
Clearly the induction of congenital 
vertebral abnormalities by hypobaric 
hypoxia is a complex process that 
seems to involve abnormalities in the 
induction and growth rates and quite 
possibly other mechanisms. Neverthe­
less our experimental model should 
provide a useful tool for further 
studies.
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Measuring Treatment Outcomes in Surgery
T .H . B rian  H aig, m d , ph  d, f a c s , f r c s [c ]
Sick people seldom question the value 
of medical care. But others often 
do, frequently with good reason, for 
they see health care expenditures 
increasing exponentially with incon­
clusive evidence of benefits. Physi­
cians, holding a perspective similar to 
that of their patients, have been insist­
ing that even more resources be fun­
nelled into medical care to sustain 
and advance “quality care”. Neither 
patients nor physicians, however, 
know what this is and no one knows 
the extent to which we are delivering 
such a commodity now. There are 
good reasons, then, for all physicians 
to learn how to measure the value of 
the work they do. But surgeons in 
general, and general surgeons in par­
ticular, have additional incentives. 
Surgery has advanced strikingly 
through subspecialization, which has 
held advantages for practising sur­
geons as well as distinct benefits for. 
some groups of patients in the past, 
and continues to do so today. It is
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certain, however, that although con­
tinued fragmentation into subspecial­
ties will increase costs, the incremen­
tal benefits derived will tend to wither 
and at some point will begin to fall. 
Our problem is to learn how to meas­
ure treatment outcomes so that we 
can plan our training programs to 
gain the most at an affordable cost.
Measures of mortality and longevity 
are good, if crude, indicators of the 
health of a population, and they are 
readily available for North America 
and western Europe. It is principally 
these statistics that call into question 
the value of modern medicine. Mor­
tality rates, for instance, show that 
a sustained and rapid improvement 
occurred over the century ending 
about 1955 followed by a flattening 
of this curve throughout the past 25 
years. In contrast, health expenditures 
were low and rose very little over 
the first half of the 20th century, 
then in the mid-1950s began an ex­
ponential increase that has only now 
shown signs of abating. So, during the 
years we spent most, we gained least, 
according to these statistics. Through­
out the years of rapid growth in 
health care spending, our tendency 
has been to measure benefits in terms 
of production functions, that is, the 
number of the units of service pro­
vided, the number of doctors, nurses, 
dentists or hospital beds, or the num­
ber of operations performed. These 
are all measures of process and not
of outcome, so it is not surprising 
that they could all show evidence of 
substantial growth while evidence of 
improved health remains meagre or 
nonexistent. Although in the last few 
years some common diseases (athero­
sclerotic heart disease, stroke and 
some cancers) have shown declining 
incidence and mortality in some 
Western countries, the evidence that 
these improvements result from bet­
ter medical care is equivocal. It seems 
that most of the substantial improve­
ments in health that have occurred in 
the West during the last 125 years 
have been due to increased wealth 
and advances in social organization 
rather than to better medical thera­
pies. This need not imply that medical 
services are of low value; more likely 
it means that mortality and related 
statistics do not measure those factors 
upon which doctors have their great­
est impact. The need now is for reli­
able measures of outcome that will 
tell us what benefits people gain from 
medical therapies in terms of comfort, 
function and outlook for their future 
well-being. Moreover, this need must 
be met formally and scientifically, be­
cause the market has become so dis­
torted by the complexities of medicine 
and by our public financing of per­
sonal services that cumulative per­
sonal demand for medical services no 
longer clearly reflects the need for 
these same services.
One way in which we might meas-
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ure treatment outcomes in surgery 
would start by considering illness to 
consist of three components — dis­
comfort, dysfunction and prognosis. 
Each might be measured separately 
and then combined in such a way as 
to derive a single numerical figure 
that would describe an individual’s 
health level at a given time. Plotting 
these individual values over time could 
then be done so as to give a graphic 
representation of changes that occur­
red as a consequence of treatment. 
Patrick and colleagues1 have shown 
how we might measure and place 
preference values on various dysfunc­
tion levels. Williams2 has suggested 
ways in which this component of ill­
ness might be combined with meas­
ures of discomfort to give an illness
index. Culyer3 has recently discussed 
the strengths and weaknesses of these 
methods and suggested some ways in 
which clinicians might use them. Al­
ternatively, the Rand health insur­
ance study4 used several experimental 
methods that might be adapted to 
work of this kind.
What expectations should we have 
for the future? Within 5 years it 
should be possible to develop and re­
fine methods for measuring the value 
that patients and the general popula­
tion place upon the work we do. It 
will then take several years to make 
the measurements and to interpret 
their meaning. This work may influ­
ence only a little the day-to-day 
decisions that each doctor makes in 
the care of individual patients. Its
real impact will be on how we use 
hospitals, how we educate medical 
students and how we train those 
who are to provide surgical services 
in the future.
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Thermography in the Diagnosis of Breast Cancer
E r n est  E . St e r n s , m d , f r c s [c ], fa c s ,* A r t h u r  C. C u r t is , MD,f Sa lly  M il l e r , rnx and
J ohn  R . H ancock , b sc , m b a §
Screening women to detect minimal 
breast cancer is controversial. Only 
a mammogram can demonstrate a 
breast cancer before a mass is de­
tected either by the patient or a physi­
cian. To pick up cancers at a pre- 
clinical stage, repeated mammograph- 
ic examinations are required, and 
this raises the issue of benefit over 
risk. Thermography has been ad­
vocated, if not to replace mammo­
graphy, then to select those patients 
for whom mammography is justified.1 
However, the role of thermography 
is unclear. We have examined its 
value in the investigation of women 
with specific breast abnormalities as 
well as those being screened.
There are two methods of thermo-
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graphy. The most common (infrared 
thermography) detects infrared irra­
diation emitted from the breast. The 
other (plate thermography) utilizes 
the principle that cholesteric crystals 
change colour within a specific tem­
perature range.2 A plastic shield im­
pregnated with these crystals is ap­
plied directly to the breast and gives 
a graphic picture of the surface tem­
perature. Both types measure the 
same temperature and should detect 
the same abnormalities. In our breast 
clinic 500 patients had more than 
700 thermograms of both types to 
compare the two methods. Although 
there was a slightly higher incidence 
of abnormal plate thermograms, the 
results using the two techniques were 
essentially the same. We then tested 
the ability to interpret thermograms 
consistently. Using strict criteria for 
interpretation, we found “normal” 
thermograms were reported consis­
tently in 85% of examinations. How­
ever, fewer than half of the thermo­
grams considered to be equivocal 
or abnormal were reported in the 
same way on two occasions, either by 
the original or a second reporter. 
This lack of consistency, particularly 
with the abnormal thermogram, made 
us sceptical about the method.
Infrared thermography was aban­
doned after the study of 500 patients; 
plate thermography was continued 
because it demanded less technical 
expertise, was less expensive and 
could, if reliable, be applied in an 
office setting. Over 2000 plate ther­
mograms were made in 939 patients 
studied. Eleven percent of all these 
thermograms were reported as ab­
normal, 24% as equivocal and 65% 
as normal.
Of the 939 patients, 179 (19%) had 
at least one abnormal thermogram, 
but only 11 (6%) of these 179 proved 
to have cancer. Nevertheless, there 
was the possibility that cancer would 
eventually be detected in a patient 
who had an abnormal thermogram. 
We reviewed the records of 317 pa­
tients followed up for between 2 and 
41/2 years. Two to eight thermograms 
were reviewed for each patient. Sev­
enty-four (23%) of the 317 had con­
sistently equivocal or abnormal ther­
mograms and 2 of the 74 (3%) were 
found to have cancer during the fol­
low-up period.
Thermography was performed on 
68 patients with invasive carcinoma 
of the breast. Only 26 (38%) ther­
mograms were abnormal. In cancers 
less than 5 cm in diameter, the rate 
of abnormal thermograms was only 
30% whereas in those greater than
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5 cm, the rate was 66%. Obviously the thermogram was of little or no use in small cancers and did not help in the diagnosis of patients with pre- clinical disease.
Thermography was also performed on 162 patients with lesions that proved to be benign. Nineteen per­cent of the thermograms were ab­normal. There was no relation be­
tween the pathological and the ther­mographic diagnoses.
Finally, despite the limitations al­ready identified, we wondered wheth­
er the thermogram could help in the diagnosis of cancer missed either on 
clinical examination or mammo­
graphy. Of 68 patients with cancer, 
only 1 was considered to have a be­nign lesion by both the clinician and
the radiologist. In that patient the thermogram was normal. Three pa­tients with malignant disease, who did 
not undergo mammography preopera- tively, were considered clinically to have a benign lesion. In two the 
thermogram was normal and in the third equivocal. We concluded that 
thermography did not enhance the ability to differentiate benign from malignant masses.
In our opinion thermography is not sufficiently refined to assist in the diagnosis or screening of breast 
cancer. It lacks specificity and selec­tivity and adds nothing to the clinical 
and mammographic diagnosis. Our follow-up is too short to predict 
whether it identifies patients in whom 
cancer may subsequently develop
or whether breast cancers that are 
thermographically abnormal have a poorer prognosis than those that are thermographically normal.
We acknowledge the assistance of Mrs. Helen Rollins, Mrs. Carol Wade and Mrs. Marie Garrah. Thermographic equipment was provided by Professor W. Vaillant, Munich, West Germany.
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Pathophysiology of Ascites
Marvin J. Wexler, m sc, md, cm , facs, frcs[c]* and Mortimer L evy, md, F R C p [ c ] f t
Traditional concepts of ascites found in textbooks of liver disease1 state that the important factors are the hepatic 
venous outflow block that stimulates the formation of excess hepatic lymph 
which eventually exceeds the capacity of the thoracic duct to remove it. Failure of the liver to synthesize al­
bumin and, hence, lowered plasma oncotic pressure, and portal hyperten­
sion with its increased splanchnic col­laterals and vascular capacity, may 
contribute. This results in progressive depletion of the effective body fluids 
that signals the renal tubules to retain 
sodium and water. Body fluids are 
again replete, more ascitic fluid is formed and the cycle begins again. 
Within this formulation, the nephron response is thought to be secondary to the development of ascites.
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Another theory, first advanced by 
Lieberman and colleagues2,3 postulates that progressive hepatic cirrhosis, for 
unknown reasons, first causes urinary sodium retention. This leads to plas ma volume expansion that then re suits in ascites because of the abnor­
mal Starling forces from hypertension in the portal system. Within this for­mulation, ascites is an “overflow” 
phenomenon because the expanded 
plasma volume encounters a vascular territory primed to permit augmented 
transcapillary transudation of fluid. Ascites is now thought to be second­
ary to an alteration in nephron phy­siology.
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FIG. 1—Comparison of traditional (left) and overflow (right) theories of pathogenesis of sodium retention and ascites in cirrhosis. RBF =  renal blood flow, GFR =  glomerular filtration rate. (Reproduced by permission from Levin- sky N: Refactory ascites in cirrhosis. Kidney Int 1978; 14: 93.)
In summary, traditional concepts suggest that sodium retention by the 
renal tubules is secondary to contrac­
tion of the effective (nonsplanchnic) plasma volume from ascites, while the overflow theory postulates that salt retention by the renal tubules and 
plasma volume expansion are primary events that precede the appearance of ascites (Fig. 1).
Temporal Relation —
Experimental Cirrhosis
To investigate more fully the tem­
poral relation between sodium reten­
tion and ascites, experiments were performed in dogs with cirrhosis in­
duced by the sporadic feeding of di- 
methylnitrosamine. This canine model 
introduced by Madden and associates4 appears to be a reasonable equivalent to human alcoholic cirrhosis. In these 
and subsequent studies the dogs were housed in large metabolic cages where 24-hour urine collections could be measured accurately. They were fed diets in which the sodium content had been accurately determined. At dif­ferent intervals during the study, plas­ma volume was measured with T 1824-Evans’ blue, total body water with antipyrine, extracellular fluid 
volume and exchangeable sodium space with sodium-22. The splanchnic and nonsplanchnic (effective) compo­nents of plasma volume were meas­ured by an exclusion technique with Evans’ blue.5
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Sodium retention started about 16 
days following the development of 
cirrhosis and preceded the appearance 
of ascites by about 10 days. Plasma 
volume increased by 10% within 3 to 
4 days of sodium retention and ex­
panded further as ascites accumulated 
(Fig. 2). Both the “effective” and the 
splanchnic component of the vascular 
space were expanded. About one 
third was consigned to the non- 
splanchnic portion of the circulation. 
Renal perfusion remained constant as 
dogs became progressively cirrhotic.
We conclude that ascites depends 
on the prior retention of urinary so­
dium and occurs as an “overflow” 
phenomenon, thus supporting the 
view of Lieberman and associates. A 
contracted effective plasma volume 
does not appear to be necessary for 
continuing sodium retention. Plasma 
levels of renin, aldosterone, estrogens 
and progesterone remained normal in 
the salt-retaining nonascitic phase of 
cirrhosis and only rose once ascites 
was present.
Role of Portal Hypertension
To document the previous observa­
tions more fully, particularly that the 
“effective” plasma volume is actually 
expanded, and to establish conclusive­
ly whether or not there might be a 
role for portacaval collaterals in the 
initiation of renal sodium retention, 
we created surgically an end-to-side 
portacaval fistula in five dogs before 
inducing cirrhosis.6 Such a prepara­
tion allows the cirrhotic process and 
its biochemical complications to be 
dissociated from portal hypertension 
and its major hemodynamic conse­
quences. It was therefore possible to 
study the pathophysiology of ascites 
in the absence of augmented splanch­
nic vascular capacity.
time (a)
FIG. 2—Sodium balance studies in 
eight dogs with progressive cirrhosis. 
Balance studies were restarted after 
course of dimethylnitrosamine (DMN) 
when dogs were deemed to be cirrhotic 
by biopsy or liver function tests. Reten­
tion of urinary sodium and plasma vol­
ume expansion precede appearance of 
ascites. (Reproduced by permission from 
Levy M: Am  J Physiol 1977; 233: 
F572-85.)
As in the previous studies, urinary 
sodium retention preceded ascites 
(Fig. 3). It was independent of hyper­
aldosteronism, hypoalbuminemia, de­
creased hepatic blood flow or de­
creased renal perfusion. Portal venous 
pressure remained normal and the 
splanchnic area free of collaterals in 
all cirrhotic dogs. Plasma volume in­
creased by 8% to 10% following 6 
days of sodium retention and pre­
ceded ascites in a temporal pattern 
similar to that in the unshunted cir­
rhotic dogs previously studied. The 
plasma volume increased by 13% 
when measured during the ascitic 
phase of cirrhosis. There was no pref­
erential consignment of retained salt 
and water to the splanchnic or non- 
splanchnic components of plasma vol­
ume. Control dogs with portacaval 
shunts and no cirrhosis showed nor­
mal renal handling of salt and no 
ascites.
The results of these investigations 
further support the concept that as­
cites represents an overflow phenom­
enon dependent upon prior sodium 
retention by renal tubules with sub­
sequent expansion of both the effec­
tive and noneffective components of 
the circulation. Moreover, such re­
tention results from the physiologic 
consequences of the cirrhotic process 
rather than portal hypertension or 
any of its known hemodynamic con­
sequences. It also reaffirms that as­
cites is a product of hepatic and not 
intestinal lymph.
Role of Third-Space Ascites
A peritoneojugular shunt was in­
serted into five dogs already cirrhotic 
and grossly ascitic from dimethyl­
nitrosamine administration to study 
further the factors mediating sodium 
retention. These dogs were compared 
with five others rendered ascitic by
FIG. 3—Sodium balance studies in 
five cirrhotic dogs with prior portacaval 
shunt. Note appearance of urinary so­
dium retention and plasma volume ex­
pansion before ascites appears. (Repro­
duced by permission from Levy M, 
Wexler MJ: /  Lab Clin Med 1978; 91: 
520-36.)
50% constriction of the suprahepatic 
vena cava.7 These models allow in­
vestigation of the factors mediating 
sodium retention by renal tubules 
once the large third space is elimin­
ated and its reaccumulation prevented 
so that ascites cannot act as a salt- 
retaining influence. Sodium balance 
and plasma volume studies were per­
formed before and after mobilization 
of the ascites and in response to saline 
loading and diuretics.
Following mobilization of the 
ascites, the plasma volume, already 
expanded, expanded a further 10%, 
indicating incomplete diuresis. After 
the acute diuresis sodium balance 
again became positive and the chal­
lenge with a high-salt diet was met 
with increased sodium retention and 
positive balance; however, ascitic fluid 
did not reaccumulate in the dogs with 
patent shunts (Fig. 4). Fluid accumu­
lated in the interstitial space and fa­
cial and leg edema developed. Plasma 
levels of renin and aldosterone fell 
markedly following insertion of the 
shunt while glomerular filtration and 
renal plasma flow remained un­
changed. Identical responses were 
seen in the cirrhotic dogs and those 
with constriction of the vena cava.
From these studies,8 we conclude 
that: (a) continuous peritoneovenous 
shunting can effectively mobilize and 
eliminate large third-space ascites with 
minimal alteration of renal dynamics. 
This eliminates chronic vascular un­
derfilling and ascites, per se, as a 
cause of the persistent sodium reten­
tion; (b) a marked reduction of aldo­
sterone and renin occurs in the pro­
cess, eliminating these hormones as 
important factors in maintaining salt 
retention; (c) marked sodium reten­
tion occurs as a result of challenge 
with high-salt intake; there is ana­
sarca but no ascites if the shunt re­
mains patent, which further eliminates 
the ascites, per se, as a mechanism in
FIG. 4—Fluid and sodium responses 
in five cirrhotic dogs before and after 
mobilization of ascites by peritoneo­
jugular shunting, and in response to 
challenge with high-salt diet. Positive so­
dium balance and inability to excrete 
salt load occurs after mobilization of 
ascites in spite of notable fall in aldo­
sterone (ALDO) and renin levels.
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sodium retention; (d) identical re­
sponses occur in cirrhotic dogs with 
abnormal liver function and dogs with 
constriction of the vena cava who 
have normal liver function. Therefore, 
abnormal liver function and cirrhosis, 
themselves, are not the cause of the 
sodium retention.
Conclusions
Intrahepatic hypertension and con­
gestion itself may be the factor that 
signals the renal tubule to retain so­
dium continuously. This is important 
in both the initiation and maintenance 
of ascites. Current studies in progress
in cirrhotic dogs with a previously 
constructed side-to-side portacaval 
shunt, which simultaneously prevents 
the development of both portal hyper­
tension and ascites and allows normal­
ization of intrasinusoidal pressure, 
support this concept.
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Superfractionation Radiotherapy 
of Malignant Astrocytomas: 
Preliminary Experimental and Clinical Results
P.J. Muller, md, m sc, frcs[c] and K.H. Shin, md, dmrt, frcp[c]
Postoperative radiotherapy is an ef­
fective adjuvant treatment for malig­
nant cerebral gliomas.1 Although con­
ventional radiation has been shown 
to increase appreciably the postoper­
ative mean survival in patients with 
grade III and grade IV astrocytomas, 
even radiation doses that approach 
brain tolerance fail to achieve lasting 
local control of such tumours.2
The radioresistance of hypoxic cells 
to conventional radiotherapy using 
low linear energy transfer radiation, 
such as roentgen or gamma radiation, 
has been well established.3 The fail­
ure of conventional therapeutic radia­
tion to sterilize malignant cerebral as­
trocytomas may result from a pool of 
radioresistant hypoxic cells that are 
able to repopulate the tumour after 
reoxygenation has occurred.
Superfractionation radiation, which 
is the administration of multiple daily
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fractions of radiation, may be more 
deleterious to the hypoxic tumour 
cells than conventional single daily 
fractionation.3 With superfractiona­
tion radiation, the dose per fraction 
is smaller than with conventional frac­
tionation and takes advantage of the 
possibility that the oxygen enhance­
ment ratio will fall with decreasing 
radiation dose per fraction.4 The few 
clinical trials using superfractionation 
radiotherapy for malignant cerebral 
gliomas have produced conflicting re­
sults.5,6
In our experiments with C57BL/ 6J 
mice there were a minimum of 10 
mice per experimental arm. Cranial 
irradiation was administered to mice 
as either a single dose, as three frac­
tions in 3 days (conventional frac­
tionation) or as nine fractions in 3 
days (superfractionation). The median 
lethal doses were 1775, 2524 and 3631 
rad respectively. Whole body irradia­
tion was administered to mice either 
as a single dose, 5 fractions in 5 days 
(conventional fractionation) or 15 
fractions in 5 days (superfractiona­
tion). The median lethal doses were 
947, 1365 and 1534 rad respectively. 
In both cranial and whole body irradi­
ation, superfractionation resulted in 
significantly (P <  0.05) less lethal 
toxicity than did conventional frac­
tionation. The effects of conventional 
and superfractionation radiation on a 
subcutaneous murine ependymoblas- 
toma were compared in a series of 
experiments in which the durations 
of treatment were 5, 12 and 19 days. 
The tumour cell survival fraction in 
the groups receiving superfractiona­
tion was lower than in comparable 
groups receiving conventional frac­
tionation.
At the Southern Alberta Cancer 
Centre, over a period of 2Vz years, 
69 cases of astrocytoma, grades III 
and IV, were randomized into super­
fractionation and conventional frac­
tionation groups in a prospective ra­
diotherapy trial. The 35 patients in 
the superfractionation group and the 
34 patients in the conventional frac­
tionation group all received a total of 
5000 rad and steroidal therapy, and 
some received cyclohexyl-choroethyl- 
nitrosourea (CCNU) (100 m g/m2) 
every 6 weeks. A preliminary assess­
ment revealed a 1-year actuarial sur­
vival rate of 54% for the superfrac­
tionation group and 21% for the 
conventional fractionation group. 
Final assessment of the series awaits 
the follow-up of those who remain at 
risk. However, a trend favouring su­
perfractionation radiotherapy was 
identified.
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Quantitative Evaluation of Blood Loss during 
Debridement and Grafting of Burns
C ha rles  F .T . Sn e l l in g , m d , f r c s [c ]
Sharp debridement and delayed graft­
ing of burns, as employed at the burn 
unit, Vancouver General Hospital, 
permits earlier final closure of the 
wound and reduces patient morbidity, 
but it also produces extensive blood 
loss during and immediately after the 
procedure. This study was designed 
to quantify the extent of blood loss 
caused by sharp and blunt debride­
ment as well as the harvesting of skin 
for grafting.
Method
During the first 3 weeks after a 
burn injury, sharp excision is re­
quired. Excision is either tangential 
with the Cobbett knife, a method par­
ticularly appropriate for areas of 
mixed partial- and full-thickness burn, 
or excision to fat or fascia with scal­
pel or scissors for areas of uniform, 
full-thickness injury. Normotensive 
anesthesia is employed and major 
bleeding vessels are controlled. The 
wound is covered with wet saline 
compresses and occlusive dressings. 
Skin grafts are harvested from suit­
able donor sites and banked. After 
the excision, the wet saline compresses 
are changed every 4 hours on the
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ward. Bleeding does continue and in 
some cases application of topical 
thrombin or ligation of discrete bleed­
ing points is necessary. Up to four 
dressings may be required before the 
wound stops oozing. Grafts are ap­
plied on the first day after the burn 
injury with sufficient analgesia but 
without general anesthesia. This meth­
od is the procedure of choice in the 
majority of adult patients; however, 
young children usually undergo de­
bridement first and autograft harvest 
and application under a second gen­
eral anesthetic the following day. The 
patients treated later in the post-burn 
course who have maturing eschar that 
is separating spontaneously may not 
require sharp excision but blunt de­
bridement and gentle scraping of gra­
nulation tissue with a scalpel handle 
to produce a bed suitable for grafting.
Our results are based on studies 
carried out on 123 burn patients (12 
years of age and older) treated during 
a 1-year period. There were 124 pro­
cedures in which sharp dissection (tan­
gential or full thickness) debridement 
plus harvest of necessary autograft 
skin was carried out. There were 35 
additional procedures in which loose­
ly adherent eschar was removed by 
blunt debridement and hypertrophic 
granulation tissue scraped off fol­
lowed by skin harvest.
The volume of whole blood lost 
was estimated to be the sum of the 
volume administered during the pro­
cedure and postoperatively until the 
patient was stable and the volume 
calculated to increase the postopera­
tive hemoglobin to the preoperative 
hemoglobin when the two values dif­
fered by more than 0.1 g/dl. When 
packed cells were used, the equivalent 
of whole blood administered was cal­
culated by multiplying the packed cell
volume by 9/5. The preoperative he­
moglobin level was that determined 
24 hours before operation and the 
postoperative level was that obtained 
on the first or second day after oper­
ation and more than 12 hours after 
the completion of blood administra­
tion. The volume of blood required 
to bring the postoperative up to the 
preoperative hemoglobin level was de­
termined by a formula based on Mol- 
lison’s observation1 that administra­
tion of 250 ml of packed cells (cells 
from a single unit of blood) would 
raise the hemoglobin of an adult pa­
tient (weight of 70 kg has been ar­
bitrarily assigned) 1.0 to 1.5 g/dl. We 
made allowance in this calculation for 
the patient’s weight at the time of 
procedure.
The patient’s blood volume at the 
time of the procedure was determined 
from Nadler’s table2 which gives the 
blood volume based on sex, height 
and weight. The percentage of the 
blood volume lost was determined. 
The term “blood loss” used in the 
results is the mean percentage of the 
patients’ calculated total blood vol­
ume lost for each 1% of the body 
surface debrided of eschar and in­
cludes the blood loss due to the har­
vest of skin required to cover the 
debrided area.
Results
Blood loss (mean ±  standard devi­
ation) due to sharp debridement (in­
cludes pure tangential, pure full thick­
ness and procedures in which both 
methods of excision were employed) 
was 6.4 ±  5.0% (n =  124) of the 
total blood volume for each 1% of 
the body surface excised, including 
blood loss from the autograft donor 
site. Blood loss due to sharp debride-
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ment alone without autograft harvest 
was 6.5 ±  3.9% (n =  35). There was 
no significant difference between 
these two groups. For blunt debride­
ment plus autograft harvest, blood 
loss was 3.3 ±  3.8% (n =  35), sig­
nificantly less (P =  0.001, Student’s 
/-test) than for blood loss due to sharp 
debridement and harvest.
During the first 2 weeks after the 
burn injury, 26 patients who under­
went pure one-stage full-thickness ex­
cision to fat or fascia had a blood loss 
of 5.3 ±  3.9%, significantly (P =  
0.001) less than the blood loss of 9.2 
±  4.7% for 37 patients who had pure 
tangential debridement in the same 
period. Thus, the clinical impression 
that early tangential excision was as­
sociated with extensive blood loss was 
substantiated. When the same two 
groups were isolated and compared 
in the third and fourth weeks after 
injury, no significant difference in 
mean blood loss could be demon­
strated.
In the first 10 days after the burn 
injury, blood loss from excision per­
formed in limbs on which a tourni­
quet was used (7.7 ±  5.5%, n =  12) 
did not differ from the blood loss 
when excision was performed without 
a tourniquet (7.0 ±  5.7%, n =  50). 
This confirmed the impression that 
although there was no blood loss 
while the tourniquet was inflated, fol­
lowing deflation there was profuse 
bleeding that had to be dealt with at 
once.
Blood loss per unit body surface 
debrided of eschar was no greater in 
patients who had extensive excision 
than in those whose excision was 
more limited. This suggests that care 
with hemostasis was equal in the two 
groups and that the large volume of 
blood administered during the exten­
sive procedures had not induced addi­
tional bleeding. Blood loss due to 
harvest of autograft alone was 1.1 ± 
1.0% (n =  5) for each 1% of the 
body surface harvested.
The magnitude of blood loss with 
sharp excision of burn eschar is evi­
dent. In the early period after the 
burn when a choice exists, one may
choose to start by excising burn eschar 
on the limbs since more effective 
compression can be applied in these 
areas. Excision of the trunk lesions 
should be delayed if possible or full­
thickness excision to fat or fascia 
should be employed. Areas that are 
suitable for blunt debridement and 
scraping of hypertrophic granulation 
tissue appear to be associated with a 
blood loss not much greater than that 
due to the harvest of a corresponding­
ly sized donor area.
The large volume of blood lost with 
sharp debridement emphasized the 
need to have on hand adequate 
grouped and matched blood before 
embarking on a major excision. From 
7% to 10% of the calculated blood 
volume will need to be replaced for 
each 1 % of the body surface debrided.
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Chemically Fixed Human Umbilical 
Vein as an Arterial Substitute
R. Guidoin, ph d , R. Benichoux, m d , P. B lais, ph d , M.F. Sigot, ph d , M. Marois, m d , M. K ing, ing and
C. GOSSELIN, MD, FACS, FRCS[C]
The development of practical, readily 
available vascular conduits of uni­
form, small diameter, with biological 
and mechanical properties compar­
able to those of saphenous vein, would 
be a great asset in cardiovascular 
surgery.1 Reported success with 
chemically processed, liquid-preserved
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human umbilical veins stimulated our 
investigations.2,3 Liquid preservation 
has some disadvantages related to 
cytotoxicity, shelf life, sterilization 
and transplantation.4 Techniques for 
preparation of dry packaged surgical 
products appear to be feasible.
Methods
Umbilical veins from selected cords 
were rinsed and dilated hydrostatically 
with heparin and antibiotic solution 
at a pressure of 300 mm Hg. Teflon 
mandrels of the appropriate diameter 
were inserted into the veins to en­
sure that they did not bend or kink 
during processing.
Veins prepared in liquid medium 
(processed 2% glutaraldehyde, 95% 
ethanol or 98% glycerin and stored 
in 0.5% glutaraldehyde, 45% or 
70% ethanol or 98% glycerin) were 
compared with those that were pro­
cessed either by critical-point drying 
or by freeze-drying and then stored 
in a dry state. The liquid storage 
media were self-sterilizing. However, 
the dry prostheses were sterilized by 
gamma irradiation or with ethylene 
oxide.
Findings
Many veins that passed the selec­
tion protocol were subsequently found 
to have thin areas in their walls, and 
not all prostheses withstood hydro­
static pressure of 750 mm Hg for 
15 minutes without incurring struc­
tural damage that might jeopardize 
the usefulness of the vein as an ar­
terial prosthesis. Sustained hydrostatic 
pressure of 300 mm Hg without visi­
ble distension throughout the length 
of vein appeared to be a more reli­
able and less destructive technique 
for excluding marginally adequate ma­
terial. Storage in liquid media pre-
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sented few mechanical difficulties. 
However, prolonged ethanol or glu- 
taraldehyde storage caused desicca­
tion with changes in the tissues re­
sulting in irregularity of the lumen. 
Freeze-dried veins were hard and 
brittle even after rehydration. How­
ever, critical-point drying produced 
prostheses that had satisfactory me­
chanical properties. Sterilization by 
gamma irradiation increased the brit­
tleness of the vein but ethylene oxide 
did not.
The potential for tissue reaction 
was evaluated by using the conven­
tional USP implant test in the para­
vertebral muscles of rabbits. It was 
also evaluated in tissue culture by 
placing the luminal surface of aortic 
segments from 14-day-old chick em­
bryos directly on the test specimen in 
a nutrient medium. All prostheses 
stored in liquid media produced tissue 
reactions but dried and rehydrated 
prostheses were less cytotoxic.
All graft samples showed improved 
antithrombogenic characteristics after 
being washed in heparinized physio­
logic saline. The most thrombogenic 
specimens were those stored in 45% 
ethanol. Critical-point drying and sub­
sequent rehydration produced veins 
with least thrombogenicity. Rehydra­
tion of dried veins can be carried out 
with solutions containing heparin, 
antibiotics and adhesion enhancing 
proteins that are adsorbed by the lum­
inal wall and may reduce thrombo­
genicity.
Comment
The problem of patency of such 
prosthetic systems still remains to be 
solved for vessels with a small diam­
eter.5 Furthermore, improvements are 
required in the resistance of the 
prosthesis to deformation and rup­
ture from internal pressure and to 
flattening by external forces. It is
hoped that this can be achieved 
through the careful examination of 
alternative preparation methods.
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New Approaches to the Measurement of Pulmonary 
Capillary Permeability and Pulmonary Edema
Luis O p p e n h e im e r , m d , f r c s [c ]
Pulmonary edema secondary to in­
creased pulmonary capillary perme­
ability in the absence of heart failure 
is a common complication of shock, 
sepsis, fat embolism syndrome and 
viral, bacterial and aspiration pneu­
monia. At present the therapy is sup­
portive, directed at maintaining oxy­
genation with increased inspiratory 
oxygen concentrations, mechanical 
ventilation and positive end-expira­
tory pressure. Advances in the devel­
opment of treatment modalities aimed 
at restoring membrane permeability 
and lowering the gradient for edema 
formation have been hampered by 
lack of methods for measuring pul-
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monary edema dynamics and capillary 
permeability in vivo.
Experimental animal preparations 
in which pulmonary lymph is col­
lected have resulted in considerable 
advances in our knowledge.1 Lym­
phatic vessels draining pulmonary 
lymph exclusively are isolated and 
cannulated. It is then assumed, in the 
absence of net liquid accumulation in 
the lungs, that pulmonary lymphatic 
flow represents edema exchange 
across the pulmonary capillary mem­
brane in the region drained by the 
lymphatic field. By relating lymphatic 
flow to the net hydrostatic and pro­
tein oncotic gradients, a measure of 
the resistance of the capillary to the 
flux of water can be obtained. Also, 
by measuring the concentration of 
tracers in the lymphatic effluent and 
relating these to plasma concentra­
tion, the sieving properties of the 
membrane in relation to the tracers 
used can be determined. Although 
some of these assumptions are not 
met (there may be a net accumulation 
in the lungs; it is impossible to meas­
ure pressure gradients across the mem­
brane and lymphatic flow may not 
come exclusively from the lungs), this 
approach has been very helpful. In 
an effort to make the approach clin­
ically applicable, Gorin and Stewart2 
have measured the rate of leakage of 
transferrin labelled with indium-113 
into edema fluid by external scin­
tillation counting and relating the 
measurement to lymphatic concentra­
tion. In patients, it is possible to 
measure the clearance of tracers in 
edema fluid suctioned from the lungs 
— the leakier the membrane, the 
closer the concentration of the tracer 
in bronchial washings will approxi­
mate that in serum.3
Determinations based on tracer 
measurements assist us in determining 
changes in capillary permeability to 
that particular tracer, but cannot be 
used to measure changes in the mem­
brane conductance to water, which 
determines the rate at which edema 
forms for a given pressure gradient 
across the capillary membrane.
Unfortunately, there is poor cor-
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relation between clinical and radio- 
logic manifestations of the amount of 
edema, although computerized axial 
tomography promises to be more dis­
criminating. Measurements of gas ex­
change and pulmonary mechanics are 
also poor predictors of edema accu­
mulation. Chinard and Enns4 in 
late 1954 introduced the double-in­
dicator dilution technique for meas­
uring pulmonary edema. This method 
calculates the distribution volumes of 
a diffusable (distributed throughout 
all water spaces in the lung) and a 
reference (limited to vascular space) 
tracer. By subtracting the intravas­
cular volume from the total water 
volume of the lung the extravascular 
water volume or the amount of 
edema can be estimated. The accu­
racy of this approach is limited bv 
the ability of the diffusable indicator 
to mix homogeneously with the extra- 
vascular space, given the short transit 
time through the lung, nonhomogene- 
ous flow distribution producing in­
accurate results. Nevertheless, with 
the use of heat as diffusable and 
hypertonic saline or indocyanine green 
as intravascular indicators,5,4 fast on­
line determinations can be obtained 
with the use of microprocessors. If 
the limitations are kept in the proper
perspective, this approach shows 
great promise, but whether the tech­
nique is adequate to follow dynamic 
changes is questionable.
We have developed a method that 
we hope will be useful to measure 
both membrane conductance and 
small dynamic changes of edema in 
vivo. It is based on measuring the 
changes in concentration of an im­
permeable tracer between pulmonary 
venous and arterial blood as it flows 
through the lung.7 If there is edema, 
the tracer will concentrate as solvent 
leaves the vascular space and it will 
dilute when edema is reabsorbed. If 
there is no net flux there will be no 
difference between the pulmonary 
venous and arterial blood samples. 
For any given pressure gradient, the 
difference in concentration between 
pulmonary venous and arterial blood 
is proportional to the rate that edema 
forms, a rate that we can measure 
continuously “on line”. By relating 
the changes in this rate to the changes 
in the pressure gradient across the 
membrane (i.e., by lowering pulmo­
nary capillary wedge pressure) we 
can determine directly the membrane 
conductance to water. The changes in 
edema over a period of time following 
hemodynamic manipulations can then
be followed, although no estimate of 
the absolute amount of edema is 
possible. At present this technique 
has been validated in isolated canine 
lung lobes and we are in the process 
of determining its accuracy in intact 
animals. If this is successful, we shall 
have a tool to measure changes in 
membrane conductance to water and 
edema exchange across the capillary 
membrane.
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SESAP III Critique
ITEM 337
To determine the outcome with autogenous vein grafts, Szilagyi and associates studied a large series of 
patients undergoing femoropopliteal and infrapopliteal procedures. From 1962 to 1972, they per­
formed 377 autogenous vein bypasses. Patients were studied angiographically before discharge or within 
six weeks after operation, one year postoperatively, and at intervals of one to three years thereafter. 
Grafts were recovered at autopsy in eight patients, and in 13 patients at surgical correction of some 
abnormality found angiographically. Anatomic changes in the recovered material correlated with pre­
viously recorded angiographic appearances, proving the validity of angiographic interpretation.
Fibrotic valves, suture stenosis and fibrotic stenosis at the site of clamping all occurred in a few 
cases, but the mean time of development was less than two years. Intimal thickening and atheroscle­
rosis occurred with equal frequency, but the mean time of onset was 45 months for atherosclerosis vs 
16 months for intimal thickening. Aneurysmal dilatation was often a manifestation of atherosclerosis, 
and occurred at a mean of 28 months. It was concluded that atherosclerosis would probably occur if 
grafts remained in situ long enough. Angiographic findings led to revision of the grafts and successful 
results in a number of cases.
0
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NOW IN STROKE
The Advantages of ENTROPHEN*
To reduce the risk 
of stroke
Now, ENTROPHEN* is 
indicated for reducing the risk 
of recurrent transient ischemic 
attacks or stroke in men who 
have had transient ischemia 
of the brain due to fibrin 
platelet emboli. At present 
there is no evidence that 
ASA is effective in reducing 
transient ischemic attacks 
in women, or is of 
benefit in the treatment 
of completed strokes 
m men or women.
Inhibition of platelet ■ 
cyclooxygenase activity 
by a single dose of 
ENTROPHEN*-10
was comparable to 
that of plain ASA, P
although the effect was 
delayed, reflecting the 
delayed appearance of 
ASA in the plasma.1
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with reduced risk 
of stomach upset
When you prescribe 
ASA for long-term use, 
it is important not to create 
additional problems for 
your patients.
While they may benefit 
from the therapeutic 
effect of ASA, there is 
still a potential for 
gastric irritation and 
upset, particularly 
when the regimen calls 
for continuous daily 
dosage.
Clinical experience 
has shown that 
ENTROPHEN*, coated 
with POLYMER 37* 
reduces gastric distress 
in long-term treatment 
with high doses of ASA.
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TABLETS
entrophen
(acetylsalicylic acid tablets, USP) 
Enteric-coated with POLYMER 37* 
Anti-inflammatory— Analgesic Agent 
Platelet Aggregation Inhibitor 
DESCRIPTION
ENTROPHEN* is an enteric-coated tablet contain­
ing acetylsalicylic acid coated with POLYMER 37*. 
a partially esterified polyvinyl alcohol.
ACTION
Acetylsalicylic acid (ASA) has analgesic, anti­
pyretic and anti-inflammatory properties.
In rheumatic diseases, although the analgesic and 
antipyretic effects are useful, the major purpose 
for which ASA is used is to reduce the intensity of 
the inflammatory process. Inhibition of prosta­
glandin synthesis may be involved in the anti­
inflammatory action of ASA.
ASA also alters platelet aggregation and release 
reaction by inhibiting prostaglandin synthesis. 
Thromboxane A2 is an essential step in platelet 
aggregation. ASA prevents Thromboxane A2 for­
mation by acetylation of platelet cyclooxygenase. 
This inhibition of prostaglandin synthesis is 
irreversible and affects platelet function for the 
life of the platelet.
The POLYMER 37* coating substantially resists 
disintegration in aqueous fluids having a pH lower 
than 3.5 for a period of at least 2 hours and is 
capable of disintegrating in aqueous fluids having 
a pH of at least 5.5 in from 10 to 30 minutes. Thus, 
POLYMER 37* coating effectively inhibits the 
release of ASA in the stomach, whilst allowing the 
tablet to dissolve in the upper portion of the small 
intestine for absorption from the duodenal area. 
Clinical experience has shown that POLYMER 37* 
coated acetylsalicylic acid diminishes or eliminates 
gastric distress during long-term treatment with 
high doses of ASA.
INDICATIONS
ENTROPHEN* is indicated whenever gastric 
intolerance to ASA is of concern.
ENTROPHEN* is indicated for the relief of signs 
and symptoms of the following:
Osteoarthritis 
Rheumatoid arthritis 
Spondylitis 
Bursitis
and other forms of rheumatism
Musculoskeletal disorders
Rheumatic fever, however, penicillin and other
appropriate therapy should be administered
concomitantly.
ASA is generally considered to be the primary 
therapy for most forms of arthritis.
ENTROPHEN* is also indicated for reducing the 
risk of recurrent transient ischemic attacks or 
stroke in men who have had transient ischemia of 
the brain due to fibrin platelet emboli. At present 
there is no evidence that ASA is effective in 
reducing transient ischemic attacks in women, or 
is of benefit in the treatment of completed strokes 
in men or women.
CONTRAINDICATIONS
Sensitivity to the ingredients 
Active peptic ulcer
Patients who had a bronchospastic reaction to 
ASA or non-steroidal anti-inflammatory drugs.
WARNINGS
ASA is one of the most frequent causes of 
accidental poisoning in toddlers and infants. 
ENTROPHEN* should, therefore, be kept well out 
of the reach of all children.
PRECAUTIONS
Salicylates should be administered with caution 
to patients with asthma and other allergic condi­
tions, with a history of gastrointestinal ulcerations, 
with bleeding tendencies, with significant anemia 
or with hypoprothrombinemia.
Salicylates can produce changes in thyroid 
function tests.
Acute hepatitis has been reported rarely in 
patients with systemic lupus erythematosus and 
juvenile rheumatoid arthritis with plasma sali­
cylate concentrations above 25 mg/100 mL.
Patients have recovered upon cessation of 
therapy.
Use in Pregnancy
ASA does not appear to have any teratogenic 
effects. ASA has been found to delay parturition 
in rats. This effect has also been described with 
non-steroidal anti-inflammatory agents which 
inhibit prostaglandin synthesis.
High doses (3 g daily) of ASA during pregnancy 
may lengthen the gestation and parturition time. 
Because of possible adverse effects on the 
neonate and the potential for increased maternal 
blood loss, ASA should be avoided during the last 
three months of pregnancy.
Drug Interactions
Caution is necessary when ENTROPHEN* 
and anticoagulants are prescribed concurrently, as 
ASA may potentiate the action of anticoagulants. 
Salicylates may potentiate sulfonylurea hypo­
glycemic agents. Large doses of salicylates may 
have a hypoglycemic action, and thus, affect the 
insulin requirements of diabetics.
Although salicylates in large doses are uricosuric 
agents, smaller amounts may depress uric acid 
clearance and thus decrease the uricosuric 
effects of probenecid, sulfinpyrazone and 
phenylbutazone.
Sodium excretion produced by spironolactone 
may be decreased in the presence of salicylates. 
Salicylates also retard the renal elimination of 
methotrexate.
ADVERSE REACTIONS
Gastrointestinal reactions: nausea, vomiting, 
diarrhea, gastrointestinal bleeding and/or ulcera­
tion. Ear reactions: tinnitus, vertigo, hearing loss. 
Hematologic reactions: leukopenia, thrombo­
cytopenia, purpura. Dermatologic and Hypersen­
sitivity reactions: urticaria, angioedema, pruritus, 
various skin eruptions, asthma and anaphylaxis. 
Miscellaneous reactions: acute reversible hepato- 
toxicity, mental confusion, drowsiness, sweating 
and thirst.
SYMPTOMS AND TREATMENT 
OF OVERDOSAGE 
Symptoms
In mild overdosage these may include rapid and 
deep breathing, nausea, vomiting (leading to 
alkalosis), hyperpnea, vertigo, tinnitus, flushing, 
sweating, thirst and tachycardia. (High blood 
levels of ASA lead to acidosis.) Severe cases may 
show fever, hemorrhage, excitement, confusion, 
convulsions or coma, and respiratory failure. 
Treatment
Treatment is essentially symptomatic and sup­
portive. Administer water, universal antidote and 
remove by gastric lavage or emesis. Force fluids 
(e.g., salty broth) to replace sodium loss. If the 
patient is unable to retain fluids orally, the alkalosis 
can be treated by hypertonic saline intravenously. 
If salicylism acidosis is present, sodium bicar­
bonate intravenously is preferred because it 
increases the renal excretion of salicylates. 
Vitamin K is indicated if there is evidence of 
hemorrhage. Hemodialysis has been used with 
success.
Respiratory depression may require artificial 
ventilation with oxygen. Convulsions may best be 
treated by the administration of succinylcholine 
and artificial ventilation with oxygen. Central 
nervous system depressant agents should not 
be used.
Hyperthermia and dehydration are immediate 
threats to life and initial therapy must be directed 
to their correction and to the maintenance of 
adequate renal function. External cooling with 
cool water or alcohol should be provided quickly 
to any child who has a rectal temperature over 
104°F.
DOSAGE AND ADMINISTRATION 
Analgesic; antipyretic
Up to 2.925 g daily as necessary. 
Anti-inflammatory
Because the suppression of inflammation in­
creases with the dose of salicylate even beyond 
the point of toxicity, the therapeutic objective is 
to employ as large a dose as possible short of 
toxicity. Most patients will tolerate blood salicylate 
levels in the range of 20 to 25 mg per cent. The 
most common reason for failing to obtain a 
therapeutic response to ASA is the administration 
of inadequate doses.
The generally accepted way to achieve effective 
anti-inflammatory' salicylate blood levels of 20 to 
25 mg per cent is to titrate the dosage by starting 
with 2.6 to 3.9 g daily, according to the size, age 
and sex of the patient. If necessary, the dosage is 
then gradually adjusted by daily increments of 
0.65 g until symptoms of salicylism e.g., auditory 
symptoms, occur. Then, the dosage is decreased 
by 0.65 g daily until these symptoms disappear 
and maintained at that level as long as necessary. 
In adults the median dose at which tinnitus 
develops is 4.5 g per day, but the range extends 
from 2.6 to 6.0 g per day.
Intermittent administration is ineffective. Patients 
should be advised not to vary the dose from day 
to day depending on the level of pain because 
that often fluctuates independently of the intensity 
of the inflammation. A continuous regimen of 
0.65 g four times daily is considered to be 
minimum therapy for adults. ENTROPHEN* 
should be administered four times daily. For night­
time and early morning benefits, the last dose 
should be given at bedtime.
Once m aintenance dose is estab lished , 
ENTROPHEN*-15 may be useful to encourage 
patient compliance.
Optimally, salicylate therapy should be monitored 
by periodic blood salicylate level determinations. 
If this is not practical, the appearance of auditory 
symptoms in the form of tinnitus or deafness are 
acceptable as an indication of the maximum 
tolerated salicylate dose.
There is an inverse relation between blood 
salicylate levels at which auditory symptoms 
appear and the age of the patient. In the young 
adult, this is usually in the range of 20 to 30 mg 
per cent. In children, however, the level may be 
much higher, or the effect apparently absent. 
Because salicylate toxicity may appear without 
such warning in children, the usual practice is to 
give ASA in a daily dose of 50 to 100 mg per 
kilogram of body weight and to follow blood levels 
aiming for a concentration of about 30 mg per cent. 
Rheumatic Fever
A total daily dosage of 100 mg per kilogram of 
body weight administered in divided doses to 
allay the pain, swelling and fever.
Cerebral ischemic attacks (men)
The recommended dosage is 1,300 mg per day 
(650 mg twice a day or 325 mg four times a day).
AVAILABILITY
No. 472— ENTROPHEN*-15 tablets containing 
975 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Oval, pale yellow, film-coated 
tablets with the FROSST name engraved on one 
face and 472 on the other and supplied in bottles 
of 100 and 500.
No. 470— ENTROPHEN*-10 tablets containing 
650 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Oval, orange, film-coated tablets, 
with the FROSST name engraved on one face 
and 470 on the other and supplied in bottles of 
100, 500 and 1,000.
No. 438— ENTROPHEN*-5 tablets containing 
325 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Round, brown, film-coated tablets, 
with the FROSST name engraved on one face 
and 438 on the other and supplied in bottles of 
100, 500 and 1,000.
FULL PRODUCT MONOGRAPH AVAILABLE 
ON REQUEST.
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Current Concepts of Oxygen-Transporting 
Blood Substitutes
R o b e r t  B. B o l in , m d
Blood substitutes are being developed 
that will provide oxygen-transporting 
capabilities as well as volume replace­
ment. Perfluorochemical and 
hemoglobin solutions have potential 
clinical use. A perfluorochemical blood 
substitute, Fluosol-DA 20%, is being 
used in clinical trials in several 
countries. These blood substitutes are 
not capable of totally replacing the 
need for blood transfusions but 
could be used temporarily in situations 
where blood is contraindicated or 
not available. They may be useful for 
a wide range of clinical conditions 
other than blood replacement, such as 
impending tissue ischemia. Before 
large-scale clinical use of these 
products is realized, more information 
is needed about drug efficacy and 
safety so that intelligent decisions 
can be made about indications for 
this type of transfusion therapy.
Des substituts du sang sont en 
developpement qui offriront des 
proprietes de transport d'oxygene 
tout en corrigeant la masse sanguine. 
Des composes perfluores et des 
solutions d'hemoglobine laissent 
entrevoir des utilisations cliniques 
prometteuses. Un substitut du sang 
perfluore, le Fluosol-DA a 20%, 
est en essai clinique dans plusieurs 
pays. Ces substituts du sang ne 
peuvent prendre totalement la place 
des transfusions sanguines mais ils 
peuvent etre employes temporairement 
dans les situations ou le sang est 
contre-indique ou lorsqu'il n'est pas 
disponible. Utilises a d’autres fins 
que pour corriger la masse sanguine, 
ils peuvent etre utiles dans une foule
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de situations cliniques, telles qu’une 
ischemie tissulaire imminente. Avant 
que ces produits ne soient utilises 
en clinique sur une large echelle, 
de plus amples informations sont 
necessaires sur leur efficacite et leur 
surete, de facon a ce que des 
decisions intelligentes puissent etre 
prises sur les indications de ce type 
de transfusion.
Blood substitutes are drugs that can 
maintain adequate cellular energy 
during hypoxic states due to compro­
mised circulation. Efforts are being 
made to develop blood substitutes 
that can transport oxygen. The use 
of an oxygen-transporting solution is 
more desirable than the use of one 
that does not have this capability, 
since aerobic metabolism can be bet­
ter maintained; aerobic metabolism is 
19 times more efficient than anaero­
bic metabolism in providing cellular 
energy.1 To understand the variables 
that influence oxygen transport, the 
Fick principle is illustrative when 
oxygen consumption is dependent on 
oxygen delivery and tissue extraction.
Vo2 =  Q X 1.34 X [Hb] X 
(Sao2 — Svo2)
Four variables that influence oxygen 
consumption (Vo2) are blood flow 
(Q), the amount of oxygen that can 
be carried by 1 g of hemoglobin 
(1.34 ml), the concentration of hemo­
globin (Hb) (g/ dl) and the arterial 
oxygen saturation (Sao2) minus the 
venous oxygen saturation (Svo2).2 
Blood flow is influenced by stroke 
volume, vascular volume, viscosity of 
the blood or the solution replacing 
the blood, and vascular tone. Blood 
flow is the most complex and impor­
tant compensatory variable in acute 
events leading to hypoxic states; for 
example, when blood volume is only 
about 50% of normal, oxygen delivery 
is irreparably compromised.3 Converse­
ly, if the hemoglobin concentration 
falls below 2 to 3 g/dl then compen­
sation by uncompromised blood flow 
is unable to maintain oxygen con­
sumption.4 Saturation differences be­
tween arterial and venous circulation
must have a critical limit depending 
on the inherent properties of the oxy­
gen-transporting solution to off-load 
oxygen into the tissue. Blood or its 
substitute is needed when the com­
pensatory capabilities of these vari­
ables to maintain adequate oxygen 
consumption are reached. Plasma ex­
panders (crystalloids or colloids) are 
blood substitutes, in a sense, because 
they expand intravascular volume and 
have better rheologic properties than 
blood for maintaining flow and, there­
fore, oxygen delivery. However, a 
blood substitute that supplies oxygen 
could maintain oxygen consumption 
by enhancing the level of compensa­
tion for oxygen delivery as well as 
tissue extraction. Three oxygen-trans­
porting substitutes could be developed 
for blood replacement: perfluoro­
chemicals,4'6 hemoglobin solutions7'9 
and synthetic chelates.10 Synthetic 
chelates have not been used as blood 
substitutes but are potential oxygen­
transporting substances. At present, 
they are only of theoretical interest 
and will not be discussed further in 
this review.
Perfluorochemicals
From the standpoint of clinical ap­
plication, perfluorochemicals are the 
most advanced oxygen-transporting 
substances. Two commercial per­
fluorochemicals, Fluosol-DA and 
Fluosol-43 (Green Cross Corp., Osaka, 
Japan), are available. Fluosol-DA is 
made in two concentrations, 20% 
and 35% active perfluorochemicals. 
Fluosol-43 has perfluorotributylamine 
as its active perfluorochemical. It is 
not adaptable to human use because 
of its prolonged retention in the 
body.11 However, it has been a good 
tool for in vitro work and animal 
studies. Fluosol-DA is currently be­
ing investigated for human use. Its 
active compounds are perfluorodecalin 
and perfluorotripropalamine.11 These 
compounds are fluoronated aromatic 
and aliphatic organic chemicals in 
which reactive hydrogen groups have 
been replaced by nonreactive fluoride 
ions. This imparts nonpolar charac­
teristics to these perfluorochemicals 
and gives them solvent properties to
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dissolve large quantities of gases such as oxygen.9 The active perfluoro- 
chemicals are emulsified with Pluronic F-68 and yolk phospholipid to stabi­lize the solution, since perfluorochem- 
icals are poorly soluble in aqueous solutions such as plasma.12 By emul­sification, small micelles are formed that have a diameter of less than 0.2 
/a. 11 The surfactants form a mem­brane that is between 30 and 40 A 
thick.13 Glycerol is added to give the solution osmolarity. Hydroxethyl- 
starch and electrolytes are added to 
give oncotic activity and sodium 
bicarbonate is added for buffering 
capacity.11 Fluosol-DA is stored froz­
en because it is unstable in emulsion 
form.12 Newer perfluorochemicals are 
being developed and may offer im­
proved emulsion stability.14
These compounds have distinct ad­vantages. In addition to carrying oxy­
gen in solution, other gases such as 
carbon monoxide15 and carbon di­
oxide16 can also be transported. Per­
fluorochemicals are less viscous than blood and, therefore, have better flow properties."
Perfluorochemicals, such as per- fluorodecalin in Fluosol-DA, have 
limited oxygen-transport capability at ambient pressures. Oxygen content is 
linear with respect to oxygen tension, 
as opposed to blood in which the rela­tion is sigmoid for oxygen.16 Blood 
can deliver 5.9 vol% oxygen to tis­sues at ambient pressure, whereas, at 
these same pressures, Fluosol-DA 
20% can only deliver about 1 to 2 vol%." But, if oxygen pressure is 
increased to one atmosphere of in­spired gas (Flo2 =  1.0), the amount 
of oxygen that can be delivered by 
Fluosol-DA 20% is about the same as blood. There is evidence that a 
lower oxygen pressure (F io2 = 0.85) 
can be used if the concentration of perfluorochemicals is increased.11
Being emulsions, these compounds have a finite life span in the intra­
vascular space; Fluosol-DA has a 
plasma half-life in rats of about 13 hours.11 Although their limited life span is less than that of red blood cells, these compounds may have po­tential in acute situations to provide volume expansion as well as oxygen delivery.
Although the intravascular half- life is short, perfluorochemicals have relatively longer body half-lives; their elimination is primarily by transpira­tion through lungs and skin.17 Fluosol- DA has a body half-life of 8.9 days." 
In animal studies, tissue deposits of these perfluorochemicals have been observed for 2 months." Little infor­
mation is available about tissue de­position in humans. Ohnishi and Kita- zawa18 studied a patient who received 
a total dose of Fluosol-DA 20% of 67 ml/kg body weight over 4 days. This patient subsequently died of renal failure; at autopsy, foamy histiocytes were found throughout the body, but mostly in the spleen, lymph nodes and liver. The histiocytes were composed of vacuoles that contained 
small particles consistent with the 
Fluosol micelles.18 The lymph nodes were enlarged and were almost de­
pleted of normal lymphocytes, par­
ticularly in the sinusoids. Perfluoro­
chemicals (about 290 mg/g wet tis­
sue) were found in the spleen.
Adverse reactions to Fluosol-DA 
have been reported in humans. Dur­ing preclinical trials in dogs, com­
plement activation was noted and 
thought to be due to the emulsifier. 
Pluronic F-68." By decreasing the amount of this emulsifier and adding 
yolk phospholipid, the activation 
phenomenon was eliminated. How­
ever, in the first patient treated with 
Fluosol-DA in the United States,19 transient hypotension and pulmonary 
infiltrates developed. In vitro evalua­tion of the Fluosol-DA showed com­
plement activation by the alternate pathway. Two other candidates with 
normovolemic anemia had symptoma­tic hemodynamic reactions to a 0.5- ml test dose.20 One hundred and 
eighty-one patients treated in Japan with Fluosol-DA have not demon­
strated adverse reactions.21In the US, clinical trials are now 
evaluating Fluosol-DA 20% in the 
treatment of hypoxic anemias (where 
blood products cannot be given).20,22 
It is also being used in controlled en­
vironments as a resuscitation fluid for hypovolemic hypoxia due to 
hemorrhage,21 but has to be used with hyperbaric oxygen which will limit 
its use to medical facilities. It has been suggested that the perfluoro­
chemicals be used as organ perfusates 
since these compounds can maintain organ viability until transplanted.23 
They may be useful as priming solu­tions for extracorporeal circulation," for treatment of carbon monoxide poisoning since this gas is highly solu­
ble in perfluorochemicals21 and for organ ischemia. Studies in dogs24 have shown that perfluorochemicals reduce the extent of injury in induced myo­cardial infarction and studies in cats25 show similar results in induced strokes.
Hemoglobin Solutions
Hemoglobin solutions were first
proposed in 1868 as a blood substi­
tute and even as early as 1916 hu­man trials were performed.28 How­ever, because of toxicity, they were not developed further until 1967 when Rabiner and associates9 devised 
techniques for removing most of the stroma from the hemoglobin. Al­though not as clinically advanced as perfluorochemicals, hemoglobin solu­
tions have some advantages. They transport oxygen as a ligand and, 
therefore, will function at ambient 
oxygen pressures,8 are oncotically ac­tive and soluble in physiologic and aqueous solutions.27 Unlike blood, 
there is no need to cross-match hemo­globin solutions since stromal ele­ments have been removed.28 They have a lower viscosity than blood29 
and can be stored for long periods,30 even at ambient temperature if the 
hemoglobin is lyophilized.31
One of the major problems of hemoglobin solutions is poor intra­
vascular retention. When it is ex­change-transfused in animals, to 95% 
blood replacement, the hemoglobin 
has a half-life time of 2 to 5 hours.28 The intravascular retention of hemo­
globin is postulated to be related to its molecular size and the fact that it is excreted through the kidneys.32 
Hemoglobin, in solution, exists as a 
tetramer (MW 68 000), which is in equilibrium with a small amount of dimer form (MW 34 000). Intravas- 
cularly, the dimers are excreted by the kidney or removed by the reticulo­
endothelial system8 which causes con­
tinual tetrameric dissociation. If the 
dose of hemoglobin is increased, such as occurs when a massive transfusion 
is used, the primary mode of elimina­
tion is by renal excretion of the dimer. If tetrameric hemoglobin could be cross-linked to stabilize the mole­
cule, there would be decreased dimer formation and a four- to fivefold in­
crease in intravascular retention.32 In- 
termolecular modification is also 
feasible. By adding glutaraldehyde to a solution of hemoglobin, polymeriza­
tion results which increases molecular weight.33 Since this reaction is non­specific, oxygen transport is im­
paired.34Hemoglobin solutions show a marked shift of the oxyhemoglobin dissociation curve to the left com­pared with normal red blood cells, since the hemoglobin has been stripped 
of its diphosphoglycerate (2,3-DPG) during processing.8,28 Diphosphogly­cerate is removed during processing since its affinity to the 2,3-DPG 
pocket of hemoglobin is by weak hydrogen bonds. Pyridoxal phosphate,
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like 2,3-DPG, can decrease oxygen 
affinity (increase P50 —  the oxygen 
tension at which 50% saturation of 
hemoglobin occurs —  from 16 to 26 
mm Hg) and can be covalently 
bonded to hemoglobin.35 Pyridoxal 
phosphate probably does not improve 
intravascular retention. To circum­
vent this, pyridoxal phosphate treat­
ment can be combined with intermo- 
lecular modification to improve intra­
vascular retention.36,37 Unmodified 
hemoglobin is first treated with pyri­
doxal phosphate to bring the P.-,n to 
23 to 26 mm Hg, almost the same as 
intraerythrocytic hemoglobin. This 
modified hemoglobin is then treated 
with glutaraldehyde to make polymer- 
ized-pyridoxal hemoglobin with a PM 
of 19 to 22 mm Hg. The final prod­
uct is a heterogenous mixture of 
polymerized hemoglobin molecules. 
When pyridoxalated-polymerized he­
moglobin solution was transfused into 
rats by exchange transfusion (95% 
exchange), all the animals survived. 
Plasma half-life of the product was 
25 hours.37
Hemoglobin solutions are currently 
being evaluated for their effects on 
coagulation, renal and reticuloendo­
thelial function in animals. Theoreti­
cally, large doses of hemoglobin, par­
ticularly modified hemoglobins, would 
be eliminated primarily by the reti­
culoendothelial system. This load 
could impair reticuloendothelial func­
tion.
The Future for Oxygen-Transporting 
Blood Substitutes
Preliminary human and animal 
studies show that both perfluoro- 
chemicals and hemoglobin solutions 
have promise as oxygen-transporting 
blood substitutes in situations where 
blood is contraindicated or is tem­
porarily not available (either banked 
blood or the patient’s own blood). 
However, these substitutes will not 
completely replace the need for hu­
man blood because of their limited 
capabilities to transport oxygen and 
to remain in the intravascular space. 
Paradoxically, their clinical utility 
may not be solely as a substitute for 
blood, but to prevent tissue ischemia, 
perfuse isolated organs or treat car­
bon monoxide poisoning where blood 
itself is not effective. Further evalu­
ation of these drugs may provide 
other uses. Blood substitutes are drugs 
with defined therapeutic indices. Be­
fore they are used clinically on a 
large scale, much more information 
is needed about the safety of infusing 
large doses of perfluorochemicals or 
hemoglobin. With this information,
intelligent decisions can then be made 
about when these drugs could be used. 
Second generation products, such as 
modified hemoglobins and perhaps 
the newer perfluorochemicals, may 
provide greater capacity to deliver 
oxygen and remain longer in the in­
travascular space.
The opinions or assertions contained 
herein are the private views of the au­
thor and are not to be construed as 
official or as reflecting the views of the 
Department of the Army or the Depart­
ment of Defense (AR 360-5) of the 
United States. The citation of trade 
names in this paper does not constitute an 
official endorsement or approval of the 
use of such items.
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Immediate Breast Reconstruction after Mastectomy Using 
a Rectus Abdominis Myodermal Flap without an Implant
J. Michael Drever, md, frcs[c]
and Neville J. Hodson-Walker, b sc, mb, ch b, frcs, frcs[c], facs
In the authors’ opinion there is no 
physical reason for a waiting period 
after total mastectomy before the 
breast is reconstructed. If the duration 
of the patient's survival is limited, 
the sooner the breast is reconstructed 
the better. The authors do not use 
silicone implants that may be blamed 
for the appearance of recurrent 
tumour but reconstruct the breast 
with a vertical rectus abdominis 
myodermal flap immediately after the 
mastectomy.
The flap is an island of skin, fat 
and muscle extending from the 
xiphoid to the pubis; it receives its 
blood supply from the perforators of 
the superior-inferior epigastric vascular 
axis on the same side as the 
mastectomy. The rectus abdominis 
muscle is the pedicle and carrier of 
the vessels that feed the ellipse 
of skin. The flap is doubled on itself 
and thus forms a cone. It is then 
passed into the breast area by 
undermining the intervening bridge of 
skin. Nipple and areola are grafted 
onto the flap.
This operation enables a wide 
resection, so that the principles 
of cancer management are not 
compromised.
Selon les auteurs, apres une 
mastectomie totale, il n’existe pas 
de raison physique d’observer une 
periode d'attente avant de reconstruire 
le sein. Quand le temps de survie 
de la patiente est limite, le plus tot
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on reconstruit le sein, mieux il vaut. 
Les auteurs n’utilisent pas d'implants 
de silicone qui pourraient etre blames 
pour I’apparition d'une recidive; ils 
reconstruisent plutot le sein avec un 
lambeau myodermique vertical du 
muscle grand droit de I'abdomen, 
immediatement apres la mastectomie.
Le lambeau est un Tlot de peau, 
de graisse et de muscle qui s’etend 
de I’appendice xiphoi'de jusqu'au 
pubis; il repoit son apport sanguin 
des veines perforantes de I’axe 
vasculaire epigastrique superieur- 
inferieur, du meme cote que la 
mastectomie. Le grand droit de 
I’abdomen est le pedicule et le support 
des vaisseaux qui irriguent I'ellipse 
de peau. Le lambeau est retourne sur 
lui meme de facon a former un cone.
II est alors positionne a la place du 
sein en soulevant la peau. Le mamelon 
et I'areole sont greffes sur le 
lambeau.
Cette operation permet une 
resection large, de sorte que les 
principes de traitement du cancer 
sont respectes.
Total removal of the breast (either 
by simple or radical mastectomy) is psychologically crippling to many 
women. This is the commonest sur­
gical procedure used in the manage­ment of carcinoma of the breast. Over 
the last two decades there has been a trend to more conservative resec­tion, with the demonstration that par­tial mastectomy (either lumpectomy or segmental mastectomy) does not reduce long-term survival in compari­
son with total mastectomy.1-4 Accept­able cosmetic results have been de­scribed.5
Even in centres where partial mas­tectomy is performed there are two groups of patients in whom total mas­
tectomy is necessary. In the first group 
are patients whose tumour is not suit­able for local resection — large 
tumours with a central location and 
those involving the nipple. The sec­ond group consists of those patients 
who do not wish to have a local re­section. In our experience a small 
but substantial number of women 
with breast carcinoma, when offered the choice of partial or total mas­
tectomy, prefer a more radical ap­proach because they believe that this 
will give them the best chance of 
controlling the cancer. Also, the evi­dence indicating that local mastectomy 
does not reduce the duration of sur­vival is far from conclusive, and a 
large group of surgeons, probably the majority in North America, believe 
that they cannot recommend any 
surgery less radical than a simple 
or modified radical mastectomy.6
It was our practice to allow the tis­
sues to heal following the mastectomy 
and, if there was no evidence of recur­
rence, to reconstruct the breast ap­
proximately 1 year later. There is actually no physical reason to wait 
1 year before reconstruction. Statis­
tics indicate that the risk of recur­
rence of breast cancer remains rela­tively constant during the first 10 
years after mastectomy; a patient can­
not be considered “cured” until 20 years after operation7,8 and if survival is limited to a few years then the sooner the breast is reconstructed the better.
Technique
The technique of mastectomy with immediate reconstruction differs slightly from that without reconstruc­
tion in that the removal of skin is 
more extensive. Instead of an ellipse
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FIG. 1— Preoperative skin markings 
made with patient standing. Width of ab­
dominal ellipse at umbilicus should be 
identical to distance between both inci­
sions of mastectomy at level of nipple.
enclosing the nipple and the tumour 
site, the lower line of excision is the 
submammary fold extending to the 
anterior axillary fold. The upper line 
of resection is also marked preopera- 
tively but it is placed in approximate­
ly the same position as for a nonre- 
constructive procedure. The actual 
removal of the breast, with or with­
out dissection of the axilla, is other­
wise the same as for a normal mas­
tectomy.
FIG. 2— Mastectomy completed. Fat 
in dotted area is bevelled outwards to 
fill undercut upper edge of mastectomy.
The reconstruction transfers to the 
excised area an ellipse of skin, sub­
cutaneous tissue and muscle of the 
same dimensions as that removed.9,10 
Before operation the skin incisions 
are marked on the standing patient. 
The transverse diameters of the breast 
and abdominal ellipse are equal (Fig. 
1). The inframammary fold incision 
is equal in length to the midline ab­
dominal incision just beside the um­
bilicus. The fat at the lateral edge is 
tapered laterally so that it will fill 
the undercut upper edge of the mas­
tectomy (dotted area in Fig. 2).
The rectus abdominis muscle fascia 
is incised along its lateral edge and 
the lateral edge of the muscle is ele­
vated by blunt finger dissection. The 
lateral perforators are divided. When 
the entire lateral side of the rectus 
abdominis muscle is elevated, the 
medial side of the sheath is incised 
parallel to the linea alba. Finally, its 
lower end is transected near the 
pubis and the inferior epigastric ves­
sels are tied off (Fig. 3).
FIG. 3— Lower end of rectus has been transected near 
pubis and inferior epigastric vessels have been tied.
FIG. 4— Myocutaneous ellipse is passed under bridge of skin 
into mastectomy site.
FIG. 5— Areolar site is de-epithelialized and labia minora 
graft applied. Nipple is constructed by grafting half of con­
tralateral nipple.
FIG. 6— Rectus abdominis area (especially lower half, where 
there is no transversus muscle) is reinforced with strong syn­
thetic mesh.
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The myocutaneous ellipse is passed 
into the mastectomy site under the 
bridge of skin (Fig. 4) and sutured all 
around. The tip of the newly formed 
cone is de-epithelialized at the same 
level as the opposite nipple. The 
areola is constructed with a labia 
minora graft (Fig. 5) and the nipple 
from half of the opposite one. A tie- 
over bolus dressing is applied for 2 
weeks.
The abdominal defect is closed by 
releasing the umbilicus and slightly 
undermining both edges Merselene 
mesh is used to fill the entire fascial 
defect and sutured securely (Fig. 6). 
The skin itself is closed with inverted 
dermis stitches retrieving the um­
bilicus through a “V” incision as in a 
lipectomy.
An elastic abdominal girdle to the 
umbilicus and dry dressing over the 
reconstructed breast area are used. 
No pressure should be applied over 
the rib cage on the muscular pedicle 
area.
Comments
Others have described immediate 
reconstructive procedures after mas­
tectomy, but one continuing concern 
with these associated with silicone im­
plants has been that eradication of 
the tumour may be compromised in 
order to preserve enough tissue to 
cover the prosthesis. Moreover, the 
thin flaps stretched over the pros­
thesis do not tolerate irradiation as 
well, if this is used as an adjuvant 
therapy.
Many local and regional flaps are 
now being used (such as the latissimus
dorsi myocutaneous flap)11 to add 
skin to the breast area. These all 
need a silicone implant to make the 
actual breast mound and are there­
fore liable to the many complications 
that these implanted foreign bodies 
have.
Because the reconstruction we de­
scribe involves the transposition of 
skin as well as muscle and fatty tis­
sue, resection of the breast is, if any­
thing, more radical than would be 
the case if a total mastectomy alone 
was being performed. Therefore, there 
is no concern that the surgical com­
pleteness of the procedure is being 
compromised. The tissue used to re­
construct the breast is well vascular­
ized and is quite able to tolerate ad­
juvant radiotherapy if indicated. The 
cosmetic result is slightly more ac­
ceptable and more natural looking 
than procedures that include implants 
(Fig. 7). If the patient knows that this 
procedure is possible then it may 
persuade her to seek attention for a 
breast lesion when previously she may 
have declined to do this because of 
fear of the mutilation caused by the 
mastectomy.
We have used the rectus abdominis 
myodermal flap for breast reconstruc­
tion in nine patients. In all, the flap 
survived entirely. We had one case 
of necrosis of the skin around the 
transposed flap, possibly due to small 
vessel disease. This was the only pa­
tient who required a second operation, 
to skin graft the remaining ulcer. 
There was one case of mild fat 
necrosis followed by infection; the 
condition cleared up in 6 weeks.
None of our patients had any
FIG. 7—Postoperative appearance at 35 days.
weakness or hernias of the abdominal 
wall. It is most important to rein­
force the abdominal wall below the 
semicircular line of Douglas (1 to 2 
cm below the umbilicus) to the pubis, 
after having removed one rectus ab­
dominis muscle. For this purpose we 
have always used a double layer of 
Merselene mesh sutured to the under­
surface of the edges of the fascial 
sheath defect with nonabsorbable 
stitches. The absence of one rectus 
abdominis muscle, when the defect 
is repaired, does not bring about any 
noticeable weakness in straining or 
sitting.
Summary
We have presented a one-stage 
operation for immediate total breast 
reconstruction after mastectomy using 
a flap from the mid- and lower ab­
domen with one rectus abdominis 
muscle as the pedicle. This flap is 
well vascularized, assuring its viabil­
ity, and forms a quite normal-looking 
breast without the risk of complica­
tions associated with the introduction 
of foreign bodies such as silicone im­
plants. Patients are also appreciative 
of having excess tissue from the 
waistline removed.
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Because “biphasic infection” 
threatens to complicate surgery 
of the large bowel...
control sepsis with
an antibiotic to arrest primary 
gram-negative aerobic infection 
in combination with
Product Monograph available on request.
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Hirschsprung’s Disease: 
Long-Term Follow-up of 65 Cases
The author reviews 65 cases of 
Hirschsprung’s disease seen and 
treated in Saskatoon between 1951 
and 1981. The annual incidence of 
this disease is 1/4000 live births.
Overall mortality was 25% and 
related to two factors: (a) delay in 
diagnosis and surgical treatment 
with a high incidence of enterocolitis 
in the earlier years of the series;
(b) a mortality of 83% in patients 
with small bowel aganglionosis.
Thirty-five resections were done 
for colonic aganglionosis; there was 
one death that occurred 20 years 
ago, indicating that surgery is safe 
in this disease, but delay in treatment 
is not. Of six patients with small 
bowel aganglionosis, only three had 
resection and only one of these 
survived. The two patients who died 
had very high small bowel 
aganglionosis, probably incompatible 
with survival.
The Rehbein type of procedure 
proved useful in high colonic aganglio­
nosis where, by necessity, 
anastomosis was done at up to 7 cm 
above the white line of the pelvis, 
with excellent end results.
There was a 35% incidence of 
Hirschsprung’s disease in females;
37% had high aganglionosis (above the 
sigmoid).
Low (white line) anastomosis was 
done in three patients available 
for 12-year follow-up. All have some 
degree of incontinence.
L'auteur passe en revue 65 cas de 
maladie de Hirschsprung qui ont ete 
vus et traites a Saskatoon entre 1951 
et 1981. L’incidence annuelle de 
cette maladie est de 1 cas par 4000 
naissances vivantes.
Dans I’ensemble, la mortalite de 
25% etait reliee a deux facteurs;
a) dans les premieres annees de la 
serie, un delai dans le diagnostic 
et le traitement chirurgical entraina 
une forte incidence d’enterocolite,
b) une mortalite de 83% a ete
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enregistree chez les patients souffrant 
d’aganglionose du petit intestin.
Trente-cinq resections ont ete 
pratiquees pour cause d'aganglionose 
colique; un seul deces est survenu 
il y a 20 ans, ce qui indique que 
dans cette maladie, la chirurgie est 
sure mais que le delai de traitement 
ne Test pas. Sur six malades qui 
avaient une aganglionose du petit 
intestin, seulement trois ont subi une 
resection et un seul de ceux-ci a 
survecu. Chez les deux patients qui 
sont decedes, la localisation de 
I'aganglionose du petit intestin etait 
tres haute et probablement incom­
patible avec la vie.
L'operation de type Rehbein s'est 
averee utile dans les aganglionoses 
coliques hautes ou, par necessity, 
I’anastomose a ete faite jusqu’a 7 cm 
au-dessus de I'arcade tendineuse du 
releveur de I'anus, avec d’excellents 
resultats.
L'incidence de la maladie de 
Hirschsprung chez les sujets de sexe 
feminin etait de 35%; 37% avaient 
une aganglionose haute (au-dessus du 
sigmoi'de).
Une anastomose basse (a I’arcade 
tendineuse du releveur de I'anus) a 
ete pratiquee chez trois patients 
pour qui on possede 12 annees de 
surveillance des suites therapeutiques. 
Tous souffrent d’un certain degre 
d'incontinence.
Sixtv-five patients seen and treated 
for Hirschsprung’s disease by a vari­
ety of pediatricians and surgeons in 
the three Saskatoon hospitals from 
1951 to 1981 are reviewed. I have 
been involved with medical and sur­
gical care of most of these patients.
Follow-up ranged from 4 to 30 
years in all but 5 patients (mean 
more than 10 years), with adequate 
follow-up in all but 3 of 38 resections. 
The long-term results were excellent, 
no matter what method of resection 
was used, even though many patients 
required repeated sphincterotomy or 
rectal dilatation, or both, during the 
first 2 years after resection.
I have reached two conclusions: 
(a) Contrary to what others report, 
excellent end-results were obtained 
with high, anterior (Rehbein type) 
anastomosis, used in high agangliono­
sis of the colon.1 (b) If a minimum of 
1 cm of mucosa is left above the 
white line of the pelvis, the diarrhea 
and incontinence sometimes seen in 
low anastomosis are prevented.1
Observations
Points of Interest
The birth weight was over 2700 g 
in all patients; this is the usual find­
ing in most series. Symptoms began 
within a few days of birth in all 
patients, including delay in passing 
meconium, abdominal distension, con­
stipation or diarrhea, or both, and 
emesis. In neonates, anal stenosis was 
a common finding. This, to my 
knowledge, has not been described 
before. Two of the 65 patients were 
siblings. One 2-day-old infant had 
pneumoperitoneum from cecal per­
foration.2
Like most centres, we had great dif­
ficulty in the early years of the study 
in obtaining early recognition and re­
ferral of patients with this disease, 
but this has greatly improved in the 
past 5 years and most delay now is 
related to parental obstruction. The 
mean age of children at the time of 
diagnosis was 37.6 weeks, in the first 
half of the series from 1951 to 1965 
it was 59.4 weeks and in the second 
half from 1965 to 1981 it was 20.7 
weeks.
Incidence and Mortality
The incidence of Hirschsprung’s dis­
ease in girls in this series was 35%, 
whereas most reports3-4 indicate 20%. 
Total colonic and small bowel agang­
lionosis was more common in girls 
(four of six) (Table I).
The incidence of long-segment 
aganglionosis (above the sigmoid 
colon) was high (37%) compared 
with other series3-4 (22% to 27% ). 
Mortality in high and low colonic 
aganglionosis was similar, about 20%, 
but there were six patients with total 
colonic and small bowel aganglio­
nosis of whom four were females; 
five (83%) of these six patients died 
(Table II). The incidence of small 
bowel aganglionosis was 10% (6 of 
59) compared with 3% (16 of 501) 
in Swenson’s study.3
All 13 children who did not under-
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go resection died: 10 children died of 
enterocolitis; 1 had a perforated sig­
moid colon at 5 years of age after 
the parents had refused all treatment;
2 died of associated major disease 
(DiGeorge syndrome and gastro- 
schisis with massive devitalization of 
the major part of the intestine). There 
were three patients with Down’s syn­
drome.
There were three deaths in 38 chil­
dren who underwent resection. Two 
were probably unavoidable for they 
were in patients with total colonic and 
small bowel aganglionosis. They oc­
curred after a Rehbein anterior re­
section.1,5
In the first half of the series (1951 
to 1967) mortality was 33% (8 of 
24) with seven deaths being due to 
enterocolitis and therefore prevent­
able. In the second half of the series 
(1968 to 1981), the mortality was 
19.5% (8 of 41), but five deaths were 
not preventable. Three deaths were 
due to malabsorption following re­
section for total colonic and high 
small bowel aganglionosis; the fourth 
was due to an associated defect (Di- 
George syndrome); the fifth was due 
to the parents’ refusal of treatment. 
There were only three deaths from 
enterocolitis. There were no deaths in 
the second half of this series in 22 
resections done for aganglionosis 
limited to the colon.
There was therefore only one death 
in 35 resections for aganglionosis 
limited to the colon and that death 
occurred 20 years ago after a Swenson 
pull-through procedure.3,6
Procedures Used
Eleven Rehbein operations1,5 (an­
terior resection) were done with ex­
cellent results in all patients available 
for long-term follow-up (one patient 
was lost to follow-up and two with 
small bowel aganglionosis died). An­
terior anastomosis was used in two 
patients with small bowel aganglio­
nosis and in two patients with adhe­
sions from pelvic peritonitis, in which 
a pull-through is difficult. However, 
this procedure was most useful in high 
colonic aganglionosis (seven patients), 
with anastomosis being performed 3 
cm or more above the white line as 
there was not sufficient bowel left for 
lower anastomosis or a pull-through 
procedure. Anastomosis in two pa­
tients with aganglionosis up to the 
hepatic flexure was done 5 cm above 
the white line in one patient and 7 cm 
above in another, with excellent end- 
results.
The Swenson procedure6 was car­
ried out in 22 patients, the anasto­
mosis being done approximately 2 
cm above the white line. Long-term 
assessment was possible in all but two 
patients who were lost to follow-up 
early in the series, and in one more- 
recent case. In those followed up, 
long-term end-results are good except 
for two patients treated by a surgeon 
who elected to anastomose at the 
white line; each patient has diarrhea 
and incontinence — one at 6 years 
postoperatively and one 12 years after 
operation.
Five Soave procedures7 (endorectal 
pull-through) were done. Two were 
done during 1965 and 1966. In one 
girl the anastomosis was done very 
low, at the white line; postoperative 
infection was a problem and she has 
some incontinence now, 14 years after 
the operation. In the other Soave 
procedure carried out at that time the 
anastomosis was 1 cm above the white 
line. This patient had a normal re­
covery and remains well. The other 
three Soave procedures have been 
done recently; the anastomosis was at 
the white line in each. The immediate 
postoperative course was excellent ex­
cept that one patient had loose stools 
for 3 weeks. There were no other 
complications. It is still too soon to 
assess continence even though one 
patient was 5 years old at the time 
of operation and the follow-up ranges 
from 6 to 8 months. Several years’ 
follow-up past school age are required 
before continence, both for gas and
Postoperative infection dropped 
from 50% early in the series to 12% 
later.
Low Level Aganglionosis
The six patients with very low 
aganglionosis were among children 
presenting at 2 to 3 years of age with 
chronic constipation who, on biopsy 
and concomitant sphincterotomy and 
dilatation, showed aganglionosis at 2 
to 4 cm above the white line. These 
are the only patients with chronic 
constipation syndrome who received 
substantial benefit from sphinctero­
tomy and dilatation. All remain well 
at 1 year or more. Some have needed 
a second dilatation.
The six patients with low rectal 
aganglionosis8 presented with early 
onset of mild symptoms suggesting 
Hirschsprung’s disease. All had 
sphincterotomy, dilatation and biopsy 
and were aganglionic on biopsy at 2 
to 4 cm above the white line. Three 
required colostomy and when they re­
turned for resection they were found 
on biopsy from within to have gang­
lion cells up to the peritoneal re­
flection (approximately 5 to 6 cm). 
These had closure of the colostomy 
and no resection. They have all man­
aged reasonably well, most requiring 
repeat sphincterotomy or dilatation, or 
both, but some do have problems with 
occasional constipation and some may 
yet require resection. The follow-up
solids, can be assessed confidently. was from 3 to 7 years.
Table 1-Sex Distribution of Hirschsprung's Disease and Length of Aganglionosis
in 65 Patients Treated between 1951 and 1981
Upward extension of aganglionosis Total Male Female
Whole colon and small bowel 6 2 4
Hepatic flexure 4 4 0
Transverse colon 3 1 2
Splenic flexure 9 6 3
Sigmoid colon 31 22 9
Low rectum 6 3 3
Ultra low 6 4 2
Table I I - Treatment and Outcome in 65 Patients
with Hirschsprung's Disease
Treatment (died)
Upward extension of aganglionosis No. Resection No resection Other
Whole colon and small bowel 6 3 (2) 3 (3 )
Hepatic flexure 4 3 1 (1)
Transverse colon 3 3 0
Splenic flexure 9 7 2 (2)
Sigmoid colon 31 22 (1) 7 (7) 2*
Low rectum 6 0 0 6t
Ultra low 6 0 0 6t
"Colostomy.
tSphincterotomy.
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Discussion
In 1949 Swenson and associates6 
first described the pull-through resec­
tion procedure for aganglionosis coli. 
They showed that the diagnosis can 
be made in infancy, when there is 
delay in the passage of meconium, 
constipation or diarrhea, or both, and 
abdominal distension and vomiting 
within the first few days of life. In­
deed, if symptoms are not present 
at or shortly after birth, the diagnosis 
is in doubt. Early reported series9 
showed a very high incidence of 
fatal enterocolitis; untreated, 50% 
of babies die within the first 2 months 
of life. It was a long time before 
pediatricians, surgeons and physicians 
recognized the importance of early 
diagnosis and early treatment, with 
early colostomy for persistent ob­
structive symptoms and antibiotics to 
prevent enterocolitis. Following co­
lostomy, resection was done electively 
at 6 to .12 months of age. Before 
1948, many of these babies were 
undiagnosed and died of what was 
termed “fatal enteritis”. Only the pa­
tients with short-segment disease man­
aged medically survived and presented 
in early or late childhood with mega­
colon with a greatly enlarged sig­
moid colon containing “fecal 
boulders”.
Early surgical resection has proved 
safe and effective. Delay in diagnosis 
and surgical treatment results in high 
mortality.
The diagnosis should be suspected 
in any newborn with delay in passing 
meconium, or with anal stenosis, con­
stipation, diarrhea and distension that 
may persist or recur. Abdominal films 
will show a distended colon. Roent­
genography after barium enema 
should be done with evacuation rather 
than filling studies, concentrating on 
lateral views of the lower abdomen 
and pelvis to demonstrate an aganglio- 
nic segment below with colonic dis­
tension above. In aganglionosis ex­
tending into the upper colon or small 
bowel, the patient presents with small 
bowel obstruction and the small bowel 
and colon distal to the distended small 
bowel show marked reduction in size.
Colostomy is indicated for any 
obstructive symptoms. Antibiotics to 
prevent enterocolitis should be given 
until the obstruction is relieved.
Definitive surgery involves resection 
of the aganglionic segment and anas­
tomosis at a level at least 1 cm above 
the white line and should be done 
as an elective procedure after 
thorough bowel preparation at age 6 
to 12 months. In preference to the
methods of resection used in this 
series, some surgeons use the Du- 
hamel pull-through procedure10,11 and 
its modifications.
Conclusions
Surgical resection for Hirsch­
sprung’s disease is a safe and effective 
procedure, but mortality remains high 
in small bowel aganglionosis and 
whenever the diagnosis and treatment 
are delayed.
Patients with high colonic aganglio­
nosis do well with high anastomosis.
Very low anastomosis at the white 
line may be associated with inconti­
nence, evident only on long-term 
follow-up. Anastomosis at 1 cm or 
more above the white line is not 
associated with incontinence but some 
constipation may persist for 2 to 3 
years. A little constipation is no prob­
lem, whereas a little incontinence is a 
serious problem. Enterocolitis may 
develop after resection and is related 
to sphincter spasm.
Very low segment aganglionosis (1 
to 2 cm above the white line) is a 
definite entity and may present at 
age 2 or older, associated with chronic 
constipation; benefit is obtained by 
sphincterotomy and dilatation. How­
ever, most patients with chronic con­
stipation and encopresis syndrome do 
have ganglion cells and do not receive 
permanent benefit from sphincteroto­
my and dilatation.
Short segment aganglionosis (5 to 6 
cm above the white line) can frequent­
ly be managed by repeat sphinctero­
tomy and rectal dilatation. Tempo­
rary colostomy may be necessary.
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Clostridium difficile: Epidemiology and Clinical Features
T J . M arrie , m d , FRCp[c],*t M . F urlong , m d , f r c p [c ],*  R.S. Fau lkner , ph D,f 
J. Sidorov , m d , fa c p , f r c p [c ],* E .V . H aldane , m b , ch b , FRCP[c]*f and E .A . K e r r !
To determine the epidemiologic features 
of Clostrid ium  d iffic ile  in Halifax, Nova 
Scotia, the authors studied two groups 
of hospitalized patients, one group of 
outpatients and a fourth group of 
54 healthy subjects.
The first group consisted of 29 
patients with diarrhea, whose stool 
was found to contain C. d iffic ile  
or its cytotoxin, or both. Twenty-two 
underwent sigmoidoscopic examina­
tions; of these, 18 had abnormal 
colonic mucosa and 6 of the 18 had 
pseudomembranous colitis.
in the second group of 127 patients 
on general medical wards, 22 (17%) 
carried C. diffic ile . Thirteen of the 22 
had diarrhea, and 3 had pseudo­
membranous colitis. Clustering of 
patients with C. d iffic ile  was evident. 
In vitro production of toxin by 
isolates of C. d iffic ile  from these 
patients was more likely if antibiotics 
had been given.
Only 1 (4.5%) of the 22 outpatients 
with various gastrointestinal disorders 
(group 3) and none of the 54 healthy 
subjects (group 4) carried C. d iffic ile .
The clinical spectrum of infection 
with C. d iffic ile  extended from 
asymptomatic patients to those with 
nonspecific colitis and pseudomem­
branous colitis.
Dans le but de determiner I'epidemio- 
logie du Clostridium  d iffic ile  dans 
la region de Halifax, en Nouvelle-Ecosse, 
les auteurs ont etudie deux groupes 
de patients hospitalises, un groupe de 
patients de clinique externe et un 
quatrieme groupe de 54 sujets sains.
Le premier groupe consistait de 
29 patients souffrant de diarrhee et 
dont les selles revelaient la presence 
de C. d iff ic ile  ou de sa cytotoxine, 
ou les deux. Vingt-deux de ces malades 
ont subi une sigmoidoscopie; parmi
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ceux-ci, 18 avaient une muqueuse 
colique anormale et 6 des 18 
souffraient de colite pseudo- 
membraneuse.
Chez le second groupe de 127 
patients de salle generate, 22 (17%) 
etaient porteurs de C. d iffic ile .
Treize des 22 souffraient de diarrhee 
et 3 avaient une colite pseudo- 
membraneuse. Un groupement des 
patients ayant du C. d iffic ile  etait 
evident. Chez ces patients, il etait 
plus probable d’obtenir une production 
in vitro de toxine a partir des isolats 
de C. d iffic ile  s’ils avaient repu des 
antibiotiques.
Seulement 1 (4.5%) des 22 patients 
de clinique externe presentant des 
affections gastro-intestinale (le 
groupe 3) et aucun des 54 sujets 
sains etait porteur de C. d iffic ile .
Le tableau clinique d’une infection a 
C. d iffic ile  va de I’absence de 
symptomes a la colite non specifique 
ou a la colite pseudo-membraneuse.
Pseudomembranous colitis was first 
described by Finney in 1893.1 In the 
late 1970s several studies suggested 
that this disease is due to a toxin- 
producing Clostridium difficile.*’3 
Subsequently, this toxin has been de­
tected in the stools of 97% of pa­
tients with pseudomembranous colitis 
and 27% o f patients with antibiotic- 
associated diarrhea.4 Most cases of 
pseudomembranous colitis due to C. 
difficile have occurred after antibiotic 
therapy,5 although cases have been 
reported without preceding antibiotic 
use6"8 and C. difficile can be iso­
lated from stool concomitantly with 
other enteric pathogens.9
Testing for stool cytotoxicity has 
been an available laboratory service 
in the Victoria General Hospital in 
Halifax since 1978.10 Use o f this test 
has gradually increased until it is now 
requested as part o f the investigation 
in most hospitalized patients with 
diarrhea. To define the epidemiology 
o f C. difficile in our area, we studied 
three patient groups and one group 
o f 54 healthy control subjects: group 
1 comprised patients whose stool 
specimen was submitted to the labora­
tory with a request for toxicity testing 
or isolation o f C. difficile, or both. 
This group was studied to enable us
to determine the background fre­
quency of diarrhea due to C. difficile 
in our hospital and to serve as a 
comparison for group 2 patients on 
medical wards who were systematical­
ly assessed for C. difficile by serial 
culture. Group 3 were outpatients, suf­
fering from various gastrointestinal 
disorders and group 4 were healthy 
subjects.
Patients and Methods
Group 1
Over a 10-month period 29 patients 
were seen in whom antibiotic-associat­
ed diarrhea was suspected and whose 
stools, on culture, were found to con­
tain C. difficile or its cytotoxin, or 
both; 27 were hospitalized. The at­
tending physician’s definition of 
diarrhea was accepted. Of the 29 pa­
tients, 17 were examined by one o f 
us (T.J.M.) and all fulfilled our defi­
nition o f diarrhea as three or more 
loose stools per day.
Group 2
In this group o f 127 patients on 
three general medical wards, 167 
stool specimens were collected over 
a 4-month period, to define the car­
riage rate o f C. difficile. The wards 
were on the same floor, but separated 
geographically.
Group 3
Stool specimens (obtained by rectal 
swabs from some patients) were col­
lected from 22 patients (10 males, 12 
females; mean age 23.2 years), who 
were seen in the private gastroen­
terology practice o f one o f us (J.S.). 
Fifteen had a functional bowel dis­
order, there was inflammatory bowel 
disease in 3, postgastrectomy syn­
drome in 1, diverticulosis in 1 and 
acute enterocolitis in 2. Twenty had 
diarrhea. Only two had received anti­
biotics within the 4 weeks before as­
sessment. Sigmoidoscopy was per­
formed on all patients and biopsy 
specimens were obtained from the 
rectal mucosa of 17 patients.
Group 4
In order to determine the distribu­
tion o f C. difficile in the general po-
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pulation, 54 healthy subjects who 
had not received antibiotics in the 
preceding 4 weeks had one stool 
specimen cultured. Nine of these sub­
jects were residents in a home for 
the elderly.
Specimen Collection, Transportation 
and Culture
Stool samples were placed in plas­
tic containers and sent to the anaerobe 
laboratory where a portion was taken 
from the centre of a formed stool 
or from the depths of a liquid stool 
and inoculated onto cycloserine-ce­
foxitin-fructose agar.11 The plates were 
incubated at 35°C in an anaerobic 
chamber (Forma Scientific, Marietta, 
Ohio) in an atmosphere of 90% 
nitrogen, 5% carbon dioxide and 5% 
hydrogen. The plates were examined 
after 24 and 48 hours of incubation 
and suspicious colonies were subcul­
tured onto prereduced brain-heart 
infusion blood agar medium (contain­
ing 5% sheep’s blood, 10/r.g of vita­
min Ki/ml and 5 pug of hemin/ml) 
for anaerobic incubation and onto 
two blood agar plates (trypticase soy 
agar [Baltimore Biological Labora­
tories Microbiology Systems, Cockeys- 
ville, Md.] containing 5% sheep’s 
blood) for incubation both aerobically 
and in an atmosphere of 5% to 10% 
carbon dioxide. Organisms that grew 
only anaerobically were identified 
by gas-liquid chromatography and by 
biochemical reactions.12
Cytotoxicity Studies
Stool specimens.—Liquid stools 
were diluted 1:5 (volume/volume) in 
basal medium-Eagles with Earles’ salts
Table 1—Antibiotic Received 
by 24 Group 1 Patients*
Antibiotic
No. of 
patients
Ampicillin 7
Amoxicillin 2
Cloxacillin 7
Penicillin G 1
Carbenicillin 1
Cephalothin 3
Cephalexin 4
Clindamycin 2
Chloramphenicol 1
Gentamicin 8
Tobramycin 2
Amikacin 1
Metronidazole 5
Vancomycin 1
T rimethoprim/sulfamethoxazole 1
Tetracycline 1
Novobiocin 1
‘ Mean no. of antibiotics received per pa-
tientwas2.1.
containing 2% fetal calf serum, am- 
picillin 100 /xg/ml, gentamicin 10 
/xg/ml and amphotericin B 5 /j,g/m\ 
(Gibco Canada Ltd., Burlington, Ont.) 
and centrifuged at 5000 g for 30 min­
utes. A portion of formed stool was 
emulsified (20% w/v) in the above 
medium and centrifuged similarly. 
MRC-5 cells (human fetal lung fibro­
blasts; American Type Culture Col­
lection, Rockville, Md.) in 0.9 ml 
of basal medium-Eagles were inocu­
lated with an aliquot (0.1 ml) of the 
supernatant for a final 1:50 dilution 
of the stool. The cells were examined 
microscopically at 24 hours. If typical 
actinomorphic changes were present, 
the remaining stool supernatant was 
diluted serially from 10'1 to 104 to 
determine the cytotoxin titre. Positive 
samples were retested after incuba­
tion with Clostridium sordellii anti­
serum (Dr. P.D. Walkers, Wellcome 
Research Laboratories, Beckenham, 
Kent, UK); neutralization of cytotoxi­
city by the C. sordellii antiserum was 
considered evidence of C. difficile 
toxin.13
Stool samples from groups 2, 3 and 
4 were frozen at -70 °C and were 
tested for cytotoxicity only if C. dif­
ficile was isolated.
Toxin production by C. difficile.—  
Clostridium difficile isolates were 
grown for 24 hours in prereduced, 
anaerobically sterilized, chopped 
meat-glucose medium (Carr-Scar- 
borough Microbiologicals, Inc., De­
catur, Ga.). The culture was then
centrifuged at 1000 g for 10 minutes 
and the supernatant passed through 
a 0.44 m filter. The filtrate was di­
luted 1:10 and tested for cytotoxicity 
as outlined above. If the result was 
negative, the test was repeated after 
the isolate had been incubated for
5 days in the chopped-meat medium.14
Statistical Analysis
The x2 test with Yates’ correction 
was used to test for statistical signifi­
cance.15
Results
Group 1
Twenty-four patients received anti­
biotics in the 4 weeks before the 
onset of diarrhea. The remaining five 
patients had cultures ordered by the 
housestaff to “rule out C. difficile 
diarrhea”. Gentamicin was the most 
common antibiotic given, followed 
by ampicillin, cloxacillin and metroni­
dazole (Table I). None of the patients 
received gentamicin alone. Only two 
patients received clindamycin. Twelve 
patients (41%) had diarrhea before 
they were admitted to hospital. Sig- 
moidoscopic examination was per­
formed on 22 patients; of 18 who had 
abnormalities of the colonic mucosa
6 had pseudomembranous colitis (Ta­
ble II). One patient had normal rectal 
mucosa, but roentgenography after 
barium enema revealed changes con­
sistent with pseudomembranous colitis 
higher in the colon.
Table II—Characteristics of 29 Group 1 Patients with Diarrhea 
Whose Stool Specimens Grew C lostridium  difficile  or 
Were Cytotoxic, or Both
Stool specimen
Characteristics
Tox in+ , 
culture +  
(n = 19)
Toxin-t-, 
culture — 
(n = 8)
Toxin—, 
culture-f- 
(n = 2)
Ratio of men to women 11:8 1:7 2:0
Mean age.yr 52 63 68.5
No. with diarrhea when admitted 
No. with diarrhea while in
6 6 0
hospital 17 8 2
Mean duration of diarrhea, d 
No. of patients with a
22.2 23 30
concomitant cause for diarrhea 
No. given antibiotics within
4* I f 0
4 weeks of onset of diarrhea 17 5 2
Sigmoidoscopic findings 15 6 i
Pseudomembranous colitis 4 2 0
Abnormal mucosa 10 1 1
Normal
Normal sigmoidoscopic findings, but 
barium enema findings consistent
1 3 0
with pseudomembranous colitis 1 0 0
‘ Diabetic autonomic neuropathy in 2, 
t io n in l.
fCrohn’s disease.
inflammatory bowel disease in 1, C am pylobacter infec-
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The results of cytotoxicity assays 
and C. difficile isolation fell into 
three categories. Stools from 19 
patients gave positive results on cul­
ture and toxin assay; from 8 patients 
samples were toxin-positive but cul­
ture-negative; in the remaining 2 pa­
tients, the samples were toxin-nega­
tive, culture-positive (Table II). All 
21 C. difficile isolates produced a 
cytotoxin in vitro.
In addition to C. difficile in their
stool, five patients (17%) had a con
" : n H n n n
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FIG. t — Temporal relation of Clostri­
dium difficile-positive patients on each 
of three general medical wards.
comitant cause for diarrhea — in­
flammatory bowel disease (two), dia­
betic neuropathy (two) and infection 
by Campylobacter sp. (one patient).
Fifteen patients were treated with 
vancomycin (Table III). Four of the 
five patients with pseudomembranous 
colitis treated with vancomycin were 
cured. Of the remaining two patients 
with pseudomembranous colitis, one, 
who had been receiving vancomycin 
and had suffered an exacerbation of 
chronic diarrhea, had prompt resolu­
tion of the pseudomembranes, but 
the baseline amount of diarrhea per­
sisted. Three weeks after discontinu­
ing vancomycin the pseudomem­
branous colitis relapsed. The other 
patient was cured by discontinuing 
her antibiotics.
Nine of the 12 patients with an 
abnormal mucosa, but no pseudo­
membranes (Table II), were treated 
with vancomycin and 6 had prompt 
resolution of their diarrhea (Table III).
Seven patients did not have sig­
Tab le  III— Response  o f G roup  1 P a tie n ts  to V a r io u s  
T h e ra p e u tic  M o d a lit ie s  A cco rd in g  to F ind ing s  
on S igm o idoscopy
F ind ing s  on s igm o idoscopy, 
no. o f pa tien ts  (responded  to  tre a tm en t)
T rea tm en t
Pseudom em branous Abno rm a l Norm al 
c o l i t is  m ucosa mucosa
V anco m yc in  
A n t ib io t ic  d iscon tinued  
V an co m yc in  p lus cho le s ty ra m in e
5 (4)* 8 (5) 1 (1) 
1 (1) 2 (2) 1 (0) 
1 (1 )
’"One responded  in it ia l ly  but la te r  re lapsed .
Tab le  IV— C h a ra c te r is t ic s  o f 22 G roup 2 P a tie n ts  
w ith  Clostridium difficile
Stoo l specim en
Toxin-1-, T o x in  — , 
cu ltu re-1 -cu ltu re -!-
C h a ra c te r is t ic s (n =  9) (n =  13)
R a tio  o f men to women 3:6 7:6
M ean age, y r
M ean (m ed ian ) d u ra t ion  of h o sp ita l
69.6 68.5
stay  w hen  C . difficile iso la ted , d 69.1 (60) 18 (11)
No. w ith  d ia rrh ea  
No. g iven  a n t ib io t ic s  w ith in  
4 w eeks o f is o la t io n  o f
7 6
C. difficile 8 3
S igm o ido scop ic  f in d in g s 2 3
Pseudom em branous c o lit is 2 1
N orm a l
T rea tm e n t w ith  vancom ycin
0 2
(n o .cu re d ) 3 (0 )* 1 (0 )
C .  d i/ / ; c l/ e f i lt r a te ,  no. 
Toxin-1- 9 4
T o x in  — 0 9
*ln two p a t ie n ts  w ith  pseudom em branous c o lit is  th e  pseudom em branes re so lved , d ia rrh ea
decreased  b u t pers is ted . The  th ird  p a t ie n t was tre a ted  tw ice  w ith  vancom yc in  w ith  tem po ra ry  
im p rovem en t on both o ccas ion s.
moidoscopy performed. One was 
treated with vancomycin and choles­
tyramine and diarrhea ceased; four 
others recovered with supportive care 
and withdrawal of antibiotic therapy; 
one patient died of causes unrelated 
to the diarrhea.
Group 2
Over a 4-month period C. difficile 
was isolated from the stool specimens 
of 22 (17.3%) of the 127 patients. 
Sixty-five of the 167 stool specimens 
were from 51 patients on ward 4A, 
42 from 30 patients on ward 4N and 
60 from 46 patients on ward 4S. 
The organism was isolated from 12% 
of the patients tested on ward 4A, 
from 30% of those on ward 4N 
and from 15% of those on ward 4S. 
The temporal relation of these cul­
ture-positive patients on each of the 
three wards is shown in Fig. 1. Fil­
trates of cultures of the C. difficile 
isolated from the stools of the 22 pa­
tients were tested for the presence 
of a cytotoxin. All nine isolates from 
cytotoxic stools produced a toxin 
compared with only 4 of 13 isolates 
from noncytotoxic stools (P <  0.01). 
Ten of the isolates from noncytotoxic 
stools failed to produce a toxin fol­
lowing 24 hours of incubation in 
chopped meat-glucose medium. One 
of the 10 produced a toxin following 
5 days of incubation. These toxin­
negative isolates were confirmed as 
C. difficile by Dr. J. Silva, Ann 
Arbor, Mich. Patients with in vivo 
toxin production were: more likely to 
have received antibiotics in the pre­
ceding 4 weeks (88% vs. 23%, P 
<  0.01), more likely to have pseudo­
membranous colitis (2 of 9 [22% ] vs. 
1 of 13 [8%]) and more likely to pro­
duce a toxin in vitro (100% vs. 30%, 
P <  0.01) (Table IV). Only four pa­
tients, three of whom had pseudo­
membranous colitis, were treated with 
vancomycin; pseudomembranes dis­
appeared and diarrhea decreased but 
did not disappear in any of them and 
two of the three died of their under­
lying diseases.
Group 3
One patient (4.5%) had C. difficile 
isolated from a stool specimen. Her 
case history is outlined briefly below:
A 19-year-old woman had diarrhea 
starting on the second day of a course 
of ampicillin therapy during Novem­
ber 1980. She discontinued the am­
picillin and the diarrhea ceased im­
mediately. Her bowel habit was nor­
mal until Jan. 15, 1981. Then she 
had no bowel movement for 4 days,
4
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followed by irregular bowel habit 
with episodic diarrhea and constipa­
tion that persisted for 3 months. 
Clostridium difficile was isolated 
twice, on days 28 and 58 after symp­
toms began. The stool specimen on 
day 58 was cytotoxic and both isolates 
of the organism produced a cytotoxin 
in vitro. No fecal leukocytes were 
seen on Gram-staining and no other 
enteric pathogens were isolated. Sig- 
moidoscopic examination revealed 
normal colonic mucosa, a biopsy of 
which showed “mild congestion”. 
Despite persistence of symptoms, a 
stool culture on day 76 was nega­
tive for C. difficile and its cytotoxin.
Group 4
All stool cultures from the 54 
healthy subjects, none of whom had 
received antibiotics in the preceding 
4 weeks, were negative for C. difficile.
Discussion
Diarrhea due to C. difficile has 
been recognized with increasing fre­
quency since a selective medium was 
introduced for isolating this organ­
ism.11 Our data show that 22% of 
patients on medical wards had the or­
ganism in their stools. In contrast, 
when clinical suspicion of antibiotic- 
associated diarrhea was used as the 
basis for ordering a culture for C. 
difficile or a stool for cytotoxicity- 
testing, it took 10 months to accu­
mulate 29 patients from the entire 
hospital (710 beds).
In some patients C. difficile car­
riage is transient and the patients 
are asymptomatic. It is also evident 
from group 1 that patients may have 
diarrhea, C. difficile in their stools, 
and still have other causes for their 
diarrhea. In this setting, the role of 
C. difficile is difficult to determine. 
The definition of antibiotic-associated 
diarrhea used by some investigators 
excludes such patients.16
When diarrhea is thought to be as­
sociated with antibiotic therapy, the 
rate of mucosal abnormalities found 
at sigmoidoscopy is usually high (18 
of 22 in our series) and the patient 
is likely to have received vancomycin 
(15 of 29). Vancomycin therapy was 
instituted in 5 patients when pseu­
domembranes were seen at sigmoido­
scopy, and in the other 10 when the 
stool was reported to be positive for 
C. difficile or its cytotoxin. Although 
13 of the 22 patients in our prospec­
tive study (group 2), from whom C. 
difficile was isolated, had diarrhea, 
only 4, including the 3 with pseudo­
membranous colitis, were treated with 
vancomycin.
The carriage rate of C. difficile 
varies considerably, ranging from 
3% of 137 adults17 to 62% of 
healthy neonates.18 Hulkower and 
associates19 isolated C. difficile from 
36 (12%) of 300 children using 
specimens obtained by rectal swab. 
Twenty-five had diarrhea and 18 of 
these had been given antibiotics. The 
carriage rate of this organism by hos­
pitalized adults is not yet defined. 
Fainstein and associates20 studied 103 
patients who received antitumour 
agents and found that 25 subsequent­
ly had colitis, 41 had mild diarrhea 
and 37 were asymptomatic. Clostri­
dium difficile was recovered from 
15, 0 and 7 patients in each of the 
three groups respectively. The seven 
asymptomatic patients were culture­
positive for C. difficile when admitted 
to hospital and three of these had 
colitis following antibiotic therapy or 
other chemotherapy. Two other pa­
tients had colitis giving an overall 
incidence of 23%. This rate is slightly 
higher than the 17% rate among our 
medical patients.
The major question in hospitalized 
adults is whether this organism is 
acquired nosocomially or whether 
antibiotic therapy alters the fecal 
flora allowing for overgrowth by en­
dogenous C. difficile. Mulligan and 
associates21 found that while none 
of five patients had C. difficile iso­
lated from stool samples before treat­
ment with cefoxitin, the organism was 
isolated from four during or after 
therapy. Heimdahl and Nord22 studied 
the effect of phenoxymethylpenicillin 
and clindamycin on the oral, throat 
and fecal microflora of 20 volunteers. 
One of the 10 given clindamycin had 
C. difficile in stool specimens ob­
tained on days 7 to 16 of the study. 
This subject had diarrhea for 8 days 
and stool cultures obtained after the 
clindamycin was discontinued were 
negative for C. difficile. The organism 
produced a cytotoxin in vitro.
Persistent contamination of the 
hospital environment by C. difficile 
has been demonstrated. Fekety and 
associates23 found that 18 of 97 cul­
tures obtained from the room of a 
patient with C. difficile colitis grew 
this organism. In the room of an 
asymptomatic carrier only 5 of 74 
surfaces were positive. Mulligan and 
associates24 demonstrated that C. dif­
ficile could be detected on room sur­
faces 40 days after a patient with 
diarrhea due to this organism had 
been moved from the room. Kim and
associates25 found that 48 (11.1%) of 
432 environmental samples in a case- 
associated intensive care unit grew 
C. difficile, compared with 6 (2.8%) 
of 218 such cultures from a control 
intensive care unit. They also showed 
that 15 (12.2%) of 123 environmental 
items from the home of an infant 
with C. difficile-associated diarrhea 
were positive for the organism com­
pared with none of 84 items in a 
control home environment. Clustering 
of cases of pseudomembranous colitis 
has been reported previously26 and 
hand carriage of the organism by 
health-care personnel caring for in­
fected patients has been demon­
strated.25 These data suggest noso­
comial acquisition of C. difficile, and 
it is now recommended that patients 
with diarrhea due to C. difficile be 
isolated.26 Since the carriage rate is 
so high in hospitalized patients, and 
contamination of the environment bv 
asymptomatic carriers low, we would 
suggest not isolating individuals in 
the latter group. They are probably 
at increased risk for diarrhea and 
pseudomembranous colitis, but this 
remains to be demonstrated. The 
development of a typing system is 
needed to determine the importance 
of nosocomial spread.
Two surprising findings in the 
prospective portion of our study 
(group 2) were the high number of 
C. difficile isolates that did not pro­
duce a cytotoxin in vitro and the 
relation of toxin production in vivo 
to antibiotic exposure. Nine (41%) 
of the 22 group 2 patients with C. 
difficile in their stools had a positive 
cytotoxin assay and 7 of the 9 had 
diarrhea. Pseudomembranous colitis 
occurred in 1 of the 13 patients 
with negative stool cytotoxicity tests. 
The absence of toxin in this patient’s 
stool and the failure of his C. difficile 
isolate to produce a cytotoxin in 
vitro is consistent with the recent 
observation that this organism pro­
duces both a cytotoxin and an entero- 
toxin.27
The role of C. difficile toxin in 
symptomatic relapse of chronic in­
flammatory bowel disease is unclear. 
Trnka and LaMont28 found that 11 
of 59 such patients had positive re­
sults from cytotoxin assay and there 
was a strong correlation with disease 
activity. Of those with severe disease 
60% were cytotoxin-positive. Meyers 
and coworkers29 found that 4 of their 
44 patients with inflammatory bowel 
disease had a positive result from 
cytotoxin assay and this was related 
to previous antimicrobial therapy. Of
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their 21 patients with chronic diarrhea 
(control group) 5 had C. difficile 
cytotoxin in their stools. In a general 
hospital these patients constitute a 
small number of those with cytotoxic 
stool as evidenced by our group 1 
patients of whom only 7% had in­
flammatory bowel disease.
Asymptomatic carriage of C. dif­
ficile is unlikely to pose a therapeutic 
problem in contrast with the presence 
of this organism or its toxin, or both, 
in the stools of patients with chronic 
diarrhea. The absence of pseudo­
membranes on sigmoidoscopy does 
not exclude their presence elsewhere 
in the colon30 making evaluation of 
these patients even more difficult.
We thank the nursing staff of wards 
4A, 4N, 4S and the anaerobic and 
virology laboratory technologists at the 
Victoria General Hospital, who made 
this study possible.
Dr. Joseph Silva, University of Michi­
gan Medical School, Ann Arbor, Mich., 
kindly tested 13 of our isolates.
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Phagocytic and Bactericidal Functions of 
Polymorphonuclear Neutrophils 
from Anergic Surgical Patients
N .V . CHRISTOU, MD, PH D, FRCS[C] AND J.L . MEAKINS,
Neutrophil adherence and polymorpho­
nuclear chemotaxis are altered in 
anergic patients, but the phagocytic 
and bactericidal capacities of their 
polymorphonuclear neutrophils are not 
known. Nineteen healthy control 
subjects, 6 reactive patients and 37 
anergic patients were studied. Patients 
were classified as reactive, relatively 
anergic or anergic if they responded 
to two, one or none, respectively, 
of five recall antigens injected 
intradermally. Polymorphonuclear 
chemotaxis (Boyden chamber assay, 
leading front method) was measured 
simultaneously with phagocytosis and 
killing capacity of Staphylococcus 
aureus 502A labelled with tritiated 
thymidine (suitably opsonized with 
10%  pooled normal serum) in a 
serum-free medium. Phagocytosis 
appeared increased in the nonreactive 
patients. There was a significant 
correlation between phagocytosed 
bacteria and depressed polymorpho­
nuclear chemotaxis (r =  0.472,
P <  0.001). Although normal polymor­
phonuclear neutrophils had lower 
phagocytosis than those from anergic 
patients, their killing capacity was 
significantly (P <  0.05) better at the 
first sampling (10 minutes). The 
polymorphonuclear neutrophils of 
anergic and reactive patients had 
similar bactericidal function after 10 
minutes up to 160 minutes.
The authors conclude that there exist 
subtle defects in bactericidal function 
of chemotactically inhibited polymor­
phonuclear neutrophils from anergic 
patients, manifested by (a) increased 
survival of S. aureus within poly-
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morphonuclear neutrophils (increased 
“phagocytosis”) and (b) decreased 
bactericidal capacity for the first 10 
minutes of neutrophil-bacterial contact.
Chez les patients anergiques, 
I’adherence des neutrophiles et la 
chimiotaxie des polymorphonucleaires 
sont alterees mais on ignore le 
pouvoir phagocytaire et bactericide 
des neutrophiles polymorphonucleaires. 
Cette etude porte sur 19 sujets sains 
temoins, 6 patients qui reagissaient 
et 37 patients anergiques qui ont ete 
classifies reactifs, relativement 
anergiques ou anergiques selon qu’ils 
reagissaient, respectivement, a deux, 
un ou aucun de cinq antigenes de 
rappel injectes par voie intradermique. 
La chimiotaxie des polymorpho­
nucleaires (determination en chambre 
de Boyden, methode du premier front 
de migration) a ete mesuree en meme 
temps que le pouvoir phagocytaire 
et bactericide sur du Staphylococcus 
aureus 502A marque a la thymidine 
tritie (apres opsonisation appropriee 
dans 10% de serum provenant d'un 
groupe de donneurs normaux) dans 
un milieu exempt de serum. La 
phagocytose semblait augmentee chez 
les patients non reactifs. II existait 
une correlation significative entre le 
nombre de bacteries phagocytees et 
une chimiotaxie polymorphonucleaire 
abaissee (r =  0.472, P <  0.001). Bien 
que le pouvoir phagocytaire des 
neutrophiles polymorphonucleaire des 
individus normaux ait ete plus faible 
que celui des patients anergiques, 
leur pouvoir bactericide etait 
significativement meilleur (P <  0.05) 
au premier echantillonnage (a 10 
minutes). Apres les premiers 10 
minutes et jusqu’a 160 minutes, la 
fonction bactericide des neutrophiles 
polymorphonucleaires etait similaire, 
chez les patients anergiques et chez 
les patients reactifs.
Les auteurs concluent qu'il existe 
chez les patients anergiques des 
defauts peu apparents de la fonction 
bactericide des neutrophiles 
polymorphonucleaires inhibes par 
chimiotaxie qui se manifestent par 
a) une augmentation de la survie de
MD, D SC, FRCS[C]
S. aureus a I'interieur des neutrophiles 
polymorphonucleaires (“phagocytose” 
augmentee) et b) une diminution du 
pouvoir bactericide pendant les 
10 premieres minutes du contact 
entre les cellules neutrophiles et les 
bacteries.
Preoperatively, failed response to five 
recall antigens using the delayed hy­
persensitivity skin test is predictive of 
increased sepsis and mortality.1'3 When 
neutrophil adherence and polymor­
phonuclear chemotaxis are altered, 
anergic patients have an increased fre­
quency of sepsis compared with nor­
mally reactive patients with normal 
neutrophil function.4 Tests for neutro­
phil adherence and chemotaxis dem­
onstrate the host’s ability to mount 
an inflammatory response as there is 
good correlation between in vitro 
polymorphonuclear neutrophil chem­
otaxis and the numbers of neutrophils 
delivered to an inflammatory focus.5 
Defective bactericidal function has 
been demonstrated in the neutrophils 
of burned patients,6 but the phago­
cytic and bactericidal functions of 
polymorphonuclear neutrophils from 
anergic surgical patients are unknown. 
This study was undertaken to measure 
simultaneously the chemotactic, pha­
gocytic and bactericidal functions of 
polymorphonuclear neutrophils from 
anergic patients and to compare these 
values with those derived from reac­
tive surgical patients and from healthy 
control subjects.
Patients and Methods
All patients, reactive and nonreac­
tive, were from the wards and the 
surgical intensive care unit of the 
Royal Victoria Hospital in Montreal. 
The 19 control subjects were healthy 
volunteers whose age ranged from 18 
to 42 years. Permission for the study 
was obtained both from the hospital 
and university ethics committees. Skin 
testing was carried out by the intra- 
dermal injection of five recall anti­
gens4 and patients were classified as 
reactive, relatively anergic or anergic 
if they responded to two, one or none
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of the antigens respectively. A re­
sponse was defined as more than 
5 mm of induration measured at 24 
or 48 hours.
Preparation of Bacteria
Our bacterial strain was Staphylo­
coccus aureus 502A and was prepared 
in batches every 3 months. Mueller- 
Hinton broth (200 ml) to which was 
added 5 mC of tritiated thymidine 
was inoculated with a 10-ml aliquot 
of an overnight culture of the or­
ganism and incubated at 37°C for 
24 hours. The bacteria were then 
washed three times with cold normal 
saline by centrifugation at 10 000 X 
g for 20 minutes. The bacterial pellet 
was resuspended in phosphate-buf­
fered saline supplemented with 5% 
glycerol to a concentration of 5 x  102 
colony-forming units/ml using an 
electronic particle counter (Coulter 
Counter, model Z, 30 fi aperture; 
Coulter Electronics, Inc., Hialeah, 
Fla.) and a standard pour plate tech­
nique for confirmation. The bacteria 
were then stored at — 70°C in 2-ml 
aliquots.
Bacterial Opsonization
A large store of normal human 
serum was obtained from 10 hospital­
ized patients and diluted to 10% with 
minimal essential medium. This was 
divided into 2-ml aliquots and stored 
at — 70 °C until use. As soon as blood 
was obtained for polymorphonuclear 
neutrophil preparation, the required 
bacteria and 10% normal human se­
rum were thawed. The bacteria were 
centrifuged at 2000 x  g for 20 min­
utes at 4°C and the supernatant 
was discarded. They were resuspended 
in an equal volume of 10% normal 
human serum and incubated at 37°C 
for 15 minutes to permit opsonization. 
The tube was then centrifuged and 
the bacterial pellet was stored on ice 
in a capped tube until used.
Polymorphonuclear Neutrophil 
Preparation
Blood was obtained by venepunc­
ture in heparinized tubes and 2 ml 
Dextran 40 was added to each 8 ml 
of blood. The leukocyte-rich super­
natant remaining after sedimentation 
of red cells was centrifuged at 200 X 
g for 10 minutes, all but 0.5 ml of 
the supernatant was discarded and 
0.5 ml of normal saline was added 
to the tube. After resuspension the 
cell pellet was loaded onto 3 ml of 
Ficoll-Hypaque (Pharmacia, Uppsala, 
Sweden) and centrifuged at 480 X g 
for 30 minutes, and the mononuclear
and polymorphonuclear cell fractions 
were isolated. The polymorphonuclear 
neutrophil pellet with some erythro­
cyte contamination was resuspended 
in 10 ml of sterile 0.87% ammonium 
chloride placed on a tilting-table ali­
quot mixer (Fisher Scientific Co., 
Pittsburgh, Penn.) at 37°C for 20 min­
utes to lyse the erythrocytes. The poly­
morphonuclear neutrophils were col­
lected by centrifugation at 200 X g 
and the process was repeated. The 
neutrophils were then washed in min­
imal essential medium and resus­
pended to a concentration of 1 X 107 
neutrophils/ml. Cell viability was as­
sessed by means of trypan blue (al­
ways more than 92%), and smears 
were prepared and stained with 
Wright’s and myeloperoxidase stains 
to assess the cell population utilized.
Phagocytic Assay
For each patient the opsonized bac­
terial tube was made up to the ori­
ginal stored volume with warm mini­
mal essential medium and mixed.7 
Five 12 X 75-mm plastic, capped 
tubes were used. Into each was placed 
0.15 ml of the bacterial suspension, 
containing 7.5 X 107 bacteria. To 
tubes 1, 2 and 3 was added 0.75 ml 
of the polymorphonuclear neutrophil 
suspension containing 7.5 X 106 neu­
trophils, while 0.75 ml of a heated 
suspension (70°C for 20 minutes) of 
polymorphonuclear neutrophils was 
added to tube 4 and 0.75 ml of mini­
mal essential medium to tube 5. Im­
mediately after mixing, a 100-yu.l 
sample was withdrawn and placed in 
4 ml of cold phosphate-buffered saline 
in an ice bucket to determine total 
available radioactivity. The assay tubes 
were then placed on a tilting-table 
aliquot mixer at 37°C. Samples of 
100 fi\ were taken at 5, 10 and 20 
minutes and placed in cold phosphate- 
buffered saline.
Bactericidal Assay
To assess bactericidal activity, a 
separate 50-/jl\ sample was taken from 
each tube and placed into 5 ml of 
cold sterile distilled water to disrupt 
the polymorphonuclear neutrophils 
and determine total colony-forming 
units. Samples were taken at 0, 10, 
20, 40, 80, 160 and 240 minutes. In 
separate experiments, the polymor­
phonuclear neutrophil to bacteria ra­
tio was varied by resuspending the 
starting concentration of polymorpho­
nuclear neutrophils or bacteria, or 
both, to the required concentration 
so as to keep the same reaction vol­
umes (0.9 ml).
Analysis of the Phagocytic Assay
The phagocytic activity in each 
tube was analysed as follows. Tubes 
taken at the time zero were centri­
fuged at 2000 X g for 20 minutes 
and the supernatant was discarded. 
The pellet was washed once with cold 
phosphate-buffered saline and then 
resuspended in 5% trichloroacetic 
acid and left overnight in the cold 
room. The tubes taken at 5, 10 and 
20 minutes were centrifuged at 160 
X g for 5 minutes, the supernatant 
was discarded and the polymorpho­
nuclear neutrophil-bacteria pellets 
were washed twice with cold phos­
phate-buffered saline. The pellets 
were resuspended in 5% trichloro­
acetic acid and left overnight in the 
cold room. The following day the 
precipitated DNA was collected by 
filtration of the samples through 2.4- 
cm glass fibre filters (GF/A, What­
man, Can-lab Biochemicals, Montreal, 
PQ) using an FH-200, 10-place filter 
holder (Hoeffer Scientific Instruments, 
San Francisco, Calif.). The filtrates 
were discarded. The filters were 
washed with 95% ethanol and dried 
with ether. They were placed in 15-ml 
glass scintillation vials with 10 ml of 
toluene-based counting fluid. Radio­
activity was determined with a Pac­
kard, tri-card, liquid scintillation 
spectrometer (Packard Instrument 
Co., Inc., Downers Grove, 111.).
The results are expressed as fol­
lows. The zero time sample repre­
sented total available bacteria. Sam­
ples taken at 5, 10 and 20 minutes 
(tubes 1, 2 and 3) represented the 
phagocytosed bacteria. Tube 4 al­
lowed a correction factor for the poly­
morphonuclear neutrophil-attached 
bacteria that were not phagocytosed. 
Tube 5 represented a control for any 
bacterial contamination of the poly­
morphonuclear neutrophil pellet due 
to cosedimentation of unattached bac­
teria despite the low speed used. Thus, 
phagocytosis is expressed as a per­
centage of initial labelled bacteria 
associated with the polymorphonu­
clear neutrophils at time “t” using the 
formula:
where At =  radioactivity associated 
with polymorphonuclear neutrophil 
pellet at time “t”, B =  total radio­
activity in tube at time zero, C =  
bacterial contamination of polymor­
phonuclear neutrophil pellet and t =  
time (5, 10 and 20 minutes).
Phagocytosis, rather than mere at­
tachment of the bacteria to the poly-
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morphonuclear neutrophil membrane, 
could then be determined by sub­
tracting the percentage of polymor­
phonuclear neutrophil-attached bac­
teria (tube 4) from the other tubes 
(1, 2 and 3) at each sampling time.
Analysis of the Bactericidal Assay
To analyse bactericidal activity in 
each tube, the samples obtained at all 
time intervals including time zero 
were further diluted to 1 in 100 by 
taking 0.1 ml of material from the 5- 
ml distilled water tube into 9.9 ml of 
phosphate-buffered saline. A 0.1-ml 
aliquot was taken from this and plated 
on standard agar plates. The bacterial 
colonies were counted after incuba­
tion for 24 hours at 37 °C. Since the 
sampling volume and dilutions were 
the same for each time period, the 
results were expressed as a percentage 
of the initial inoculum killed at each 
time using the formula:
. . .Ao — Bt
% bactericidal function = ----------- ,
A o
where A« =  the number of colony­
forming units in the tube at time zero, 
Bt =  the number of colony-forming 
units in the tube at time “t” and t =  
time (10, 20, 40, 80, 160 or 240 
minutes).
Chemotaxis Assay
A modified Boyden chamber tech­
nique was used to measure polymor­
phonuclear neutrophil chemotaxis.3 A 
2.5-cm Sykes-Moore tissue culture 
chamber was separated into an upper 
and lower compartment by a 2.5-cm, 
3-/z Millipore filter. The polymorpho­
nuclear neutrophils to be tested were 
placed in the upper chamber at 
5 X 10s cells/ml in minimal essential 
medium and the chemoattractant 
casein (5 mg/ml in minimal essential 
medium) was placed in the lower 
compartment. After 90 minutes of 
incubation the filters were processed 
and inspected under a microscope 
(40 x objective). Migration distance 
was determined by the penetration 
into the filter of the neutrophil lead­
ing front and expressed in microns.
Results
Phagocytosis
Characterization of the method.— 
Two control subjects were used to 
evaluate the technique. Table I shows 
the phagocytic capacity of polymor­
phonuclear neutrophils in these two 
subjects. A total of 12 assays were 
done on different days over 12 weeks. 
Maximal phagocytosis was seen at 10
Table 1 -Phagocytic Capacity of Polymorphonuclear 
Neutrophils from Two Healthy Control Subjects, and the 
Variability of the Method*
Control Subjects
Time, min 1 (7 assays) 2 (5 assays) P valuet
5 45.1 ±  3.9 46.6 ±  5.2 NS
(34.4-53.8) (32.0-61.2)
10 46.3 ±  5.3 51.2 ±7  .3 NS
(31.6-58.3) (30.9-71.5)
20 43.8 ±  4.6 41.0 ±  5.8 NS
(30.9-54.3) (25.0- 50.0)
'Figures are mean percent ±  standard error of bacterial uptake; 95% confidence limits of mean are 
shown in brackets.
tAnalysis of variance and Scheffe's test.
Table ll-Phagocytic Capacity (%) of Polymorphonuclear Neutrophils from 
Control Subjects, and Hospitalized Reactive and Nonreactive 
Skin Test Responders
Time,
min
Control 
(n = 19)
Reactive 
(n = 6)
Nonreactive 
(n =  37)
5 *40.8 ±  3.5 NS 52.5 ±  4.8 P <  0.05 65.6 ±  3.1*
10 t48.6 ±  4.3 P <  0.05 62.6 ±  5.3 P <  0.05 76.1 ±  2.8t
20 440.9 ±  3.3 P <  0.05 62.2 ±  5.6 NS 64.0 ±  2.64
*  vs. *, t vs. t and 4  vs. 4= = P <  0.05.
minutes, representing approximately 
50% of the available bacteria. In the 
control subjects, 14.9 ±  5.6% (mean 
±  standard error, 95% confidence 
limits of mean, 9.3% to 19.5%) of 
the bacteria were found to be poly­
morphonuclear neutrophil-attached 
but not phagocytosed. Similarly, bac­
terial contamination in the polymor­
phonuclear neutrophil pellet by free 
bacterial cosedimentation was found 
to be 7.7 ±  1.0%. The percentage 
of bacteria attached to polymorpho­
nuclear neutrophils from the anergic 
patients, but not phagocytosed, was 
19.8 ±  1.6% (95% confidence limits 
of mean, 16.6% to 22.8%), not sig­
nificantly different from the percent­
age for the normal control subjects 
(14.5 ±  5.6%, 95% confidence limits 
of mean, 9.3% to 19.5%). All poly­
morphonuclear neutrophil to bacteria 
ratios, which varied from 1:2 to 1:50, 
demonstrated similar overall uptake. 
However, the number of assays with 
each ratio (less than 10) did not per­
mit reliable statistical analysis.
Phagocytic capacity between con­
trol subjects and hospitalized pa­
tients.—The phagocytic capacity of 
polymorphonuclear neutrophils from 
21 healthy control subjects against S. 
aureus 502A was measured and com­
pared with that from 18 hospitalized 
patients with a reactive skin test re­
sponse and 37 nonreactive patients (9 
with relative anergy and 28 with 
anergy). Analysis of variance was 
used to compare the three groups at 
each sampling time simultaneously, 
and significance was determined by 
the paired Student’s f-test. Table II 
shows that polymorphonuclear neu­
trophils from nonreactive patients had 
higher phagocytosis at all times 
sampled than control subjects. Signif­
icant differences (P <  0.05) were 
also noted between controls and re­
active patients at 10 and 20 minutes, 
as well as between reactive and non­
reactive patients at 5 and 10 minutes.
Abnormal polymorphonuclear neu­
trophil chemotaxis was defined as less 
than 123.8 /i, the lower 95% con­
fidence limit of the control subjects. 
Simultaneous measurements of poly­
morphonuclear neutrophil chemotaxis 
in the three groups showed that the 
mean polymorphonuclear neutrophil 
chemotaxis for control subjects was 
127.1 ±  0.5 fJL, for reactive patients 
121.0 ±  2.2 fj. and for nonreactive 
patients 116.6 ±  1.6 fx (P <  0.05). 
Fig. 1 presents graphically the phago­
cytosis of polymorphonuclear neutro­
phils with normal mean chemotaxis 
equal to 125.6 ±  0.4 jx (n =  49), 
compared with those with decreased
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mean chemotaxis of 109.0 rfc 1.5 /a 
(n =  22). Polymorphonuclear neu­
trophils with decreased chemotaxis 
demonstrated increased phagocytic ca­
pacity. Furthermore, there was a sig­
nificant correlation between depressed 
chemotaxis and phagocytosed bacteria 
at all times tested (5 minutes: r =  
0.47, P <  0.001; 10 minutes: r =  
0.54. P < 0.001; 20 minutes: r =  
0.26. P <  0.05).
Bactericidal Function
Characterization of the method.—  
As for phagocytosis, the same two 
control subjects were used to charac­
terize the technique for measuring po­
lymorphonuclear neutrophil bacterici­
dal function (Table III).5 There was 
an 85.5% kill of the initial bacteria 
by control polymorphonuclear neutro­
phils, reducing the inoculum from 
3 X 107 colony-forming units to 
5 X 10' colony-forming units after 
240 minutes. In the first 10 minutes. 
50% to 60% of the bacterial ino­
culum was killed. The 95% confi­
dence limits were very wide especially 
at the early sampling times. No dif­
ference in killing was noted in the 
two controls. Bacteria incubated in 
medium without polymorphonuclear 
neutrophils lost no viability up to 240 
minutes, and increased in number.
Polymorphonuclear neutrophil bac­
tericidal function between control 
subjects and hospitalized patients.—  
Table IV shows the bactericidal capa­
city of polymorphonuclear neutro­
phils from 19 control subjects. 6 hos­
pitalized reactive skin test responders 
and 15 nonreactive responders. Anal­
ysis of variance indicated that both 
reactive and nonreactive patients had 
a significant (P < 0.05) decrease in 
bactericidal function at 10 minutes.
FIG. 1—Comparison of phagocytic 
capacity of polymorphonuclear lympho­
cytes with normal (hatched bars) and 
decreased (black bars) chemotaxis. * =  
P <  0.05.
No difference could be detected after 
10 minutes. There Was no correlation 
between polymorphonuclear neutro­
phil chemotaxis and bactericidal capa­
city at any time. Paired r-test analysis 
of control subjects and nonreactive 
patients studied on the same day 
showed no difference in bactericidal 
function even though the polymorpho­
nuclear neutrophils of nonreactive pa­
tients demonstrated increased phago­
cytosis.
Discussion
Phagocytosis as indicated by the 
numbers of intact bacteria detected 
within neutrophils was increased in 
patients with nonreactive skin tests 
(with relative anergy and anergy), and 
this increase correlated highly with 
decreased polymorphonuclear neutro­
phil chemotaxis. The assay as per­
formed here identifies cell-associated 
bacteria on the basis of relatively
intact DNA. During phagocytosis, 
bacteria are first attached to the poly­
morphonuclear neutrophil membrane, 
then phagocytosed. The intracellular 
bacterium is then combined with lyso­
somal enzymes to form the “phago­
lysosome”. The enzymes within this 
structure may only punch holes in 
the bacterial wall or totally digest the 
whole bacterium depending on the 
bactericidal capacity of the polymor­
phonuclear neutrophil. A totally di­
gested bacterium would not be de­
tected as a phagocytosed bacterium in 
this assay since free thymidine or 
thymidine incorporated into small- 
chain polynucleotides (less than 1000 
nucleotides) would not be retained 
by the glass fibre filters to be counted 
subsequently. On the other hand, a 
partially digested bacterium, that is, 
one with a few breaks in its cell wall 
but with intact DNA, would be de­
tected as a phagocytosed bacterium. 
When such a bacterium is placed in
Table III-Bactericida l Capacity of 
Polymorphonuclear Neutrophils from Tw o 
Control Subjects*
Control Subjects
Time, min 1 (7 assays) 2 (5 assays) P  valuet
10 60.3 ±  3.7 
(44.3-69.4)
52.0 ±  7.0 
(21.9-82.1)
N S
20 65.2 ±  4.1 
(57.0-70)
64.0 ±  5.4 
(40.9-78.9)
N S
40 69.3 ±  3.2 
(60.4-77.1)
74.8 ±  4.7 
(61.9-87.7)
N S
80 75.3 ±  3.5 
(65.7-83.8)
78.0 ±  4.5 
(65.6-90.4)
N S
160 83.4 ±  2.9 
(75.4-90.5)
82.2 ±  4.8 
(68.9-95.5)
N S
240 85.5 ±  3.2 
(78.1-92.1)
- -
'F igu re s are mean percentage of total bacteria killed ±  standard enor; 9 5 %  confidence limits of the 
mean are show n in brackets. 
tStudent’s  f-test.
Table IV -Bactericida l Capacity (%  Kill of Initial Inoculum ±  SEN D  
of Polymorphonuclear Neutrophils from Control Subjects, and 
Hospitalized Reactive and Nonreactive Skin  Test Responders
Time,
min
Control Reactive 
(n =  19) (n =  6)
Nonreactive 
(n =  15)
10
20
40
80
160
*63.5 ± 2 . 6  P  <  0.05 45.0 ±  3.2 
64.1 ±  2.6 60.0 ±  4.3 
73.3 ±  2.2 69.8 ±  4.5 
78.6 ±  2.1 77.3 ±  3.2 
83.9 ±  2.0 80.9 ±  2.6
50.0 ±  2.9* 
60.8 ±  2.3 
73.2 ±  2.3
83.0 ±  1.7 
86.5 ±  1.6
*  VS. * =  P <  0.05.
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distilled water, however, it would be 
lysed and killed, thus counted as a 
killed bacterium in this assay. One 
explanation for the higher proportion of radioactivity associated with poly­
morphonuclear neutrophils would be 
that the digestion and “real” killing 
of bacteria is different. There were 
fewer intracellular bacteria at 20 
minutes in both control polymor­
phonuclear neutrophils and those with 
decreased chemotaxis than at 10 min­utes. However, bactericidal activity 
did not differ in these two groups. 
At least 85% kill of the inoculum was 
observed with normal control cells, 
yet the maximum phagocytosis ever 
detected was only 50%. More than 
50% of the bacterial inoculum was 
killed within 10 minutes. These data 
taken together indicate that once 
phagocytosed, bacteria are killed and 
disposed of very rapidly. It is possible 
that “crippled” bacteria (with breaks in cell walls only) within the neutro­
phils but not fully “killed” would 
be killed by hypotonic lysis in the 
distilled water used to break up the 
neutrophils; thus, the assay would 
detect them as killed due to bacteri­
cidal function of the polymorphonu­
clear neutrophils. The thesis is, then, 
that the increased phagocytosis asso­
ciated with polymorphonuclear neu­
trophils, demonstrating decreased 
chemotaxis, represents decreased bac­
terial digestion and disposal, not up­
take.
There was no difference in phago­
cytosis or killing by normal control 
or patient neutrophils when the neu­
trophil to bacteria ratios were altered 
from 1:2 to 1:50. We conclude that 
a major bactericidal defect of poly­
morphonuclear neutrophils did not 
exist in the nonreactive patients 
studied. If a subtle defect in killing 
is indicated by the phagocytosis data, 
then a more sensitive bactericidal 
function is needed to detect it. The 
first 10 to 15 minutes of the assay 
may be important,7 and initial killing rates with samples at 2-minute inter­
vals may be more appropriate. Data 
in the literature support this thesis. 
The burn patients studied by Alexan­
der and associates6,8 were severely 
stressed due to the burn injury and 
showed marked inhibition of bacteri­cidal function. Yet, Balch9 found that 
the phagocytosis of heat-killed sta­phylococci by polymorphonuclear 
neutrophils from severely burned pa­tients was increased. These are the 
patients, however, who demonstrate decreased bactericidal function ac­
cording to Alexander and associates. It is possible that more severely
stressed individuals exhibit more 
marked alterations in phagocytic and 
bactericidal cell functions.
Conclusions
The polymorphonuclear neutrophils 
of patients with skin test anergy show 
no major bactericidal defect by pres­
ently available assay methods. The 
polymorphonuclear neutrophils taken 
from anergic patients show increased 
phagocytosis, which correlates highly 
with decreased neutrophil chemotaxis. 
This decreased chemotaxis has clin­
ical significance in that it correlates 
well with delivery of inflammatory cells (polymorphonuclear neutrophils) 
to sites of tissue injury.5 If a phago­
cytic cell cannot reach the site of 
bacterial invasion, it is of no use, even 
if “armed to the teeth” and capable 
of devastating phagocytic and bac­
tericidal activity. These preliminary 
data suggest that there may be, in 
addition to decreased chemotaxis of 
polymorphonuclear neutrophils from 
anergic surgical patients, defects in 
phagocytic and killing capacity that 
will be identified by more sensitive 
and reliable in vitro assays.
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Sigmoid Mesenteric Tumour as a Manifestation 
of von Recklinghausen’s Disease
Malcolm L. Brigden, md, frcp[c], R.T. Hosie, md, frcs[c] and W.D. McCauley, md, mcfp
The gastrointestinal tract may be 
involved in up to 25% of cases of 
von Recklinghausen's disease. The 
authors report such a case in which an 
18-year-old girl presented with gastro­
intestinal symptoms secondary to a 
tumour in the sigmoid mesentery. 
There was no family history so it 
was presumed to be a case of spon­
taneous mutation. The authors discuss 
the protean manifestations of 
neurofibromatosis emphasizing the 
gastrointestinal presentations and 
the need for careful surgical 
management.
Un exemple de la maladie von 
Recklinghausen qui demontre des 
symptomes gastrointestinaux secon- 
daires a une tumeur sigmoide 
mesenterique est decrit. II n'y avait 
pas d'evidence de cette maladie dans 
I’histoire medicale de la famille, 
alors on a presume que c'etait une 
mutation spontanee. On decrit les 
manifestations qui sont extremement 
variables de "neurofibromatosis" 
mettant I'accent sur les presentations 
gastrointestinales et sur le besoin 
d’une intervention chirurgicale, 
approfondie.
Von Recklinghausen’s disease may 
manifest itself in a broad spectrum 
of clinical presentations.1 Although 
the neurologic aspects of this syn­
drome are usually emphasized, the 
gastrointestinal tract may be involved 
in up to 25% of cases.2 This report 
describes a girl who presented with 
a mesenteric sigmoid tumour as the 
initial manifestation.
Case Report
An 18-year-old girl had a 6-month history of intermittent crampy pelvic pain. On physical examination seven prominent cafe-au-lait spots were noted, ranging in size from 3 to 8 cm (Fig. 1). The patient had seen a dermatologist
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at 3 years of age but no clinical im­portance was attached to these cutane­ous lesions. Neurologic examination and screening tests for pheochromocytoma gave results that were within normal limits. Findings from preoperative pelvic examination under anesthesia, sigmoido­scopy and roentgenogram after barium enema were normal. Laparoscopy was performed and a large mass was seen in the mesentery of the sigmoid colon. A biopsy specimen obtained at laparo­scopy showed only fibrous tissue. Two
weeks later at laparotomy, biopsy speci­mens were obtained from the abdominal mass. The pathological diagnosis was plexiform neuroma with myxoid degen­eration. Computerized axial tomography of the abdomen and pelvis confirmed the presence of the sigmoid mass but failed to demonstrate any other ab­normality (Fig. 2). The tumour was resected en bloc with 18 cm of sigmoid colon. Despite the low tumour location, an end-to-end anastomosis was made possible with the EEA Auto Stapler (Auto Suture Company, Division of United States Surgical Corp., Stamford, Conn.). The gross specimen measured 1 1 x 5 x 7  cm and was paracolonic in location (Fig. 3). Histopathological preparations revealed a plexiform neu­roma with marked myxoid degeneration but no obvious sarcomatous transforma­tion (Fig. 4).
Discussion
FIG.  ^4—Photomicrograph of specimens shows plexiform neuroma with myxoid degeneration (hematoxylin and eosin, reduced by 30% from x250).
■
FIG. 1—Cafe-au-lait spot on ab­domen.
FIG. 2— Computerized axial tomo­gram of pelvis shows extrinsic mass compressing bladder (arrow).
The protean manifestations of neu­
rofibromatosis are often not fully ap-
FIG. 3—Surgical specimen.
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preciated; a delay in diagnosis re­
sults.1 The diagnosis may be further 
obscured by the lack of a family his­
tory expected in an autosomal domi­
nant syndrome. In such circumstances 
it is assumed that the propositus rep­
resents a sporadic mutation.
The minimal cutaneous criteria 
necessary to establish a diagnosis of 
von Recklinghausen’s disease include 
the presence of at least two peripheral 
neurofibromas or at least six cafe-au- 
lait spots exceeding 15 mm in greatest 
dimension.3 The large cafe-au-lait 
spots in our patient were sufficient to 
make the diagnosis.
The gastrointestinal manifestations 
of von Recklinghausen’s disease may 
be diverse. The most common present­
ing features include abdominal pain, 
a palpable mass, chronic gastrointes­
tinal blood loss and bowel obstruc­
tion.4 Bowel obstruction may occur 
from the tumour mass on a mechani­
cal basis or result from intussusception. 
The sporadic abdominal pain experi 
enced by our patient may have rep­
resented intermittent obstruction al­
though a frank episode of bowel 
obstruction was never documented.
Tumours may occur in virtually 
any area of the gastrointestinal mu­
cosa from the tongue to the rectum.
The ileum is the most frequent ana­
tomical location.4 The lesions proba­
bly begin in Auerbach’s plexus in the 
submucosa. In a series of 57 patients 
in whom the location of the tumour 
was specified, 25 were extraluminal, 
18 were intraluminal, 6 were intra­
mural and 7 were combined.5 The 
lesion in this patient was extraluminal.
Since sarcomatous degeneration 
has been reported in up to 29% of 
visceral neurofibromas,1 complete sur­
gical excision of all mesenteric tu­
mours in von Recklinghausen’s disease 
should be carried out. Surgery should 
be carefully planned to allow complete 
excision since an increased tendency 
for malignant degeneration has been 
reported after local trauma, espe­
cially partial resection.6 The incidence 
of sarcomatous degeneration increases 
in patients over 40 years of age mak­
ing early intervention and careful 
follow-up advisable.
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THE ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA
EXAMINATIONS: EMERGENCY MEDICINE
The first examinations in the specialty of Emergency Medicine will be held in September 1983. 
Prospective candidates should note the following:
1. Every candidate for admission to the exam­
inations must submit an application for 
assessment of training.
2. Candidates who wish to take the exam­
inations in 1983 should apply for a pre­
liminary assessment of training as soon 
as possible, and in any case, not later than 
September 1, 1982. Only candidates whose 
assessment of credentials is complete will 
be accepted to sit for the examinations.
3. Candidates who desire to take the exam­
inations in Emergency Medicine, having 
complied with the above requirement of 
preliminary assessment of training, must 
notify the College in writing of their intent 
before February 1, 1983. Upon receipt of 
this notice of intent, the evaluation of the 
candidate’s performance during training 
will be added to the previously completed 
assessment of credentials. Each candidate 
will then receive notification as to eligibility
together with an application form for ad­
mission to the examinations, which must 
be completed and returned.
4. The following documents may be obtained 
from the College office:
(a) Application forms for assessment of 
training.
(b) General information booklet of regula­
tions relating to the examinations.
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Urinary Calculi in Pregnancy
Jean-Paul Perreault, md, frcs[c],* Jean-Marie Paquin, md, FRCs[c],f 
Raymond Faucher, md|  and Francois Mauffette, md, FR C s[c]t
Between January 1975 and March 1980, 
19 pregnant patients with urinary 
calculi were admitted to hospital.
They constituted 0.23% of all women 
delivered at the Hopital St-Luc during 
that period. The symptoms were 
characteristic: pain in the flank and 
right lower quadrant, hematuria, 
frequency and dysuria. Noninterven- 
tional therapy was successful in 14 
patients. Two patients were operated 
upon during pregnancy without 
complications.
Ultrasonography is a useful 
diagnostic procedure during the first 
trimester. Pyelography should be 
considered only after adequate time 
has elapsed to allow spontaneous 
elimination of the calculi and, if used, 
one exposure before and one 30 
minutes after injection of the contrast 
material will ensure the radiation 
dose is low enough to avoid causing 
any fetal abnormality.
The authors believe that treatment 
must be individualized depending on 
the location and size of the calculus, 
the degree of obstruction, presence 
of infection, age of the fetus and 
condition of the patient. Spontaneous 
elimination after hydration and 
analgesia is the ideal, lumbar uretero­
lithotomy or basket extraction can 
be considered, although surgical 
procedures are best postponed until 
the postpartum period.
Entre janvier 1975 et mars 1980, 19 
patientes enceintes souffrant de 
calculs urinaires ont ete recues a 
I'hopital. Elies representaient 0.23% 
de toutes les femmes enceintes qui 
ont accouche a I’hopital St-Luc durant 
cette periode. Les symptomes etaient 
caracteristiques: ils comprenaient
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douleur lombaire et au quadrant 
inferieur droit, hematurie, pollakiurie 
et dysurie. L'echographie ultrasonique 
est un instrument diagnostique utile 
durant le premier trimestre. La 
pyelographie ne devrait etre envisagee 
qu'apres avoir alloue suffisamment 
de temps pour permettre [’elimination 
spontanee des calculs; si on y a 
recours, un cliche pris avant et un 
pris 30 minutes apres I’injection de 
la substance de contraste assurera 
une dose de radiation suffisamment 
faible pour eviter de causer une 
anomalie foetale. Un traitement non 
interventioniste a reussi chez 14 
patientes. Deux patientes ont ete 
operees durant la grossesse, sans 
complications.
Les auteurs croient que le 
traitement doit etre individualise 
d’apres la localisation et la taille du 
calcul, le degre d’obstruction, la 
presence d'infection, I'age du foetus 
et I’etat de la patiente. L’elimination 
spontanee apres hydratation et 
analgesie est la solution ideale; 
I’ureterolithotomie lombaire ou 
('extraction par sonde a panier peuvent 
etre envisagees, mais il vaut mieux 
retarder les interventions chirurgicales 
apres le post-partum.
Urinary calculi are rarely found 
during pregnancy. The incidence has 
been reported to vary between 0.03% 
and 0.35%.* When they do occur they 
often present a diagnostic problem, 
they can lead to kidney damage and 
may affect the outcome of pregnancy. 
We have reviewed our experience 
with this problem over the last 5 
years in order to delineate the assess­
ment and treatment of such patients.
Patients and Methods
Between Jan. 1, 1975 and Mar. 31, 
1980 at our institution there were 
8378 deliveries. During that period, 
19 pregnant women were admitted 
to hospital because of urinary calculi. 
It was impossible for us, because of 
the nature of our medical records, to 
include in our study the patients who 
were seen only in the outpatient de­
partment for renal colic. Ages ranged 
from 16 to 41 years (mean 26.9 
years). There were nine primiparas, 
five secundiparas and five multiparas.
The symptoms were usually charac­
teristic: flank pain (16 patients), right 
lower quadrant pain (1), hematuria 
(3), frequency and dysuria (6 pa­
tients). Percussion of the renal area 
produced pain in 94% of patients. In 
all, urinalysis revealed the presence 
of microscopic hematuria, but urine 
cultures grew no organisms, despite a 
previous history of urinary tract in­
fection in two patients.
Serum calcium, phosphorus and 
uric acid levels were normal. Idio­
pathic hypercalciuria was documented 
in one patient.
The diagnosis was made from the 
clinical findings in 16 cases (85%) but 
pyelography was used in all patients 
— either to confirm or, in 3 patients, 
to reach the diagnosis.
Three women had a previous his­
tory of urinary calculi: one had had 
a similar problem during a previous 
pregnancy; the second, a severely dia­
betic patient, had undergone opera­
tion for a staghorn calculus which 
had since recurred; the third woman 
was known to have had a calculus in 
the renal pelvis before her pregnancy.
The distribution of calculi to left 
and right were similar. All but four 
were in the inferior ureter. The others 
were situated in the kidney, the pelvis 
and superior segment of the ureter 
(two cases).
Results
Of the 19 calculi, 14 from the uret­
erovesical junction were spontaneous­
ly eliminated, 2 from the upper ureter 
were extracted during pregnancy by 
ureterolithotomy; one patient under­
went a nephrolithotomy in the post­
partum period for multiple renal 
stones; one had a therapeutic abortion 
and pyelolithotomy for stones in the 
pelvis. The last woman with a stag­
horn calculus refused treatment and 
was lost to follow-up. The outcome 
of pregnancy was favourable for both 
mother and child in 17 patients.
Fourteen calculi were analysed and 
found to contain calcium, oxalate and 
phosphate.
Discussion
Urinary calculi rarely complicate 
pregnancy.1 In our study the rate was 
0.23% — 19 cases in 8378 deliveries.
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They are no more frequent in preg­
nant women than in the rest of the 
population, even though during preg­
nancy there are predisposing factors 
such as increased intestinal absorp­
tion of calcium,2 ureteral dilatation 
and frequent urinary tract infections.
Because the disease is important 
and because the rate of diagnostic er­
rors in our series was high (15%), 
rigid criteria for investigation must be 
followed, as proposed by Harris and 
Dunnihoo.1 Urinary calculi should be 
sought in patients with: (a) symptoms 
suggesting urinary lithiasis such as 
renal colic, hematuria and pain radi­
ating to the renal area; (b) a previous 
history of urinary calculi; (c) severe 
pyelonephritis and (d) recurring and 
resistant urinary tract infection.
We have observed, as others have, 
the virtual absence of urinary calculi 
during the first trimester.3 Contrary 
to the findings of other series,4'5 mul­
tiparity was not a predisposing factor 
in our study.
The urologic investigation must be 
carefully planned, even if the dose of 
radiation to mother and fetus is only 
0.2 R per abdominal film. According 
to Swartz and Reichling,6 there is a 
1% to 3% risk of causing a congeni­
tal abnormality if the dose of radia­
tion directed to the pelvis during the 
first trimester is in the order of 5 
to 15 R. To reduce the amount of 
radiation, pyelography was modified 
— only one exposure before and one 
30 minutes after administration of the 
contrast material were made. If the 
calculus is small and localized at the 
ureterovesical junction, pyelographic 
examination should be considered 
only after an appreciable period of 
time has elapsed to allow its spon­
taneous elimination. This strategy was 
successful in 14 of our patients. If 
the calculus is situated high, the uter­
us must be carefully shielded during 
the radiologic procedure.
Ultrasonography may be useful 
during the first trimester but it is of 
little value to localize the calculus 
and to assess renal function during 
the second and third trimesters be­
cause of the pre-existing hydrone­
phrosis.
Treatment during pregnancy must 
be individualized according to the size 
and location of the calculus, the de­
gree of obstruction, the presence or 
absence of infection, the general con­
dition of the patient and the age of 
the fetus.
Fourteen calculi situated at the 
ureterovesical junction were spon­
taneously eliminated following hydra­
tion and analgesia. Surgical proce­
dures such as basket extraction can be 
considered but careful observation is 
the ideal treatment.
A lumbar ureterolithotomy can be 
done with adequate anesthesia without 
any risk to the fetus. It is desirable 
to postpone operation until the post­
partum period, conditions permitting, 
especially if the calculus is situated at 
the ureterovesical junction or if a 
nephrolithotomy must take place.
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A Computerized Study of Knee-Ligament Injuries: 
Repair versus Removal of the 
Torn Anterior Cruciate Ligament
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A retrospective review of 202 patients 
with acute injury to knee ligaments 
was carried out by chart review, 
scored questionnaire and scored 
physical examination. Of 62 patients 
with complete midsubstance injury 
to the anterior cruciate ligament, 
repair was attempted in 46, while 16 
had complete excision of the ligament 
without replacement or augmentation.
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Computer analysis revealed that 
these groups were similar with respect 
to mean age of the patients, sex 
distribution, incidence of meniscectomy 
and distribution of associated injuries. 
At 4-year follow-up, there was no 
advantage of primary repair over 
excision for these injuries. In fact, 
repair seemed to be subjectively 
and objectively worse than excision, 
being associated with increased pain 
and decreased range of motion.
The high rate of signs and symptoms 
of deterioration in both groups sug­
gests a need for better alternatives in 
the acute phase of anterior cruciate 
ligament injury.
line analyse retrospective portant 
sur 202 patients qui avaient eu 
des blessures aigues des ligaments 
du genou, a ete realisee au moyen 
d’une revision de dossiers, d’une 
cotation des reponses a un ques­
tionnaire et d’une cotation de I’examen 
physique. Une reparation avait ete 
tentee chez 46 des 62 patients qui 
souffraient d’une dechirure complete 
du milieu du ligament croise anterieur 
alors que les 16 autres avaient subi 
une excision complete, sans rem- 
placement. (.’analyse sur ordinateur 
a revele que ces deux groupes etaient 
comparables pour I’age moyen, la 
repartition des sexes, I’incidence des
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meniscectomies et la repartition des 
blessures associees. Au bout de 4 
ans de surveillance, on ne constatait 
aucun avantage de la reparation 
primaire sur I'excision. De fait, 
subjectivement aussi bien qu'objecti- 
vement, les resultats de la reparation 
semblaient pires que ceux de 
I'excision, la douleur etant plus intense 
et I'amplitude des mouvements plus 
limitee. La frequence elevee des 
signes et symptomes de deterioration 
dans les deux groupes indique le 
besoin de trouver de meilleures 
solutions pour la phase aigue des 
blessures des ligaments croises 
anterieurs.
The first report of a primary repair 
of the anterior cruciate ligament was 
by Battle in 1900; it was performed 
incidentally during open reduction of 
a traumatic dislocation of the knee.1 
The result was good. This and re­
ports of similar successes by Robson2 
in 1903 and Pringle3 in 1907 lent 
early cruciate repair a degree of re­
spectability, as it seemed to offer a 
favourable alternative to established 
conservative methods.
Controversy began, however, in 
1917 when Hey Groves challenged the 
efficiency of these intra-articular re­
pairs4 and proposed cruciate replace­
ment as another alternative.5 He be­
came the first of many investigators 
who found primary repair ineffective 
in many cases, despite extensive ef­
forts.4,614 Some of these researchers 
recognized that all cruciate injuries 
and treatments were not identical 
and began to speculate on the reasons 
for their failures. Kennedy and asso­
ciates,9 in 1974, noted that tears lo­
cated in the middle of the anterior 
cruciate ligament carried a much 
poorer prognosis than bony avulsions 
or insertional ruptures. Disturbingly, 
though, this has not been the com­
mon experience. Many have continued 
to report excellent results with pri­
mary cruciate repair;15-28 even with 
midsubstance lesions.
Review of the literature, therefore, 
leads to the conclusion that midsub­
stance tears of the anterior cruciate 
ligament can either be repaired or 
not repaired with equal justification 
and equally uncertain prognosis.
In the hope of clarifying this situa­
tion we examined our own experience 
with this entity.
We compared two groups of pa­
tients: those who had primary repair 
of the anterior cruciate ligament and 
those with identical injuries treated 
by complete cruciate excision without
replacement or augmentation. Our 
hypothesis is that a repair, if it is 
to be termed successful, should be 
better subjectively or objectively, or 
both, than cruciate excision at com­
parable follow-up.
Patients and Methods
We carried out a retrospective re­
view of 650 patients with acute knee- 
ligament injuries admitted to five 
Calgary hospitals over the 12-year 
period 1966 to 1978. Data was syn­
thesized from charts, detailed ques­
tionnaires and knee examinations with 
details from each being computerized 
for unbiased recording, selective com­
parison and statistical analysis of 
both subjective and objective para­
meters.
The diagnosis in each case was 
confirmed by arthrotomy. Operative 
summaries were used to document 
treatment methods and materials.
Patients completed multiple-choice 
questionnaires, which were computer- 
scored by a modification (Table I) of 
the system used by others.21,29 A 
score greater than 35 signified an un­
satisfactory result of unquestionable 
subjective disability.
Complete knee examinations were 
performed by a single examiner with­
out the bias of history, according to 
the techniques of Hughston and asso­
ciates,30 with the addition of range of 
movement, muscle mass and strength 
measurements, patellofemoral assess­
ment and confirmation of jerk test 
results by the methods of Macintosh 
as reported by Galway and associates31
Table I— Questionnaire Scoring
Present frequency of (score 0-4 by increa­
sing frequency):
Pain
Locking
Clicking
Instability
Swelling
Weakness
Giving way
Pre- versus postinjury (score 0 4 by increa­
sing disability)
Activity levels 
Approach to sports 
Fitness
Comparison to normal knee 
Subjective impressions (score 0-2 by 
degree)
Fear of reinjury
Significant problem in life now?
Needs further surgery?
Knee causes anxiety now?
Knee causes depression now?
Personal profile and history (not scored)
Maximum disability =  54 points.
and Slocum and Larson.32 Compo­
nents of these tests were scored by 
severity (Table II) for computer to­
talling. A score greater than 15 points 
signified a definite disability and an 
unsatisfactory objective result.
After complete analysis of these 
diverse ligament injuries, patients with 
complete midsubstance anterior cruci­
ate tears alone or those in combina­
tion with other ligament injuries were 
isolated by computer. “Midsubstance” 
referred to ruptures not of bony avul­
sion or pure insertional shearing 
types. The patients were then divided 
into those whose ligaments were re­
paired (group 1) and those whose 
torn cruciate ligament stumps were 
excised without augmentation or re­
placement (group 2). Repairs, al­
though not standardized (performed 
by eight different surgeons), were 
similar to those described by O’Don- 
oghue21 and Marshall and associates,28 
with appropriate drill-hole traction 
sutures on cruciate stumps, with or 
without interrupted sutures at the site 
itself and without augmentation or 
replacement.
The two groups were then compared 
by computerized -y2 cross tabulation 
of a number of variables that may 
be significant to follow-up evalua­
tion (Table III). After this check to 
ensure comparability, certain key 
questionnaire and physical examina­
tion indices were selected for com­
parison of the two groups (Table IV), 
testing those indices thought to be 
most sensitive and specific for anterior 
cruciate deficiency.9,15,17,33
Findings
Of the 650 cases reviewed, 305 pa-
Table II— Physical Examination Scoring
Stability tests (score 0-3 for severity) 
Abduction stress at 0° and 30°
Adduction stress at 0° and 30°
Anterior drawer: 
in neutral 
in internal rotation 
in external rotation 
Posterior sag (score 3 if positive) 
Anterolateral instability 
McMurray test for torn menisci 
Measurements (score 0-2 for significant 
loss)
Muscle mass above and below knee 
Extensor strength 
Flexor strength 
Range of flexion 
Range of extension 
Palpation (score 0-2 for severity)
Patellar tenderness
Crepitus
Effusion
Maximum disability =  40 points.
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tients returned questionnaires. Of 
those, 202 reported for the detailed 
physical examination and thereby had 
complete documentation of injury, 
treatment and follow-up.
Of these 202 patients, 85 (42%) 
had injuries to their anterior cruciate 
ligament documented at arthrotomy; 
23 had either bony avulsion, inser- 
tional shearing or partial midsub­
stance injury and were eliminated 
from the study. Of the remaining 62 
patients, 46 had primary repairs 
while 16 had complete anterior cru­
ciate excision.
Comparison of the two groups for 
significant variables revealed their 
similarity, with roughly equal follow­
up (4.1 years), mean age (32 years), 
sex distribution (75% men), time of 
surgery (most less than 1 week after 
injury), incidence of acute meniscec­
tomy (42%) and distribution of asso­
ciated injuries (Table III). Approxi­
mately 12% were reported as isolated 
anterior cruciate injuries.
There was no statistical difference 
by x2 analysis between the groups for 
any of the indices mentioned. While 
not matched, these populations are, 
therefore, at least roughly compara­
ble.
Subjective Results (Table V)
Although group 2 patients had 
slightly less frequent giving way of 
the affected knee than group 1, the 
difference was not significant (P >  
0.05).
The subjective frequency of in­
stability was similar, with approxi­
mately 80% of both groups report­
ing some degree of instability.
Interestingly, group 2 patients re­
ported significantly (P <  0.02) less 
frequent pain; 31% reported that 
they never had pain, as opposed to 
only 4% of group 1 patients.
As a rough index of definite sub­
jective failures, total questionnaire 
scores were examined. Of the group 
2 patients, 19% reported consider­
able disability, while 39% of group 1 
patients had similar complaints. Al­
though not statistically significant, 
this difference again favours exci­
sion.
Objective Results (Table VI)
Anterior drawer tests in neutral 
were similar for both groups, accord­
ing to Hughston’s grading system. 
Testing in both external and inter­
nal rotation again revealed no statis­
tical difference.
Both groups had a low rate of
anterolateral rotatory instability, not 
statistically different.
Range of movement testing re­
vealed that the group 1 patients had 
slightly more limited flexion than the 
group 2 patients. This difference ap­
proaches significance at P <  0.05.
Total physical examination scores 
were taken as a rough index of ob­
jective failure of treatment, and we 
found again that group 1 scored more 
poorly, having a slightly increased 
failure rate that approaches statis­
tical significance.
Discussion
Our retrospective review, with 
limited comparative indices and arbi­
trary scoring systems, similar but 
unmatched study populations (of 
which 88% had similar but combined 
injuries) and statistical analysis of a 
large number of variables, must not 
be over-interpreted. (If enough com­
parisons are made, some will be statis­
tically significant by chance alone.)
Although a prospective study with 
more detail of isolated anterior cru­
ciate injuries would be better, we 
believe that a number of interesting 
observations are nevertheless possible 
from our data.
In our diverse group of ligament 
injuries, cruciate damage is fairly 
common. Our visual assessments have 
no doubt missed some subclinical or 
subsynovial tears, suggesting that the 
true incidence of partial injury is 
probably higher than our figure of 
17% suggests.11
We found a 12% rate of the con­
troversial entity “isolated cruciate 
tear”. Cruciate avulsions and inser- 
tional injuries were relatively rare 
(only 12% of the total) with midsub­
stance injury being far more common.
Our results also suggest the lack
of sensitivity of standard anterior 
drawer testing at 90° for detecting 
absence of the anterior cruciate liga­
ment. A substantial number of 
known cruciate-deficient knees (ex­
cision) were noted to have either 
normal or minimally positive results 
from anterior drawer testing. This 
points to the functional importance 
of the secondary static and dynamic 
stabilizers of the knee and how they 
confuse drawer testing,11 particularly 
in the conscious patient. The more 
recently described Lachman test 
(drawer testing in only a slight degree 
of knee flexion) may be more sensi­
tive but was unfortunately not per­
formed at the time of initial review.
Similarly, our historical informa­
tion is not as sensitive as we would 
hope. Of our known cruciate-defi­
cient patients, 19% reported no in­
stability and 68% never had experi­
enced giving way of the knee. If 
combined with a normal drawer test 
result, the diagnosis would easily be 
missed in these cases.
More importantly, perhaps, we 
have demonstrated a high incidence 
of subjective failure in our treatment 
of cruciate injuries by both repair 
and removal. Of all those treated, 
50%, at the time of writing, con­
tinued to complain of giving way,
Table IV— Indicators of Chronic 
Cruciate Deficiency
Subjective 
Giving way 
Instability 
Pain
Questionnaire score 
Objective
Anterior drawer (3 positions) 
Anterolateral instability 
Range of motion 
Overall score
Table Ill— Statistical Comparability*
Group 1 Group 2
Variable (repaired) (excised)
Mean follow-up, yr 4.2 4.0 (range 1-10)
Mean age, yr 31.5 32.6 (range 18-72)
Sex, %  men 76 75
Surgery within 1 wk of injury, % 74 77
Acute meniscectomy, % 40 44
Other injuries, %
Medial collateral 67 62
Lateral collateral 4 0
Posterior cruciate 9 6
Medial meniscus 58 50
Isolated anterior cruciate
ligament 11 13
*P >  0.05 for all variables.
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approximately 80% had chronic in­
stability and about 85% had chronic 
pain. These figures are all consistent 
with similar reports9’28-34 and will 
probably only get worse with time.
Similarly, we have shown objective 
evidence of the failure of our treat­
ments. Approximately 65% have 
evidence of chronic anteromedial ro­
tatory instability of some degree (in­
dicative of the frequency of combined 
cruciate-collateral ligament injury) 
and about 50% have not regained a 
full range of movement.
Anterolateral rotatory instability 
was much less frequent than we ex­
pected,31 and may be a reflection of 
the average examiner’s difficulty in
performing these diagnostic maneuvers 
correctly and reliably. Reassessment 
in the future may reveal a higher in­
cidence of this instability as it evolves 
and we become more familiar with 
the methods of diagnosis.
Most orthopedists have felt that 
primary repair of the anterior cruciate 
ligament is “worth a try”. As noted 
by Jones29 in March 1980, “the ina­
dequacies of present techniques are 
not acceptable reasons to make no 
attempt to repair recently torn cru­
ciate ligaments”. Our study suggests 
that we should add to his statement 
“assuming that you do no harm in 
the attempt”.
It is possible from our results that
more extensive arthrotomies, more 
drill holes and intra-articular mani­
pulations may lead to much more 
rapid or extensive deterioration of a 
knee in terms of both pain and stiff­
ness, without achieving subjective or 
objective stability and function that 
will stand the test of time. We there­
fore question the justification of “try­
ing a repair”. At best, these repairs 
are equivalent to cruciate removal but 
quite likely they are worse. Moreover, 
cruciate excision is not an acceptable 
alternative for acute complete mid­
substance injuries of the anterior cru­
ciate ligament.
Our results confirm what others 
have stated before us, that cruciate 
deficiency, in most cases, leads to pro­
gressive and variably symptomatic 
degeneration of the knee.34
Conclusions
The practical conclusion of this 
study is that there is no apparent 
advantage, as seen at 4-year follow­
up, in repairing an acute, complete, 
midsubstance tear of the anterior 
cruciate ligament by the methods we 
have discussed. The failure of such 
an attempt may do more harm than 
good.
The high incidence of signs and 
symptoms of deterioration of the 
knee in all of our cruciate-deficient 
knees supports the need for further 
investigation into the use of replace­
ment or augmentation.11,34
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Corrections
The article “Intestinal bypass and gastric 
partitioning for morbid obesity: a com­
parison”, published in the May 1982 is­
sue of the journal, contained two typo­
graphical errors: lines 10 and 11 of the 
summary read “stress incontinence, which 
where relieved by weight loss after 
surgery”. These two lines should have 
read “stress incontinence which were re­
lieved by weight loss after surgery.”
Owing to a printer’s error, Figs. 1 and 
2 on page 306 of the May 1982 issue, 
in the article “The conduct of chole­
cystectomy: incision, drainage, bacteriol­
ogy and postoperative complications”, 
were not printed. These two illustrations 
appear below. We apologise to Dr. Lewis 
and his colleagues.
FIG. 1— Bacteriology: gallbladder, sub­
cutaneous fat, infected wounds.
FIG. 2— Risk index: factors in wound 
infections.
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Pancreatic Abscess
J.M. W atters, b sc, m d* and J.E. M ullens, ms, md , FRCs[c]f
Pancreatic abscess, although an 
uncommon complication of pancreatitis, 
is a serious cause of morbidity and 
death. During the 5-year period 
beginning in March 1976, 19 patients 
with pancreatic abscess were seen 
at the Ottawa Civic Hospital. 
Abdominal pain, mass, fever and 
leukocytosis were common; the serum 
amylase value was usually normal. 
Twelve patients underwent external 
drainage; in 6 the abscess was drained 
internally through the posterior wall 
of the stomach. The overall mortality 
was 16%. Morbidity was high; 7 
(37%) of the 19 patients required 
reoperation for recurrent sepsis. 
Differentiation of pancreatic abscess 
from phlegmonous pancreatitis or 
pseudocyst can be difficult. Ultra­
sonography may be useful but 
computerized axial tomography is the 
the diagnostic method of choice. 
Prompt debridement and external 
drainage are the mainstays of surgical 
treatment but internal drainage may 
be appropriate in selected patients.
Bien que ce soit une complication peu 
frequente de la pancreatite, I'abces 
du pancreas represente une cause 
serieuse de morbidite et de deces. 
Au cours d'une periode de 5 ans 
debutant en mars 1976, 19 patients 
souffrant d'un abces du pancreas ont 
ete recus a Ottawa Civic Hospital. 
Une douleur abdominale, une masse, 
de la fievre et une leucocytose etaient 
des observations frequentes; les 
amylases seriques etaient habituelle- 
ment normales. Douze patients ont 
subi un drainage externe; chez 6 
I’abces a subi un drainage interne a 
travers la paroi posterieure de 
I'estomac. La mortalite globale fut 
de 16%. La morbidite etait elevee; 7 
(37%) des 19 patients ont necessity 
une reintervention pour recidive de 
I'infection. II peut etre difficile de
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differencier un abces pancreatique 
d'une pancreatite phlegmoneuse ou 
d'un faux kyste. L’echographie ultra- 
sonique peut etre utile mais la 
tomographie transverse axiale avec 
ordinateur demeure la meilleure 
methode diagnostique. Un debridement 
immediat suivi d'un drainage externe 
sont le pivot du traitement chirurgical 
mais un drainage interne peut etre 
approprie chez des patients choisis.
Pancreatic abscess is an uncommon 
complication o f acute pancreatitis, oc­
curring in 4%  to 8%  of patients, but 
the associated mortality has been re­
ported to be as high as 51% .' Some2,3 
believe that because the management 
o f early complications o f pancreatitis 
has improved, more patients will sur­
vive long enough for abscesses to de­
velop, and pancreatic abscess appears 
to be an increasingly important cause 
of death in acute pancreatitis.3,4
In this report, pancreatic abscess 
includes any localized collection of 
necrotic tissue and pus arising in the 
pancreas as a complication o f pan­
creatitis. It often extends into the re- 
troperitoneum and into the lesser sac. 
An ill-defined mass o f devitalized tis­
sue in an enzyme-rich fluid milieu 
may become infected early in acute 
pancreatitis or there may be seeding 
o f bacteria into a mature, previously 
sterile pseudocyst.
We reviewed a 5-year experience 
with patients who had a pancreatic 
abscess, to assess its clinical presenta­
tion, the role o f new methods o f diag­
nosis, its management and immediate 
outcome.
Patients
Of 330 patients with acute pancrea­
titis and 140 patients with chronic 
pancreatitis admitted to the Ottawa 
Civic Hospital during the 5 years be­
ginning in March 1976, 19 had pan­
creatic abscess. The mean age o f all 
patients was 59 years (range from 33 
to 77 years) and the male-to-female 
ratio was approximately 2:1. The 
diagnosis was confirmed at operation 
in 18 and at autopsy in 1. N o patient 
who may have survived without oper­
ation has been identified.
Findings
Clinical Presentation
Pancreatic abscess complicated an
episode o f acute pancreatitis in 16 
patients. Three patients with chronic 
pancreatitis, not known to have had 
pseudocysts, presented with signs and 
symptoms o f an abscess without evi­
dence o f acute pancreatitis. Pancrea­
titis was associated with alcoholism in 
10 patients, it was secondary to biliary 
tract disease in 2, it occurred post- 
operatively in 2 and clinically pre­
ceded carcinoma o f the pancreas in 
1 patient. Etiology was undetermined 
in four cases.
Abscess developed in 3 patients 
during the first week o f illness, in 4 
during the second week and in 13 o f 
16 within the first 5 weeks. In the 
other three with acute pancreatitis, the 
abscess developed after 5 weeks.
Abdominal pain and fever were 
each present in 17 (89% ) o f the 19 
patients and abdominal tenderness in 
14 (74% ). A  mass was palpable in 11 
patients (58% ). The mass was found 
most frequently in the epigastrium 
(seven patients) but occasionally else­
where in the abdomen and flank.
Leukocytosis was present in 18 pa­
tients (95% ). The serum amylase 
value was normal in 13 patients 
(68% ). Pleural effusion was seen on 
the chest roentgenogram in 11 pa­
tients (58% ) —  in the left pleural 
space in 8 and bilaterally in 3.
Diagnosis
Various investigations were used to 
confirm or exclude the diagnosis of 
pancreatic abscess (Table I). Compu­
terized axial tomography distinguished 
between an abscess and a pseudocyst 
in three patients by identifying gas 
and debris within the mass and by 
assessing the density o f its fluid (Figs. 
1 and 2). Plain abdominal roentgeno­
graphy showed a pathognomonic 
soap-bubble appearance in one pa­
tient.
Treatment
Eighteen patients were treated sur­
gically: debridement and external
drainage with sump and soft rubber 
drains were used in 12, internal drain­
age in 6; anastomosis o f mature 
abscess wall to the posterior wall 
of the stomach was done in all 6. 
Fifteen patients were explored through 
an anterior approach. Flank incisions 
were used on two occasions and the 
abscess in one patient was approached 
through a healed drain site. Percuta-
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neous aspiration using computerized 
tomography for guidance was carried 
out in one patient who had been 
thought to have a sterile pseudocyst 
and whose abscess was later drained 
internally.
Blood cultures were positive in only 
3 patients while cultures obtained from 
the abscess were positive in 16. Esche­
richia coli was the organism most fre­
quently grown and cultures were often 
polymicrobial.
Complications
Recurrent abscess requiring reoper-
FIG. 1— Computerized tomogram of 
pancreatic abscess showing well-circum­
scribed, relatively dense mass in lesser 
sac (large arrow) at level of pancreas 
(small arrrows).
FIG. 2—Tomogram shows ill-defined 
retroperitoneal collection of debris (ar­
row) and characteristic air-bubble ap­
pearance, below level of pancreas.
ation was the most common complica­
tion, occurring in seven patients 
(37%), two of whom had drainage 
for three recurrences each. None of 
the six patients who had had internal 
drainage required reoperation for re­
current or persistent abscess. Compli­
cations were recorded in 15 of 19 
patients and were frequently multiple 
(Table II).
Mortality
Three (16%) of the 19 patients 
died; 2 were treated surgically and 
the third was not. Massive pulmonary 
embolism was the immediate cause of 
death in one patient, but a pancreatic 
abscess extending into the lesser sac 
was identified at autopsy. Another 
died of acute renal failure secondary 
to congestive heart failure. The pos­
sible role of recurrent sepsis in the 
death of the third patient was unclear. 
This patient had severe arteriosclero­
tic heart disease and at autopsy was 
found to have residual pancreatitis.
The mean hospital stay of surviv­
Table 11-Com plications in 19 Patien ts  
w ith  Pancreatic Abscess
No. of
Complication patients
R ecurrent abscess 7
Respiratory 9
A cute respiratory failure 6
Pneumonia 2
Pulm onary embolism 1
Gastric ou tle t obstruction 4
Fistula 3
Pancreatocolic 1
Enterocutaneous 1
Pancreatocolocutaneous 1
Upper gastrointestinal tract 
bleeding 2
W ound infection 2
W ound dehiscence 2
A cute renal failure 2
Intra-abdominal hemorrhage 1
Fem oral artery  embolism 1
Table  1- Diagnostic M ethods
M ethod
N o. of 
patients
Diagnostic  
o f abscess
Findings, no. (% )
Suggestive of 
cystic mass
Norm al or no 
indication 
of mass
Ultrasonography
Computerized
12 0 9 (75) 3 (25)
axial tomography 
Abdominal
7 3 (43) 4  (57) 0
roentgenography 
Roentgenography a fte r
7 1 (14) 3  (43) 3  (43!
barium meal 4 0 2 (50) 2  (50)
ing patients was 54 days (range from 
27 to 191 days).
Discussion
An abdominal mass often develops 
during the course of severe acute 
pancreatitis. It may be a pancreatic 
phlegmon, an acute pseudocyst or a 
pancreatic abscess.5 The incidence and 
natural history of these lesions have 
become better understood with the in­
troduction of ultrasonography. Clin­
ically, it may be difficult to differen­
tiate these lesions but this is important 
because the management of each is 
quite different.
Most acute pseudocysts remain ste­
rile, but they are excellent culture 
media and may become pancreatic 
abscesses. If an acute pseudocyst re­
mains sterile, does not cause early 
complications and fails to resolve as 
pancreatitis subsides, a mature pseu­
docyst will form. Seeding of bacteria 
at this stage converts it to a pancrea­
tic abscess, referred to by some as 
an infected pseudocyst.5,6 The terms 
primary and secondary pancreatic ab­
scess have been used to differentiate 
the development of suppuration in 
acute and mature pseudocysts respec-" 
tively.7-8 Unfortunately, no single def­
inition of pancreatic abscess is widely 
accepted. Some authors specifically 
exclude infected mature pseudocysts 
when discussing pancreatic abscess, 
referring only to infected acute col­
lections of fluid and debris, with the 
implication that the clinical presenta­
tion, course and outcome are differ­
ent.2,3,9,10 But it has also been sug­
gested that the patients are equally 
seriously ill and that the distinction 
is unwise.8 Clearly a localized collec­
tion of pus must be considered an 
abscess although the medium in which 
suppuration occurs may influence its 
clinical presentation and management.
Pancreatic abscess, as defined ear­
lier and considered in this study to 
include infected mature pseudocysts, 
was identified in 5% of patients ad­
mitted with acute pancreatitis during 
the 5-year study period. In 1963, Alte- 
meier and Alexander11 reported an 
incidence of 4.5%. In several other 
series reported since,1,3,4,7,8,12 the in­
cidence has ranged from 2% to 8.5% . 
Although these figures offer no evi­
dence that pancreatic abscess is occur­
ring more frequently, the condition 
does appear to be an increasing con­
tributor to the overall mortality of 
acute pancreatitis. Ranson and Spen­
cer3 noted that, of patients with acute 
pancreatitis seen between 1971 and 
1975, pancreatic abscess was a con-
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tributing factor in 64% of deaths, 
much higher than the 16% reported 
by Steedman and associates4 in pa­
tients treated between 1954 and 1966. 
These findings are in keeping with the 
reported decline in the overall mor­
tality of acute pancreatitis and change 
from early to late complications as 
causes of death.3
Abdominal pain, tenderness, mass, 
fever and leukocytosis were common 
findings in our group of patients as 
they have been in others. Of note is 
that the serum amylase value was 
elevated in only about one third of 
patients. Pleural effusion, particularly 
on the left side, was common, occur­
ring in 61% of our patients. It is a 
well-known accompaniment of intra­
abdominal sepsis and has been re­
ported to occur in 29% of patients 
with acute pancreatitis and 20% with 
pancreatic pseudocyst.3'5
Delay in the diagnosis of pancreatic 
abscess has been associated with in­
creased morbidity and mortality.1,4,8,12 
A prompt assessment by ultrasono­
graphy or by computerized tomo­
graphy should be obtained when the 
diagnosis is considered. Ultrasono­
graphy is widely available and in­
creasingly reliable, but its usefulness 
may be limited in patients with fresh 
abdominal wounds, drains or accu­
mulated intestinal gas from paralytic 
ileus.3 Computerized tomography was 
highly reliable in identifying, local­
izing and, occasionally, defining in­
flammatory masses in our patients, 
and this has been the experience of 
others.13'15 When available it is clearly 
the diagnostic method of choice in a 
patient suspected of having a pan­
creatic abscess.
Upper gastrointestinal contrast ro­
entgenography may demonstrate the 
presence of a mass lesion, as it did 
in two of four of our patients, but 
provides no indication of the nature 
of the mass. Intravenous pyelography, 
roentgenography after barium enema 
and selective angiography have been 
advocated in the diagnosis of pan­
creatic abscess but they are indirect 
methods, have a low yield and have 
largely been superseded by ultrasono­
graphy and computerized tomography. 
Angiography is important in patients 
with suspected intra-abdominal or gas­
trointestinal hemorrhage.
Once the diagnosis of pancreatic 
abscess is made, appropriate treat­
ment must not be delayed. Nonopera­
tive management and failure of the 
diagnosis almost always result in the 
patient’s death. Surgical debridement 
and external drainage have been the 
mainstays of treatment since the re­
port of Altemeier and Alexander.11 
Most authors advocate an anterior, 
transperitoneal approach permitting 
wide exploration of the abdomen and 
careful debridement and drainage of 
all abscess cavities.
Donahue and associates8 achieved 
a recurrence rate of only 17% by 
emphasizing dependent drainage and 
bringing sump and soft rubber drains 
through a posterolateral flank inci­
sion whenever possible. Berne and 
Donovan8 described synchronous an­
terior celiotomy and posterior drain­
age through the bed of the twelfth 
rib in nine selected, young patients, 
only one of whom required reopera­
tion. Davidson and Bradley13 managed 
six patients by debridement and mar­
supialization and reported no recur­
rence of the pancreatic abscess. They 
observed large fragments of necrotic 
debris that would have occluded sump 
drains. Internal drainage by anasto­
mosis to stomach, duodenum or jeju­
num is widely accepted as the treat­
ment of choice for mature pancreatic 
pseudocysts. Although internal drain­
age of pancreatic abscesses is specif­
ically proscribed by some authors,7,8 
others11,18 have found this a useful 
method of drainage in selected pa­
tients with so-called secondary pan­
creatic abscesses or infected pseudo­
cysts. Six patients in our group were 
found to have abscesses with mature, 
fibrous walls that were drained through 
the posterior wall of the stomach in 
each case. All six survived, none re­
quiring reoperation for persistent or 
recurrent abscess. Drainage of an ab­
scess must not be delayed and if 
doubt exists at the time of operation 
about the maturity of its walls, then 
it should be drained externally.
Recurrent or persistent abscesses 
have been a common complication and 
a frequent cause of death.1,2,9,11'13,17,18 
Reoperation for sepsis has been re­
quired in as many as 71% of pa­
tients10 and in our patients was neces­
sary in 37%. Others have drawn at­
tention to the singularly destructive 
and invasive nature of pancreatic ab­
scess, presumably due to the presence 
of both activated proteolytic enzymes 
and bacteria.8,10 In some patients per­
sistent sepsis may reflect ongoing pan­
creatitis and pancreatic necrosis. Ac­
curate preoperative localization of 
abscesses, the provision of adequate 
drainage following debridement, and 
aggressive follow-up and reoperation 
when necessary may lessen recurrent 
abscess formation with its high mor­
tality.
Before 1978 the reported mortality 
of pancreatic abscess ranged from
22% to 57%, two series reporting 
patients treated as early as 
^ S h .1"4,7’11’12,17,18 However, more re­
cent reviews, in some instances of 
selected, nonconsecutive patients, 
have quoted lower mortality, ranging 
from 8% to 35%.8,10,13 In our series 
the mortality was 16%. In the small 
groups reported there appears to have 
been a modest decline in the overall 
mortality of pancreatic abscess. More 
frequent and earlier recognition have 
been important contributors to this 
improvement.
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Kystes hydatiques du poumon traites chirurgicalement
A. KHALFALLAH, MD,* R. LETAIEF, MD,f M. F arhat, m d J et  S. G ha rbi, m d §
L'echinococcose pulmonaire reste une 
maladie tres repandue en Tunisie, 
comme dans I'ensemble des pays 
d'Afrique du nord. Elle atteint une 
population jeune (198 malades ont un 
age inferieur ou egal a 30 ans soit 
74% de nos cas). La latence clinique 
est de 8% dans notre serie et le 
plus souvent (92% des cas) c’est 
au stade des complications que le 
diagnostic est pose. Le traitement 
chirurgical a ete conservateur 
(perikystectomie) chez 204 patients 
(76% des cas) et du type resection 
chez 64 malades (24%). La mortality 
operatoire a ete de 1.5% et les 
complications postoperatoires (8%) 
ont interesse les cas operes au 
stade de I'infection du kyste. A 
defaut de supprimer la maladie 
hydatique par une prophylaxie radicale, 
les auteurs preconisent une detection 
precoce au stade de kyste sain, ce 
qui permettra une cure chirurgicale 
denuee de toute complication.
Pulmonary echinococcosis is still 
widespread in Tunisia as in most 
countries of North Africa. The segment 
of population affected is young; 198 
(74%) of 268 patients studied by 
the authors were less than 30 years 
old. There were no symptoms in 
8% of patients and 92% presented 
with some complication. The treatment 
of choice is surgical but conservative 
pericystectomy was performed in 
204 (76%) patients and resection 
in 64 (24%). Operative mortality was 
1.5% and postoperative complications 
were noted in 8% of patients with
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an infected cyst. If it is impossible 
to prevent the disease, the authors 
recommend early detection, permitting 
surgical treatment without 
complications.
En Tunisie, comme dans I’ensemble 
des pays d'Afrique du nord, l’echi- 
nococcose pulmonaire pose un cer­
tain nombre de problemes par sa 
frequence, son association avec d’au- 
tres localisations, ses complications, 
son diagnostic et enfin les moyens 
therapeutiques opposes a ce type de 
lesion.
Rappel parasitologique
Dans les pays d’Afrique du nord, 
la maladie hydatique evolue de fagon 
endemique. Elle y presente un cycle 
dit domestique,1 alors qu’en Ameri- 
que du nord elle evolue de fagon 
sporadique et selon un cycle dit syl- 
vestre.2
Elle est causee par le tenia echino- 
coque granulosus qui est l’hote de 
l’intestin grele du chien.
En broutant l’herbe souillee par les 
dejections des chiens parasites, les 
herbivores (surtout les ovins) ingerent 
les oeufs d’echinocoque. La majorite 
des embryons arrivent au niveau du 
foie par l’intermediaire du systeme 
porte et s’y fixent, donnant naissance 
au kyste hydatique du foie. D’autres 
depassent ce premier filtre et parvien- 
nent aux capillaires pulmonaires et 
donnent naissance au kyste hydatique 
pulmonaire. Tres rares sont les em­
bryons qui franchissent ce deuxieme 
filtre et qui vont se developper dans 
d’autres organes.
En mangeant des visceres de mou- 
tons contenant des kystes hydatiques, 
les chiens s’infestent et ainsi le grand 
cycle de ce cestode est ferme.
En Tunisie l’abattage familial ou 
clandestin, encore de pratique cou-
Tableau 1 -Age des malades
Age, ans No.
2- 8 46
8-15 68
15 30 84
30-40 46
>50 24
rante, multiplie les sources d’infection 
des chiens domestiques ou errants.3
Dans ce grand cycle, l’homme peut 
aussi servir d’hote intermediate.
Materiel d’etude
Dans le service de chirurgie gene- 
rale de l’Hopital Universitaire de 
Sousse durant la periode de janvier 
1974 a aout 1980, 268 malades ont 
ete operes de kystes hydatiques pul­
monaires. Us se repartissent en 114 
enfants et 154 adultes, 115 de sexe 
masculin et 153 de sexe feminin.
Origine
Le milieu rural des gouvernorats 
de Sousse, Monastir et Mahdia a four- 
ni la plupart des cas. Cette apparte- 
nance geographique est la meme que 
celle du kyste hydatique du foie.
Age (tableau I)
Le plus jeune avait 2 ans et le plus 
age, 75 ans. La majorite des patients 
etaient des sujets jeunes (70% avaient 
moins de 30 ans). Cette notion a 
deja ete signalee par Dor et colle- 
gues.4
Mode de revelation des kystes
Le mode de revelation est tres va­
riable (tableau II). Vingt-deux fois le 
diagnostic de kyste hydatique du pou­
mon a ete le fruit d’un examen radio- 
logique systematique et la latence 
fonctionnelle etait complete. Ce pour- 
centage de l’ordre de 8% serait plus 
important si la campagne de depistage 
de la maladie hydatique ou de la 
tuberculose etait poursuivie periodi- 
quement. De l’analyse des signes fonc-
Tableau II -Mode de revelation
Mode No. ( % )
Decouverte radiologique
fortuite 22 (8.2)
Douleurthoracique 88 (32.8)
Hemoptysie abondante 5 (1.9)
Crachats hemoptoiques 47 (17.5)
Toux 67 (25.0)
Hydatoptysie 4 (1.5)
Signes de suppuration
pulmonaire 28 (10.4)
Dyspnee 13 (4.9)
Detresse respiratoire 15 (6.0)
VOLUME 25, NO. 4, JULY 1982 /  THE CANADIAN JOURNAL OF SURGERY 463
tionnels emerge l’importante fre­
quence des cas cliniques reveles par 
des complications. Parmi ces compli­
cations nous avons retenu:
•  L’hemoptysie: sa frequence est 
importante, soit 52 fois (19.4%). Elle 
est inquietante pour le malade et 
l’amene a consulter; generalement, ce 
sont des hemoptysies de petite abon- 
dance mais parfois elles prennent 
une allure dramatique nous obligeant 
a operer en urgence (cinq cas).
•  La classique vomique hydatique: 
nous signalons sa rarete dans notre 
statistique (quatre cas).
•  La dyspnee a ete signalee 13 
fois: 6 fois chez des enfants de 3 
a 8 ans oil elle est due au volume 
tres important du kyste (fig. 1), 7 fois 
chez des adultes jeunes, due a l’ag- 
gravation de l’etat pulmonaire ante- 
rieur par le volume important du 
kyste.
•  La detresse respiratoire par rup­
ture du kyste dans la grande cavite 
pleurale: c’est une complication inha- 
bituelle, car 1’evolution normale du 
kyste se fait de fagon progressive 
vers la fissuration ou la rupture tran­
che dans les bronches. Cet accident 
est rare (0.6% dans la statistique de 
Kourias,5 1.5% chez Demirleau6). 
Dans notre statistique cet accident a 
ete releve 15 fois (5.6%) et ce, selon 
deux tableaux —  un de pneumo­
thorax compressif, 6 fois dont quatre 
chez des enfants, et un de pyothorax, 
9 fois dont trois chez des enfants.
Les donnees radiologiques
Topographie (tableau III)
Les kystes se localisaient au niveau 
du poumon droit 153 fois (57.1%)
T a b leau  I I I -T o p o g r a p h ie
P o u m o n %
D ro it
L o b e  s u p e rieu r 18
L o b e m o y e n 9
L o b e  in fe r ie u r 30
G a u c h e
Lo b e  s u p e rieu r 19
Lo b e  in fe r ie u r 22
et 115 fois au niveau du poumon 
gauche (42.9%).
Ils etaient bilateraux chez 22 ma- 
lades et multiples et bilateraux chez 
3 malades.
Signes radiologiques (tableau IV)
Le kyste hydatique du poumon 
passe classiquement par trois stades 
evolutifs auxquels correspondent des 
images radiologiques.
Au stade de voyer ferme, on re- 
trouve une image homogene a con­
tour regulier (fig. 2), c’est 1’image 
en boulet de canon, en citron, en bal­
lon de rugby; nous les avons retrou- 
ves 108 fois (40%).
Au stade de fissuration ou de pre­
rupture, on retrouve un croissant ga- 
zeux au pole superieur d’une opacite 
pulmonaire: c’est le pneumokvste
(fig. 3), retrouve 21 fois (7.8%).
Et enfin, le stade de rupture: 57% 
ou nous avons plusieurs types d’ima- 
ge-
Association des kystes hydatiques du 
poumon a des kystes hydatiques du foie
Nous relevons dans notre statisti­
que une association de kyste hydatique 
du poumon a une echinococcose he- 
patique chez 27 patients (10%). II 
faut noter que la decouverte du kyste 
hydatique du foie a ete due soit. 
avant 1977, aux signes d’appels abdo- 
minaux justifiant la pratique de la 
scintigraphie hepatique ou, apres 
1977, a 1’exploration systematique du 
foie par scintigraphie ou, plus re- 
cemment par echotomographie chez 
tous les malades porteurs de kyste 
hydatique du poumon.
Arguments diagnostiques
En pratique, le diagnostic de kyste 
hydatique du poumon est pose en 
confrontant les donnees cliniques et 
radiologiques et accessoirement la 
biologie (60% de positivite).
L’interrogatoire doit systematique- 
ment rechercher: l’appartenance a 
une zone d’endemie hydatique, la no­
T a b le a u  IV — S ig nes  rad io lo g iq u e s
S ta d e S ig n e N o.
F o y e r  fe rm e O p a c ite s  a c o n to u rs  re g u lie rs 108
P re ru p tu re P n e u m o k y s te 21
R u p tu re M e m b ra n e  f lo tta n te 72
N iv e a u  l iq u id e  h o r izo n ta l 21
D o u b le  a rc 3
R e te n tio n  de  m em brane 28
H y d ro p n e u m o th o ra x 15
tion de profession exposee (berger, 
eleveur, chevillard, boucher), les vo- 
miques hydatiques, les expectorations 
de debris de membrane et 1’associa- 
tion a une autre localisation.
Les examens radiologiques restent 
les moyens les plus fideles pour poser 
le diagnostic, non pas tant au stade 
de kyste ferme ou est pose le diag­
nostic d’une opacite ronde intra-tho- 
racique, qu’au stade d’ouverture ou 
sont pathognomoniques les images
FIG. 1—Volumineux kyste hydatique lobaire inferieur gauche chez une fem­me de 40 ans.
FIG. 2— Image en “boulet de canon” de kystes hydatiques du poumon bilate­raux chez un sujet de 14 ans.
FIG. 3— Image de pneumokyste (fle- che) retrouvec 1 semaine apres chez la malade de la fig. 1.
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en double arc, de la membrane flot- 
tante (fig. 4) ou de la retention de 
membrane (fig. 5).
Les tomographies et la broncho- 
graphie n’ont qu’une valeur relative 
pour l’appreciation du retentissemenv 
du parasite sur l’arbre bronchique et 
le parenchyme adjacent, car l’explo- 
ration peroperatoire nous a donne un 
meilleur renseignement sur la viabi- 
lite et les possibilites de reexpansion 
de parenchyme restant.
Au cas ou l’opacite de la base 
droite pourrait etre a priori aussi 
bien hepatique que pulmonaire, la 
radio centree sur la coupole diaphrag- 
matique apres pneumoperitoine per- 
met de trancher.
Mais ceci ne met pas a l’abri de 
certaines surprises puisque six fois 
nous avons porte abusivement le dia­
gnostic de kyste hydatique du pou- 
mon et seule la thoracotomie a re- 
dresse le diagnostic: deux fois, il 
s’agissait de cancer bronchopulmo- 
naire, une fois de pleuresie enkystee. 
une fois de lobite tuberculeuse et deux 
fois de tumeur a point de depart 
mediastinal (un teratome et un th\- 
mome).
En conclusion, c’est l’etape chi- 
rurgicale qui finalement assure la cer­
titude diagnostique.
Traitement de nos cas
Le traitement du kyste hydatique 
du poumon est exclusivement chirur- 
gical. Actuellement, personne n’espere 
qu’une vomique totale du parasite 
puisse entramer la guerison car il per-
FIG. 4—Double kyste hydatique du 
poumon. Kyste hydatique ferme du lobe 
moyen et kyste hydatique rompu avec 
une membrane flottante au niveau du 
lobe inferieur chez une femme de 29 
ans.
siste une cavite residuelle infectee ou 
sujette a des infections repetees. De 
meme, le traitement medical au “thy­
mol iode” et la broncho-aspiration 
n’aboutissent qu’a des echecs.
Nous pensons qu’un kyste hydati­
que diagnostique doit etre rapidement 
opere. Neanmoins il y a deux cir- 
constances ou la chirurgie doit etre 
differee: en cas d’association avec 
une tuberculose pulmonaire, le trai­
tement du kyste hydatique du pou­
mon doit se faire apres traitement 
antituberculeux, et en cas de pyo­
pneumothorax hydatique ou il est 
clair qu’un traitement antibiotique 
adapte et un drainage s’imposent.
Traitement chirurgical
La voie d'abord
Elle a toujours ete une thoracoto­
mie laterale dans le lit de la 6e cote 
et, le plus souvent, sans resection de 
la cote.
Les constatations peroperatoires
Dans plus de 70% des cas, le pou 
mon adherait a la plevre et sa libera­
tion s’est revelee hemorragique dans 
30%. Deux fois, le poumon etait 
completement d6truit (un gauche et 
un droit). Dans deux tiers des cas. 
la localisation etait bi- ou pluriseg- 
mentaire, ou detruisait tout un lobe: 
soit que le kyste occupe tout le lobe, 
soit qu’il entraine des troubles venti- 
latoires irreversibles dans le reste des 
segments avec infection.
Nature du kyste
Quarante-trois fois (16%) le conte- 
nu du kyste etait clair eau de roche. 
Quatre fois le kyste etait vomique et 
il ne persistait qu’une cavite residuelle
FIG. 5—Tomographie montrant une 
“image de retention seche de membrane” 
chez une femme de 44 ans.
suppuree. Pour le reste le contenu 
etait subinfecte ou franchement sup- 
pure.
Nature de nos interventions 
(tableau V)
Deux techniques ont ete choisies.
Interventions conservatrices.— La
perikystectomie partielle, plus ou 
moins etendue, associee a un capiton- 
nage a ete choisie deliberement pour 
les kystes uni- ou plurisegmentaires, 
quelle que soit la nature de leur con­
tenu. Le perikyste en regard du pa­
renchyme sain, est laisse en place, 
lorsqu’il est fin. Lorsqu’il est epais et 
infecte, il est excise le plus loin et dans 
certains cas il est reseque entiere- 
ment.
Les exereses.— L'exerese reglee est 
indiquee chaque fois qu’un territoire 
pulmonaire systematise est detruit par 
le kyste ou parait irrecuperable en 
raison de l’extension des phenomenes 
atelectasiques et infectieux du paren­
chyme; le plus souvent il s’agit d’une 
lobectomie.
Les gestes associes.—La decortica­
tion pleuropulmonaire a ete pratiquee 
huit fois chez les malades de pachy- 
pleurite epaisse, sequelle de rupture 
du kyste hydatique du poumon dans 
la plevre.
Resultats du traitement
Les suites operatoires immediates
Elies ont ete emaillees de compli­
cations serieuses chez 38 de nos 
operes parmi lesquels 4 (1.5%) sont 
morts.
Trois sont decedes dans les 24 pre­
mieres heures; un par hemorragie 
postoperatoire precoce, un par inon- 
dation pulmonaire due a une rupture 
peroperatoire d’un gros kyste et un 
par detubation accidentelle au cours 
d’une pneumonectomie droite diffi­
cile.
Un patient de 57 ans opere d’un 
kyste hydatique infecte du poumon
T a b le a u  V — N a tu r e  d e s  in te r v e n t io n s
In te r v e n t io n N o . ( % )
In te r v e n t io n s  c o n s e rv a tr ic e s  
E n u c le a t io n  ( te c h n iq u e  de
204 (7 6 )
U g o n ) 7
P e r ik y s te c to m ie  p a r t ie l le 176
P e r ik y s te c to m ie  to ta le 21
E xe re s es 64 (2 4 )
L o b e c to m ie 53
P n e u m o n e c to m ie 2
S e g m e n te c to m ie  re g le e  
G estes  a sso c ies
9
D e c o rt ic a t io n  p u lm o n a ire 8 (3 )
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et qui a developpe un pyothorax avec 
fistule bronchique intarissable est de- 
cede au 16e jour dans un contexte 
septicemique grave.
Les complications postoperatoires
II est a signaler que les kystes non 
compliques ont evolue de fagon tres 
simple. Par contre, des kystes ont 
presente des complications de type: 
pyothorax avec fistule bronchique:
: 9 (3.4%) dont 2 dans la serie des 
kystes hydatiques du poumon ouverts 
dans la plevre et 1 d’origine tubercu 
leuse reconnue en postoperatoire; he- 
morragie postoperatoire ayant neces- 
[ site des reprises, 5 cas (1.9%); pleu- 
resie purulente, 3 cas (1.1%) et ate- 
lectasies, 12 (4.5%).
Les autres ont presente des suites 
simples.
Commentaires
Quelques points sont a discuter.
•  La proportion de 40% des kys- 
j tes paraissant sains sur la radiogra-
phie est a discuter. En realite, la 
transition entre les stades sain et com- 
plique est insensible. On peut consi- 
derer comme kyste complique, tout 
kyste fissure ou fistulise dans les 
branches meme si radiologiquement il 
parait intact et cliniquement, non in- 
fecte.7
•  En cas de kystes bilateraux, la 
conduite la plus sage est d’operer en 
deux temps.8
•  En cas dissociation a des kys­
tes hepatiques, la double intervention 
separee s’impose. Le mieux est de 
proceder en deux temps, en commen 
gant par le temps pulmonaire, sauf 
si le kyste du foie reclame un traite- 
ment prioritaire.9
•  Les kystes volumineux peuvent 
beneficier de la perikystectomie eten- 
due et on est souvent surpris par la 
facilite de reexpansion du parenchyme 
restant.
Conclusion
Nous constatons et a regret que 
les kystes hydatiques pulmonaires 
compliques ont occupe une place im- 
portante dans notre statistique.
La tendance actuelle est d’etre eco- 
nome de tissu pulmonaire en ma- 
tiere de chirurgie de kyste hydatique.
| Ceci souligne l’importance en region 
endemique d’un depistage radiologi- 
que systematique chez tous les ci- 
toyens afin de poser un diagnostic 
precoce et offrir des interventions 
simples, denuees de complications 
postoperatoires.
Neanmoins, en ce qui concerne la 
Tunisie, ces mesures a visee curative 
ne sauraient faire releguer les regies 
d’une prophylaxie suffisamment pro- 
longee afin d’enrayer definitivement 
ce fleau.
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This atlas comprises a very large and 
high-quality collection of colour photo­
graphs in a well-designed format. The 
left-hand page contains a short clinical 
note pointing out the significant aspects, 
together with a short comment on treat­
ment, of the condition shown in the 
photograph on the facing right-hand 
page. The material was supplied by gen­
eral surgeons and subspecialists and 
represents a broad coverage of clinical 
surgery. The author was responsible for 
the selection and organization of the 
material.
Simply organized by regions and by 
subspecialties, the book starts with the 
head and finishes with the skin and 
miscellaneous items. It is very read­
able and interesting — some of the 
photographs are true rarities. Instruc­
tion is very low key while eye appeal is 
emphasized. The illustrations have been 
selected to show a good cross-section 
of surgical practice but, wisely, no at­
tempt is made to provide complete cov­
erage. Each section details some of the 
rare and some of the common condi­
tions: the poor results of certain treat­
ments together with complications of 
standard methods of treatment: and 
congenital deformities, trauma, tumours 
and infections and how they are treated. 
Quite a large selection of emergency 
problems are presented. By far the 
largest section is on the abdomen fol­
lowed by the thorax, leg and arm. The 
sections on the head, the neck, skin, 
and infections are short. There are no 
references within the sections but there 
is a list of 16 at the end of the book. 
There is a good index.
I find this atlas difficult to evaluate. 
It is readable and pleasing to the eye. 
The quality throughout is tops — photo­
graphy, printing, paper and translation 
— but it would not. in my opinion, aid 
in surgical diagnosis and it is not a 
reference book. It is more like a photo­
graphic museum of morbid conditions, 
with the specimens in living colour, very 
easily applied to the problems seen in 
practice. This is really the charm and 
value of the whole presentation. How­
ever. colour atlases of surgical conditions 
are rare and this is a very good one. It 
would be useful to have in a library 
as a source of good illustration for lec­
tures, teaching rounds and for students 
as visual aids.
T.P. L e a d m a n . m d , c m . f r c s [c ]
Chief of surgery.
Grace General Hospital.
Ottawa. Ont.
TUTORIALS IN SURGERY 1. F.G. 
Smiddv. 331 pp. Pitman Medical Pub­
lishing Co. Ltd., Tunbridge Wells, 
Kent; University Park Press, Balti­
more, 1977. $14.95, paperbound. ISBN 
0-272-79417-1.
TUTORIALS IN SURGERY 2. F.G. 
Smiddy. 294 pp. Illust. Pitman Medical 
Publishing Co. Ltd., Tunbridge Wells, 
Kent; University Park Press; Balti­
more, 1979. $24.50, paperbound.
ISBN 0-272-79545-3.
These two volumes have been written 
especially for candidates who are pre­
paring for the fellowship examination in 
surgery. The first volume includes sur­
gical principles, endocrine surgery, sur­
gical oncology, orthopedics, soft tissue 
injury, gastrointestinal surgery, urology 
and vascular diseases. The individual 
presentations under these headings are 
designed to cover specifically those 
topics important for examinations. The 
material is well presented in terms of 
classification and the “must knows’’ 
and is written in a clear, concise fashion. 
The print and spacing make for easy 
reading.
The book obviously has not been 
written to replace a text and does not
CLASSIFIED ADVERTISING
As a further service to its readers
the Canadian Journal of Surgery is 
pleased to accept suitable classified 
advertisements. The deadline is 1 
month before the issue date. Copy 
should be mailed to: Canadian 
Journal of Surgery. PO Box 8650, 
Ottawa, Ont. K1G 0G8. Rates are 
available on request.
GENERAL SURGEON: BC — General surgeon 
required for northern, BC community of 20 000 
with 100-bed hospital. Applicant must have Can­
adian Fellowship in General Surgery and will 
need experience in traumatic orthopedics, and 
gynecologic emergencies. Reply to: Dr. D.W. 
Strangway, #301 - 4622 Greig Ave., Terrace, BC 
V8G 1Y3. —S82-008
ROYAL COLLEGE FELLOWSHIP SURGEON —
wanted to join a busy, challenging long estab­
lished family practice. Vanderhoof is situated in 
the centre of British Columbia, Canada, a fast 
growing logging and farming community located 
in prime recreational area where all outdoor 
activities are available; skiing, hiking, fishing, 
hunting, etc. We have a 65-bed hospital with a 
well equipped operating room. The clin ic is 
within three minutes walk of the hospital. Please 
contact: Dr. G.C. Joly, Dr. C.H. Stephen or Mrs. 
J. Philips at RR#2, Vanderhoof, BC V0J 3A0. 
Tel. (604) 567-2201. —S82-009
SURGEON: BC — Well established multi­
specialty and family practice clinic in Vernon. 
BC w ill require a general surgeon January 1984 
to replace a retiring partner. For further informa­
tion. interested applicants please contact: Dr. 
J.A. Barr, 3009 - 31st Ave., Vernon, BC V1T 2G7.
S82-015
follow any classic order as one would 
expect in a major textbook. It contains 
no bibliography, although there is occa­
sional reference to an author within the 
text material but without journal refer­
ence. The book suffers from the com­
plete absence of figures or tables which 
would enhance the learning process for 
most candidates. There was an attempt 
to correct this deficiency in the second 
volume by inclusion of an occasional 
figure.
The second volume should be looked 
upon as complementary to the first. It 
is written in the same clear and concise 
fashion. It adds further topics under 
some of the chapter headings previously 
described, namely general principles, 
general surgery, urology and arterial and 
venous surgery.
These two manuals may act as an 
aide-memoire for a student who has 
already reviewed a major textbook in 
surgery. It will also prove of value, in 
terms of the presentation of material, to 
teachers of surgery.
H a r v e y  H .  S ig m a n , m d , f r c s [c ]
Department of surgery,
Sir Mortimer B. Davis-Jewish
General Hospital,
Montreal, PQ
KIDNEY FOUNDATION 
RESEARCH FELLOWSHIPS 
ALBERTA, CANADA 
1983-84
Applicants invited for Postdoctoral 
Medical Fellowships in Nephrology 
or Urology to run concurrently from 
July 1, 1983 at the University of 
Alberta, Edmonton and the Univer­
sity of Calgary (Faculty of Medicine).
Interdisciplinary training in basic re­
search and/or clinical investigation 
available. Programs provide oppor­
tunity for full enrollment in School 
of Graduate Studies.
Salary concordant with qualifications 
and prior training to maximum S35000 
per annum.
Fellowship is for one year but second 
year application anticipated.
For application forms contact:
KIDNEY FOUNDATION 
OF CANADA 
Alberta Branch 
103, 5920- 1A St. SW 
Calgary Alta., Canada 
T2H 0G3
APPLICATIONS POSTMARKED AFTER 
OCTOBER 31. 1982 WILL NOT BE 
ACCEPTED.
— S82-016
VOLUME 25, NO. 4, JULY 1982 / THE CANADIAN JOURNAL OF SURGERY 467
Claforan
I  (cefotaxime sodium)
ANTIBIOTIC
ACTION
In  v itro  studies indicate tha t the bacterial action o f CLAFORAN (cefotaxime sodium ), a 
sem isynthetic cephalosporin antib iotic, results from  inh ib ition  o f cell wall synthesis.
INDICATIONS AND CLINICAL USES
CLAFORAN (cefotaxime sodium ) m ay be indicated fo r the trea tm ent of in fections 
caused by susceptible s tra ins of the designated m icro-organism s in the diseases listed 
below:
Lower respiratory tract infections: pneum onia and lung abscess caused by 
Streptococcus pneum oniae  (fo rm erly Diplococcus pneumoniae), other Streptococci 
(excluding[Enterococci, e .g ,,S. faecalis), Staphylococcus aureus  (penicillinase and 
non-penicillinase producing), Escherichia co/i. Hem ophilus influenzae, (including 
am picillin-resistant strains), and unspecified Klebsiella  species.
Urinary tract infections: caused by Escherichia coli, unspecified Klebsiella species 
(including K. pneumoniae), Proteus m irabilis, indole-positive Proteus, Serratia 
marcescens and Staphylococcus epiderm idis. A lso, uncomplicated gonorrhea caused 
by N. gonorrhoeae  including penicillin-resistant strains.
Bacteremia/Septicemia: caused by Escherichia coli, unspecified Klebsiella stra ins and 
Serratia marcescens.
Skin infections: caused by  Staphylococcus aureus (penicillinase and non-penicillinase 
producing), S. epiderm idis, Group A  Streptococci, Escherichia coli, Proteus m irab ilis  
and indole-positive Proteus.
Intra-abdominal infections: caused by Escherichia coli, and unspecified Klebsiella  
species.
Gynecological infections: including pelvic in flam m atory disease, endom etritis  and 
pelv ic ce llu litis  caused by£ . coli, G roup A  Streptococci and Staphylococcus 
epiderm idis, anaerobic bacteria including unspecifiedPeptococcus and 
Peptostreptococcus  strains and some strains o f Bacteroides frag His. In several cases, 
a lthough clin ica l cures w e re  achieved, bacteriological fo llow -up  was not available. 
C linical experience w ith  CLAFORAN in anaerobic in fections is lim ited. CLAFORAN has 
been used w ith  some success in wound and in tra-abdom inal infections against some 
strains o f unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been show n to be active against som e strains o f Pseudomonas.
In the trea tm ent o f infections encountered in im m unosuppressed and granulocytopenic 
patients, results o f therapy w ith  cefotaxim e have not been impressive.
CLAFORAN should not be considered in the trea tm ent o f enterococcal in fections, i.e. 
Strep, faecalis.
Specimens fo r bacterio logic culture should be obtained p rio r to  therapy in o rder to  
isolate and iden tify  the causative organism s and to  determ ine the ir susceptib ilities to 
CLAFORAN. Therapy m ay be instituted before results o f susceptib ility studies are 
know n; antib io tic  treatm ent should be re-evaluated once these results become 
available.
CONTRAINDICATIONS
CLAFORAN is contraindicated in patients who have shown hypersensitivity to  
cefotaxim e sodium , the cephalosporin, o r the pen ic illin  groups o f antibiotics.
WARNINGS
Before therapy w ith  CLAFORAN is instituted, it m ust be determ ined whether the  patient 
has had previous hypersensitivity reactions to  cefotaxim e, cephalosporins, pen ic illins 
o r other drugs. CLAFORAN should be given w ith  caution to patients with Type 1 
hypersensitiv ity reactions to  penicillin. Antib io tics, including CLAFORAN shou ld be 
adm inistered w ith  caution to  patients who have dem onstrated som e form  o f allergy, 
particu larly to  drugs. If an allergic reaction to  CLAFORAN occurs, the drug shou ld  be 
d iscontinued and the patient treated w ith  the usual agents (e.g. epinephrine, 
antih istam ine, pressor am ines or corticosteroids).
PRECAUTIONS
Pregnancy: The safety o f CLAFORAN (cefotaxime sodium ) in pregnancy has not been 
established. Consequently, use of the drug in pregnant wom en requires that the  likely 
benefit from  the drug be we ighed against the possible risk to  the m other and fetus. 
Nursing Mothers: CLAFORAN is excreted in hum an m ilk in low  concentrations. Caution 
should be exercised when the drug is adm inistered to nursing mothers.
Pediacric Use: The safety and effectiveness o f CLAFORAN in in fants and children have 
not yet been established. I t  has, however, been used in  children at a dosage range o f 
700-150 m g /k g /d a y  in 2-4 d iv ided  doses.
Kidney: A lthough CLAFORAN rarely produces alterations in kidney function, evaluation 
o f renal status is recommended, especially in severely ill patients receiving h igh doses. 
Patients w ith  m arkedly im pa ired renal function should be placed on the special dosage 
schedule recommended under DOSAGE AND ADMINISTRATION, because norm al 
doses in these individuals are likely to  produce excessive serum concentration o f the 
metabolites.
Prolonged use o f CLAFORAN m ay result in the overgrow th of nonsusceptible 
organism s. Constant observation o f the patient's cond ition is essential. If superinfection 
occurs, therapy should be d iscontinued and appropriate measures taken.
Positive direct Coomb's test is known to develop in individuals during  treatm ent w ith  
the cephalosporin group o f antib iotics, including cefotaxim e sodium.
In laboratory tests a false positive reaction to glucose m ay occur w ith  reducing 
substances but no t with the  use of specific glucose oxydase methods.
ADVERSE REACTIONS
The m ost frequent adverse reactions encountered are:
Local (5%) -  in jection site in flam m ation w ith  in travenous adm inistration. Pain, 
induration and tenderness a fter in tram uscular injection.
Hypersensitivity (1.8%) -  Rash, pruritus, fever.
Gastrointestinal (1.7%) -  C o litis  (not pseudom embranous), diarrhea, nausea, and 
vom iting . A  few  cases o f pseudom em branous co litis  have been reported.
Hemic and Lymphatic System -  M ild reversible leukopenia, granulocytopenia and 
throm bocytopen ia  have been reported. Some patients developed positive d irect 
Coom b's test du ring  trea tm ent w ith  CLAFORAN (cefotaxime sodium).
Genitourinary System -  M oniliasis, vaginitis.
Central Nervous System (0.2%) -  Headache.
Liver -  Transient elevations in SGOT, SGPT, serum  LDH, and serum alkaline 
phosphatase levels have been reported.
Kidney -  Increased serum creatinine and BUN have occasionally been observed.
SYMPTOMS AND TREATMENT OF OVERDOSAGE
Since no case o f overdosage has been reported to date w ith  CLAFORAN, no specific 
in form ation  on sym ptoms o r trea tm ent is available. Treatment o f overdosage should be 
sym ptomatic.
DOSAGE AND ADMINISTRATION
CLAFORAN (cefotaxime sodium ) may be adm inistered in travenously or 
in tram uscularly after reconstitution (see table w ith  recommended mode of 
reconstitution according to  route of adm in istration). Dosage and route of adm in istration 
should be determ ined by susceptib ility  o f the causative organisms, severity o f the 
in fection and condition o f the patient.
USUAL ADULT DOSAGE OF CLAFORAN (CEFOTAXIME SODIUM)
T y p e  o f  In fe ctio n
D o ily  D o so  
(g ra m s ) F ra q n e n c y  a n d  Roata
Uncomplicated Gonorrhea 1 1 gram IM (single dose)
Uncomplicated infections 
such as pneumococcal 
pneumonia or acute urinary 
tract infection
2 1 gram every 12 hours 
IM or IV
Moderately severe 
infections
3-4 1 gram every 6-8 hours 
IMor IV
Severe infections 4-6 1 gram every 4-6 hours 
IMor IV
Infections commonly 
needing antibiotics in 
higher dosage 
(e.g., septicemia)
6-8 2 grams every 6-8 hours IV
Life-threatening infections up to 12 2 grams every 4 hours IV
THE MAXIM UM  DAILY DOSAGE SHOULD NOT EXCEED 12 GRAMS.
A dm inistra tion o f CLAFORAN should be continued fo ra  m in im um  of 48 to  72 hours 
after the patient defervesces o r after evidence o f bacterial eradication has been 
obtained; a m in im um  of 10 days o f trea tm ent is recom mended fo r infections caused by 
Group A beta-hem olytic Streptococci in order to  guard against the risk of rheumatic 
fever o r glom erulonephritis; frequent bacterio logic and clinical appraisal is necessary 
during  therapy of chronic urinary tract in fections and m ay be required fo r several 
m onths after therapy has been com ple ted; persistent in fections m ay require prolonged 
treatm ent. Doses less than those recom m ended shou ld  no t be employed.
DOSAGE FOR PATIENTS WITH IMPAIRED RENAL FUNCTION
In patients w ith  estimated creatin ine clearance o f less than 20 m l/m in /1 .73 m 2 the dose 
o f CLAFORAN must be halved (see PRECAUTIONS). If serum creatinine values alone are 
available, the fo llow ing form ula (based on sex, w e igh t and age of the patient) m ay be 
used to  convert these values in to  creatin ine clearance.
Males: Weight (kg) x (140 -  age)
72 x serum creatinine
Females: 0.85 x above value
RECONSTITUTION
The fo llow ing  table is provided as a guide fo r reconstituting CLAFORAN (cefotaxime 
sodium ) fo r both intram uscular and in travenous adm inistration.
A M O U N T  O F A P P R O X IM A T E A P P R O X IM A T E
D I L U E N T  T O W IT H D R A W A B L E A V E R A G E
B E  A D D E D V O L U M E C O N C E N T R A T IO N
S T R E N G T H (m l)* (m l) (m g / m l)
I n t r a m u s c u l a r
500 mg vial 2 2.2 230
1 g vial 3 3.4 300
2 g vial 5 6.0 330
I n t r a v e n o u s
500 mg vial 10 10.2 50
1 g vial 10 10.4 95
2 g vial 10 11.0 180
•Shake to dissolve.
Parenteral drug products should be inspected visua lly  fo r particulate matter and 
d iscoloration p rio r to  adm inistration. So lutions o f CLAFORAN range from  light ye llow  
to  amber, depending on concentration and diluent used. The dry powder as we ll as 
solutions tend to darken, depending on storage conditions.
For intramuscular use: CLAFORAN should be reconstituted on ly  w ith  Sterile Water for 
Injection in accordance w ith  the volum es recom mended in the preceding table.
For intravenous bolus use: 500 mg, 1 gram  and 2 gram  via ls should be reconstituted 
w ith  at least 10 m l o f any o f the so lu tions recom mended under COMPATIBILITY/ 
STABILITY.
For intravenous infusion use: 1 o r 2 gram s o f CLAFORAN m ay be reconstituted
w ith  50 o r 100 m l o f any o f the so lu tions recom mended under COMPATIBILITY/STABILITY.
ADMINISTRATION
Intramuscular: CLAFORAN (cefotaxime sodium ) should be injected well w ith in  the body 
o f a relative ly large muscle such as the upper outer quadrant o f the buttock (i.e., gluteus 
m axim us); aspiration is necessary to  avoid inadvertent in jection in to a blood vessel. 
Intravenous: The intravenous route is preferable fo r patients w ith  bacteremia, bacterial 
septicemia, or other severe or life -threatening infections, or fo r patients who m ay be 
poor risks because o f lowered resistance resulting from  such deb ilita ting conditions as 
m alnutrition , trauma, surgery, diabetes, heart fa ilure, o r malignancy, particularly if 
shock is present or impending.
For bolus adm inistration a solution conta in ing 1 gram  or 2 gram s o f CLAFORAN can be 
in jected over a period of three to five  m inutes. Using an in fusion system, it may also be 
given over a longer period o f tim e  through the tubing system by which the patient may 
be receiving other in travenous solutions. Butterfly® or scalp vein type needles are 
preferred fo r th is type of infusion. However, during in fusion o f the solution containing 
CLAFORAN, it is advisable to  discontinue tem pora rily  the adm inistration of other 
so lutions at the same site.
COMPATIBILITY AND STABILITY
CLAFORAN (cefotaxime sodium ) m ay be reconstituted w ith  any o f the fo llow ing and 
should be used freshly prepared:
Sterile Water for Injection 
Sodium  Chloride Injection B.P.
5% Dextrose Injection B.P.
Dextrose and Sodium Chloride Injection 
Compound Sodium  Lactate Injection B.P.
If a solution m ust be stored, on ly the so lution prepared w ith  Sterile Water fo r Injection 
m ay be kept under refrigeration (below  5°C) fo r not longer than 24 hours. Any unused 
solutions should be discarded.
CLAFORAN is com patible w ith  1 % lignocaine. O nly fresh ly prepared solutions should 
be used. CLAFORAN solutions exh ib it m axim um  stability  in the pH 5-7 range.
A  solution o f 1 gram of CLAFORAN in 14 m l o f Sterile Water fo r Injection is isotonic. 
So lutions o f CLAFORAN must not be adm ixed w ith  am inoglycoside solutions. If 
CLAFORAN and aminoglycosides are to be adm inistered to the same patient, they must 
be adm inistered separately and not as a m ixed injection.
DOSAGE FORMS
CLAFORAN (cefotaxime sodium ) is supplied as a sterile, w h ite  to  pale ye llow  powder, in 
via ls containing 500 mg, 1.0 gram  and 2.0 gram s o f cefotaxim e sodium  (expressed as 
acid on a dry basis).
CLAFORAN in the dry state should be stored at room  tem perature (below 30°C), 
protected from  ligh t and heat. So lutions o f CLAFORAN range from  light ye llow  to 
amber, depending on concentration and the d iluent used. The solutions tend to darken 
depending on storage conditions and should be protected from  elevated temperatures 
and excessive light.
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